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X-ray crystallography has been widely used for determination of protein 
structures for many years. Protein structures are essential in advancing our 
understanding of their function, thus providing useful information in many areas, 
such as drug discovery. Seven different proteins have been studied by X-ray 
crystallography and other methods, and the information has been gained with the 
intention of applying it to real-life challenges in the biomedical sphere. 
The outbreaks of human epidemic nonbacterial gastroenteritis are mainly caused 
by noroviruses. Viral replication requires a 3C-like cysteine protease (3CLpro) 
which processes a 200 kDa viral polyprotein into six functional proteins. The 
3CLpro has attracted much interest due to its potential to act as a target for antiviral 
drugs. The ligand-free crystal structure of the Southampton norovirus 3CLpro 
(SV3CP) had been determined to 1.3 Å and a system for growing high-quality 
crystals has been established. This allowed for crystal-based fragment screening 
to be performed with non-covalent fragments, which identified several hits that 
will guide drug discovery for SV3CP. Screening with covalent fragments is on-
going. 
Three mutants of Bacillus megaterium porphobilinogen deaminase affecting a 
key catalytic residue have been analysed. Comparison with the wild-type enzyme 
shows significant domain movements and suggests that the enzyme adopts 
‘open’ and ‘closed’ conformations in response to substrate binding. 
Potato cathepsin D inhibitor (PDI) is a glycoprotein composed of 188 amino acids 
which inhibits both the aspartic protease cathepsin D and the serine protease 
ii 
 
trypsin. The first crystal structure of PDI has been determined to a resolution of 
2.1 Å, revealing that PDI adopts a typical β-trefoil fold with several protruding 
inhibitory loops, as is typical of the Kunitz-family protease inhibitors. 
The family B DNA polymerase from Pyrobaculum calidifontis (Pc-polymerase) is 
distinct from other homologues (e.g. those from T. gorgonarius, T. Kodakarensis 
and P. furiosus) with a low amino acid sequence identity of 37%. The crystal 
structure of Pc-polymerase has been refined to a resolution of 2.8 Å and several 
unique features have been identified which may account for its high processivity 
and thermostability. A complex model with the primer-template duplex of DNA 
suggests that large movements of the thumb domain occur upon DNA binding. 
The type III pullulan hydrolase from Thermococcus kodakarensis (TK-PUL) 
possesses both pullulanase and α-amylase activities and has many potential 
applications in the industrial food processing sector. The crystal structure of TK-
PUL represents the first type III pullulan hydrolase to be analysed, revealing N-
terminal and C-terminal domains with differences from homologous structures. 
The crystal structure of the L-asparaginase from Thermococcus kodakarensis 
(TkA) has been determined at 2.2 Å, revealing a number of distinctive structural 
features. The enzyme has many applications in food processing and 
chemotherapy. 
Finally, on-going studies of juvenile hormone diol kinase (JHDK) are described 






Structural biology has a major impact on studies of living systems at every level 
of organisation by offering a profound understanding of biological function in 
terms of molecular and supra-molecular structure. Of the various methods 
currently available for studying complex structures and assemblies, X-ray 
diffraction and cryo-electron microscopy (cryo-EM) stand out as the predominant 
techniques for providing information at molecular- and, in some cases, atomic-
resolution on individual proteins and other biological macromolecules. In 
particular, the combination of X-ray diffraction, cryo-EM and solution scattering 
has probably had the most significant impact on studies of key biological 
assemblies that are central to the processes of life such as DNA replication and 
protein synthesis as well as cell division and signalling. 
The astounding successes of structural biology in recent decades have impacted 
greatly on the physical, engineering and computational sciences, and 
methodological developments in structural biology are highly synergistic with 
technical advances in these fields. However, arguably the greatest societal 
impact of structural biology is in the pharmaceutical sector, where it provides an 
unsurpassed level of detail on macromolecules that are pivotal to the processes 
of health and the treatment of disease. Structural biology is the only experimental 
technique which permits the rational design of therapeutic agents and there are 
many examples of its highly successful use; the structure-based discovery of 
drugs for hypertension, AIDS and influenza are just a few examples of how it 
impacts on the health and quality of life for hundreds of millions of people with 
otherwise untreatable, terminal diseases. 
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Our work on in-crystallo compound screening against the noroviral 3CL protease 
will have an important bearing on engineering novel compounds as therapeutic 
agents through the elaboration of the inhibitors we have discovered. In addition, 
our work on porphobilinogen deaminase bears heavily on the study of its catalytic 
mechanism and how it relies on rigid body movements of the protein domains. 
DNA polymerase is recognised as playing a highly important role in the 
extraordinarily complex and co-ordinated enzymatic processes of DNA 
replication and error-correction. Studies of pullulan hydrolase and asparaginase 
from various hyperthermophilic species has yielded key information on the 
thermostability and catalytic mechanisms of these enzymes. Our characterisation 
of these proteins by a number of complementary methods, which are at the 
forefront of methodological developments in the field, is likely to impact heavily 
on many other research areas and has provided an interesting, informative and 
influential training. 
The current global market for antibacterial drugs is estimated to be around £40 
billion and is projected to rise substantially over the next few years. The high and 
ever-rising incidence of drug resistance in bacteria and viruses means that there 
is an overriding concern that the pharmaceutical sector has not been able to 
discover new antibiotic and antiviral therapies fast enough. The success of our 
preliminary structure-based drug screening studies of the 3CL protease attests 
that our work forms a very sound platform for discovery of novel antiviral 
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1. Chapter 1 










1.1 Overview of Protein X-ray Crystallography 
The development of protein X-ray crystallography can be traced back to England 
in the 1930s when Professor Dorthy Crowfoot Hodgkin and Professor John 
Desmond Bernal first reported on the diffraction pattern of a protein crystal, 
pepsin (Bernal and Crowfoot, 1934). Later in the 1950s Sir John Cowdery 
Kendrew and Max Ferdinand Perutz determined the very first protein structure of 
sperm whale myoglobin which allowed them to share the 1962 Nobel Prize in 
Chemistry (Kendrew et al., 1958). 
Protein X-ray crystallography is an experimental technique used to generate a 
3-dimensional model of a protein molecule. It is essentially a very high resolution 
form of microscopy which enables visualisation of protein structures at or near 
atomic level in order to understand their function. Since the distance between 
individual atoms within a protein molecule is only around 1.5 Å (0.15 nm), it is not 
possible to see them under visible light (with wavelengths λ = 400-700 nm), 
because in order to ‘see’ something in detail, the wavelength of ‘light’ used must 
match the object being viewed. X-rays have a wavelength ranging from 0.01 to 
10 nm which can be used to ‘view’ protein molecules in detail. When X-rays hit a 
target protein crystal, the diffracted beams cannot be focused by lenses so the 
diffraction patterns are recorded by detectors such as a charge-coupled device 
(CCD) or a pixel detector. These diffraction patterns are then analysed and used 
to build models of the protein molecules using computer programs. 
There are some reasons why we use protein crystals rather than single molecules 
during a diffraction experiment. Firstly, the diffraction from a single molecule 
would be incredibly weak and extremely difficult to measure. Secondly, X-rays 
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are a form of electromagnetic radiation which has harmful effects on samples 
known as radiation damage, so single molecules are usually destroyed fairly 
quickly. The extremely high X-ray doses required by diffraction experiments, 
damage protein crystals significantly so data collection is always performed at 
100K with carefully-chosen strategies in order to reduce radiation damage. Since 
protein crystals contain trillions (or even more) ordered molecules in 
3-dimensions, they are used for data collection so as to magnify the signal to a 
measurable level and to reduce the effects caused by radiation damage. 
Figure 1.1 illustrates an overview of protein structure determination by X-ray 










Figure 1.1 An overview of protein structure determination using X-ray crystallography. An 
initial screening for crystallisation conditions is taken with highly purified protein, which is 
often followed by optimisation steps in order to get protein crystals with good diffraction 
quality. The crystals are exposed to an X-ray beam and the diffraction patterns are recorded 
using a detector. The intensity (I) and position (hkl) of each diffraction spot are measured 
which provide information of the unit-cell dimensions and space group. An initial electron 
density map is calculated by combining the structure factor amplitudes (|F| = I1/2) and the 
estimated phases, which are either borrowed from a homologous structure (molecular 
replacement) or determined by experimental phasing. A model is generated by interpreting 
the electron density map. Several rounds of model building and refinement are carried out to 




1.2 Protein crystallisation 
1.2.1 The phase diagram 
Obtaining well-diffracting crystals plays a key role in protein crystallography and 
is still the rate limiting step (Doerr, 2006; Geerlof et al., 2006). Crystal growth is 
usually achieved by taking the protein solution through two rather distinct but 
inseparable steps: nucleation and growth. This is often performed by gradually 
reducing the solubility of the protein to reach a point where crystal nuclei can form 
and grow. However, nucleation is the most difficult problem to address because 
the molecules pass from a disordered state to an ordered one. 
Figure 1.2 is the phase diagram for crystal growth which illustrates the phase 
transition behaviour of a protein solute affected by the protein and precipitant 
concentrations. Creation of a supersaturated state is required during 
crystallisation since the equilibrium is broken in this state and can be 
re-established by the formation and development of a solid state such as crystals 
(McPherson and Gavira, 2014). Different crystallisation systems take different 
routes through the phase diagram, for examples, vapour diffusion method takes 
route A whilst batch method takes route B, as indicated by the arrows in the figure. 
In vapour diffusion experiments, the solution is concentrated as water diffuses 
from the droplets into the well solution until the system enters the nucleation zone 
from the metastable zone. Then the concentration of protein in solution begins to 
decrease as a result of nucleation, which brings the system back to the 
metastable zone where nuclei grow to form crystals. In batch experiments, the 
system starts directly in the nucleation zone and shifts to the metastable zone, 
as the protein concentration decreases, where crystal growth from the nuclei 




Figure 1.2 The phase diagram. A plot showing the effect of protein (y axis) and precipitant 
(x axis) concentrations on crystal growth. The diagram is divided mainly into two large regions: 
the undersaturation zone in which no precipitation can occur and the supersaturation zone 
which can be further divided into the metastable, nucleation and precipitation zones. Nuclei 
can be formed in the nucleation zone. Such nucleation does not happen in the metastable 
zone, but sizeable and ordered crystals can form in the presence of nuclei. In contrast, protein 
molecules usually aggregate and precipitate spontaneously in the precipitation zone. The 
optimal strategy in any crystallisation experiment is to bring the system just into the nucleation 
zone to form some but not too many nuclei. As crystals grow, the protein concentration 
reduces and the system is then moved back to the metastable zone where crystals can grow 
larger and nuclei formation is diminished. (Figure generated based on http://www-
structmed.cimr.cam.ac.uk/Course/Crystals/Theory/phases.html). 
1.2.2 Experiment techniques 
One of the most frequently used methods to crystallise a protein is the hanging-
drop method that is based on vapour diffusion (Figure 1.3a). In this method, a 
small volume of highly purified and concentrated protein (e.g. 10-20 mg/ml) is 
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mixed on a siliconised coverslip with the same volume of the relevant well solution, 
which often contains precipitant, salt and buffer solution. The coverslip is then 
sealed upside down tightly on top of the relevant greased well containing the 
reservoir solution. Since the well solution concentration in the droplet is half of 
that in the reservoir, the system will equilibrate slowly during the evaporation of 
water from the droplet and condensation into the reservoir via the vapour phase. 
Crystallisation will occur around the nuclei which are formed during the 
concentration of the precipitant in the droplet. Another vapour diffusion method is 
the sitting-drop method (Figure 1.3b) that allows larger volumes of protein to be 
used and may produce larger crystals. In this method, the droplet sits (always in 
a well) on top of a plastic bridge above the well solution (Rhodes, 2010, Ch. 3). 
 
Figure 1.3 Vapour diffusion methods. a) The hanging-drop method. b) The sitting-drop 
method. [Figure generated based on (Ghosh et al., 2015)]. 
Other crystallisation methods, such as the batch method and dialysis, are used 
less commonly. In the batch method, the protein is mixed with the precipitant so 
that their concentrations are just below those required to cause turbidity. The 
solution is then sealed in tubes or under a layer of oil on a supporter (the 
microbatch method) and left to crystallise. Crystallisation by dialysis involves 
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separating the protein and precipitant solutions with a semi-permeable 
membrane in between. The precipitant permeates slowly into the protein solution 
through the membrane which may lead to crystallisation. 
1.2.3 Factors affecting protein crystallisation 
Purity of a protein is the most important prerequisite for crystallisability but this 
should not be overemphasised. In general, a sample that contains at least 95% 
of the protein molecule of interest is considered pure enough for crystallisation 
(Sherwood and Cooper, 2011, Ch. 10). This also means that the protein should 
be homogenous because different forms of oligomer can affect the formation of 
the crystal lattice. A suitable protein concentration is also important because it is 
difficult for the system to enter the metastable zone with a low protein 
concentration. Conversely a protein may precipitate at very high concentration or 
form showers of tiny crystals. It is usually preferable to use fresh protein since it 
may degrade with time and the mixture becomes heterogeneous. The presence 
of a co-factor or a ligand often stabilises the protein and helps crystallisation. 
Several other factors in the crystallisation solution, such as pH, salt and 
precipitant, have an influence on the protein solubility. The solubility of a protein 
is the lowest at its isoelectric point and most proteins tend to crystallise over a 
very narrow pH range. Salt concentration affects the solubility of a protein through 
the phenomena known as ‘salting in’ and ‘salting out’. A lower level of salt ions 
balances the electrostatic charges of a protein and increases its solubility whilst 
at a higher level, they start to compete for water molecules with the protein which 
reduces its solubility. Ammonium sulphate is commonly used as a precipitant in 
protein crystallisation. Other precipitants are usually polymers or organic solvents 
9 
 
which dehydrate protein solutions in similar ways. Polyethylene glycols (PEGs) 
in a variety of molecular weights are found to be the most effective both in terms 
of precipitation ability and cost effectiveness (McPherson, 1976). PEGs compete 
for water molecules and exert volume exclusion effects which induce separation 
of protein molecules from solution (Atha and Ingham, 1981). Unlike protein 
molecules, PEGs have no consistent conformation and occupy large space in 
solution. In addition, they can reduce the dielectric constant of solutions and 
increase the strength of electrostatic forces as a result. These effects force the 
protein molecules out of the solution (McPherson and Gavira, 2014). 
Temperature is another important factor that influences nucleation and crystal 
growth as well as the solubility of protein. Low temperature limits bacterial growth 
and decreases protein degradation. Crystals with better diffraction quality may be 
obtained at lower temperature which slows down crystal growth and can give 
more ordered crystals (Park et al., 2010). 
Since it is currently still impossible to predict the crystallisation conditions for a 
protein, initial screens for conditions can be performed using a wide range of 
sparse matrix crystallisation screening kits (also known as incomplete factorial 
screening) (Jancarik and Kim, 1991) that are available commercially. They were 
designed based on conditions that are known to work for other proteins and are 
generally still being developed. Application of these kits with automatic robots 
allow for screening of thousands of conditions with drop sizes on the nano-litre 
scales. Once crystals, or even tiny crystals, of the protein of interest are obtained, 
further optimisation is performed by gradually varying each of the factors or even 
omitting some of them carefully which, hopefully, gives well diffracted 
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crystals (Figure 1.4). This process is usually time-consuming and more difficult 
than one might expect (McPherson and Gavira, 2014). 
 
Figure 1.4 A factorial crystal screen. Crystallisation conditions obtained from commercial 
sparse matrix screening kits can always be optimised by using a factorial crystal screen in 
order to produce crystals with better diffraction quality. A factorial screen involves testing all 
or some of the factors systematically by gradually increasing and/or decreasing and/or 
omitting them entirely (Sherwood and Cooper, 2011, Ch. 10). 
1.3 Data collection 
Once well-ordered crystals of a suitable size have been obtained, they are usually 
mounted in loops and kept at 100K using a nitrogen gas stream during data 
collection. Other strategies may be used as well, for example, data collection at 
15K gave more useful information, such as some of the hydrogen positions, 
compared with those performed at 100K or room temperature (Blakeley et al., 
2008; Vandavasi et al., 2016). Also, there has been a growing interest in in situ 
data collection (collecting data directly from the crystallisation devices) at room 
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temperature which usually gives remarkably low mosaicity (Axford et al., 2012; 
Michalska et al., 2015). Generally, a crystal is exposed to an X-ray beam and 
while rotating it gradually during data collection, the resulting reflections are 
recorded by a detector as diffraction patterns (Figure 1.5). Depending on the 
symmetry, at least a minimum proportion of the axis rotation need to be collected 
in order to get a full data set. For example, at least 90-95% of the total number of 
unique reflections need to be obtained to any given resolution. 
 
Figure 1.5 A typical diffraction pattern of protein X-ray crystallography. A diffraction pattern 
of juvenile hormone diol kinase (JHDK) collected at Diamond Light Source station I03 using 
0.15° oscillation. Each of the spots (reflections) is the record of an X-ray beam diffracted by 




1.3.1 Bragg’s law 
Bragg diffraction occurs when X-ray beams pass through a crystal during data 
collection. X-ray waves are scattered from lattice planes with an inter-planar 
distance dhkl by a scattering angle θ (Figure 1.6). When the difference between 
the path lengths (2dhklsinθ) of two scattered waves equals to n times of the 
wavelength (λ), where n is an integer, they interfere constructively and remain in 
phase. This is known as Bragg’s law: 
                             =2 sinhklnλ d θ                         (1.1) 
Only those very strong reflections, known as Bragg peaks, are recorded on 
diffraction patterns during data collection, at the positions where the scattering 
angles satisfy Bragg’s law. 
 
Figure 1.6 An explanation of Bragg’s law. Two incident waves with identical wavelengths 
and phases are scattered by two lattice planes within a set. Wave 2 travels an extra distance 
which is AB + BC = 2dhkl sin θ. Constructive interference will occur if the distance is equal to 




1.3.2 X-ray sources 
X-rays are a form of electromagnetic radiation which is emitted either when fast-
moving charged particles accelerate or decelerate violently, or when an electron 
in an orbital of higher energy in an atom falls into a vacant orbital which was 
occupied by another electron. 
There are three X-ray devices commonly used to generate X-rays for protein 
crystallography: rotating anode generators and X-ray tubes which are used as 
laboratory sources, and synchrotrons. X-rays from a rotating anode generator are 
generated by colliding electrons into a metal rotating anode in an electric field 
under vacuum. The electrons are generated by heating a filament, usually 
tungsten, to reach a high temperature so that thermionic emission takes place. 
The rotation of the anode at high speed effectively dissipates heat and permits 
higher currents to be used. X-ray tubes have a similar way of producing X-rays 
but the target anode is fixed. Figure 1.7 illustrates a typical spectrum of X-rays 
produced by a rotating anode. It is composed of a continuous background 
spectrum of white radiation and a few peaks due to electronic transitions in the 
anode material. Copper is the most commonly used anode material which has 
characteristic peaks as follow (Sherwood and Cooper, 2011, Ch. 11): 
Kα1 = 1.54051 Å 
Kα2 = 1.54433 Å 
Kᾱ = 1.54184 Å 
Kβ = 1.39217 Å 
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The Kα1 and Kα2 components of the X-ray radiation are the most useful parts and 
are directed to the crystals as Kᾱ since they are not always resolved. The others 
are eliminated or minimised by using devices such as filters or monochromators. 
 
Figure 1.7 The X-ray spectrum derived from an X-ray tube. It shows a continuous spectrum 
with three peaks labelled as Kα1, Kα2 and Kβ. The Kβ peak is generated as a result of an M-
K electron transition while the Kα peaks, which are not always resolved, are produced when 
electrons from the L shell displace those in the K shell (Drenth, 2007, Ch. 2) [Figure 
generated based on (Döbelin, 2013)]. 
Synchrotrons are the most powerful X-ray sources that are usually established 
as national or international facilities. At a synchrotron facility (Figure 1.8), an 
electron beam, generated by a linear accelerator, is fed into a booster ring to gain 
energy. The beam is then directed into a big storage ring with a lattice of bending 
magnets at each corner and ‘insertion devices’, called wigglers, as well as 
undulators in the straight sections. Radiation is produced when the charged 
particles change direction at the corners and oscillate in the insertion devices. 
The wavelength of the undulator radiation is ‘tunable’ by adjusting the gaps 
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between the magnets. X-rays generated by the modern 3rd generation 
synchrotron sources are very intense which allows the collection of high 
resolution data with short exposure times, however, radiation damage to crystals 
has to be considered carefully. 
 
Figure 1.8 The general layout of a synchrotron radiation facility (Synchrotron Soleil). 
Electrons (light blue) are accelerated to very high speeds by the accelerator and the booster 
ring before being fed into the storage ring. Electrons are then accelerated in electric fields 
(green squares) and radiation, especially X-rays, is emitted when the electrons are bent by 
the bending magnets and deflected by the insertion devices. Radiation is directed into 
different beamlines for experiments. (Figure from https://en.wikipedia.org/wiki/SOLEIL). 
1.3.3 Electronic detectors 
Charge-coupled devices (CCDs) were used at synchrotron beamlines and are 
still used in many laboratory X-ray generators. These detectors consist of a large 
phosphor screen which absorbs the photons generated by the X-rays. The 
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photons are transmitted to the photon-sensitive CCD chip by a fibre-optic taper 
and the incident photons are then converted to electrical charge (in proportion to 
the number of photons in that specific location) that is stored in capacitors. The 
charge in each capacitor is finally shifted and dumped into an amplifier which 
gives a voltage that is digitised and stored. 
Nowadays the third generation synchrotron facilities use pixel detectors that 
convert the energy of X-rays into electrical charges. However, unlike CCD 
detectors, they record incident X-rays directly without a phosphor-fibre-optic 
coupling and there is no need to shift each charge because each pixel behaves 
as a separate detector. The readout time is just a few milliseconds which allows 
‘real time’ diffraction data recording. Pixel detectors have the advantages of low 
background and broad dynamic range (~ 106). 
1.3.4 The rotation method 
Protein X-ray data collection is usually carried out by slowly rotating the crystal 
through small angles about a fixed horizontal axis (the ϕ axis) perpendicular to 
the beam (shown in Figure 1.9). This is referred to as the rotation method. In 
order to minimise the influence of variations of the motor speed and the intensity 
of the incident beam during data collection with long exposures, each diffraction 
image can be recorded by repeating the rotation a few times, thus it is also known 
as the oscillation method (Arndt et al., 1973; Wilson and Yeates, 1979). However, 
with modern pixel detectors which have very fast readout, the data are recorded 
in real time as the crystal is rotated. Data collection by rotating the crystal about 
only one axis causes the ‘blind region’ because the spots near the rotation axis 
in reciprocal lattice will never cross the Ewald sphere. This is usually not a 
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problem for crystals with moderate to high symmetry because there will be 
symmetry-related spots that are recorded elsewhere. However, these spots in the 
‘blind region’ can be recorded properly by introducing other rotation axes such as 
the Κ axis or by collecting data from another randomly placed crystal. 
 
Figure 1.9 The rotation method scheme. Data collection is usually performed by slow rotation 
of the crystal about the fixed ϕ axis that is usually perpendicular to the X-ray beam. The 
distance between the crystal and the detector can be optimised in order to get well separated 
spots filling the active area of the detector. 
1.3.5 Radiation damage 
When a beam passes through a protein crystal, the absorption of photons causes 
radiation damage to the crystal because of the photoelectric effect or Compton 
scattering. The photoelectrons generated cause ionization events which 
subsequently cause the formation of radical species in the crystal. Also, the 
energy deposited by the beam raises the temperature in the crystal. The effects 
of radiation damage include loss of spot intensity, expansion of unit-cell volume, 
worsening of internal consistency of measurements (Rmerge), increase of atomic 
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B-factor values in refined structures, etc. Structural changes, as a result of these 
effects, may cause non-isomorphism leading to problems in structure 
determinations (such as by MAD or MIR). Also when radiation damage is severe, 
in order to get complete data, multiple datasets must be collected and merged 
which introduces errors from crystal to crystal variation. 
Radiation damage is reduced significantly by lowering the temperature to 100 K 
during data collection since many of the radical species diffuse much more slowly 
or not at all, and the effect of the local heating is reduced as well. ‘Smart’ data 
collection strategies may be adopted in which a complete data set is collected 
before significant radiation damage happens. 
1.4 Data processing 
The aim of data processing is to properly index each recorded reflection, integrate 
the intensity and calculate the structure factor amplitude for the following structure 
determination. 
1.4.1 Unit-cell parameters, crystal orientation, Bravais lattice, space group, 
real and reciprocal space parameters 
The first step of data processing involves the determination of unit-cell 
dimensions and crystal orientation. The unit-cell dimensions are described by the 
lengths of three unit-cell edges (a, b, c) and three crystallographic angles (α, β, 
γ). The unit-cell dimensions give useful information in the determination of which 
of the 7 crystal systems (triclinic, monoclinic, orthorhombic, tetragonal, trigonal, 
hexagonal and cubic) the crystal falls into. Combining these 7 crystal systems 
with 5 lattice types (P - primitive, C – base centred, I – body centred, F – face 
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centred and R - rhombohedral) gives 14 Bravais lattices, as shown in Figure 1.10. 
There are also three possible symmetry operations that can be applied to the 
asymmetric unit within protein crystals known as rotation, translation and screw 
(a combination of both rotation and translation). Combining these symmetry 
operations with the 14 Bravais lattices results in 65 allowed space groups in 
protein crystallography. This is far less than the 230 space groups because 
proteins nearly always contain only L-amino acids thus some of the symmetry 
operations (such as mirrors) are not possible in protein crystals. 
 
Figure 1.10 The 14 Bravais lattices in 3D space [Figure generated based on wikipedia and 
Hahn (2002). https://en.wikipedia.org/wiki/Bravais_lattice#CITEREFHahn2002]. 
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Autoindexing allows the determation of unit-cell dimensions and crystal 
orientation from diffraction images of a randomly placed crystal (Kabsch, 1988) 
and has been used by many data integration programs such as iMosflm (Battye 
et al., 2011; Powell et al., 2013), XDS (Kabsch, 2010) and DIALS (Waterman et 
al., 2013). For any 2-dimensional diffraction image, the calculation of the 
coordinates (x, y, z) of each spot in the reciprocal space can be carried out 
automatically by using this method from its coordinates (Xd, Yd) on the detector 
and the crystal-to-detector distance D (Leslie, 2006). The coordinates of each 
spot, together with a ϕ angle (initially assigned as being the midpoint of the ϕ 
range), usually give enough informaiton to determine the unit-cell dimensions and 
its orientation. For a successful autoindexing step, the predicted spot positions 
must agree with the observed spots, by visual inspection and by checking the 
RMSD values between the observed and calculated spot coordinates. 
After indexing, the unit-cell parameters and orientation matrix are refined together 
with other parameters such as the beam position, mosaicity and detector position. 
This is usually called post-refinement because it requires that one round of 
integration has already been performed. 
During the integration step, the intensity of each spot is calculated by summing 
the pixels of the peak and subtracting the pixel counts of the background. The 
background counts cannot be measured directly from the pixels around each 
diffraction peak within a mask. Whilst for any weak reflections, more accurate 
methods, such as ‘profile fitting’ (Balzar, 1992; Enzo et al., 1988), can be 
performed. A ‘profile’ is the average spot shape of reflections nearby in the same 
part of the detector and is included during intensity calculation. The standard 
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deviation of each intensity (σI) is calculated which is then used as weights in the 
subsequent data processing, structure determination and refinement steps. 
At this stage, the most probable Laue group symmetry can be determined by 
using programs like Pointless (Evans, 2006). It scores all possible Laue groups 
that are consistent with the crystal class by matching potential symmetry 
equivalent reflections based on two scoring mechanisms: a ‘likelihood estimate’ 
and a ‘combined Z-score’. Relevant systematic absences are tested for all 
accepted Laue groups which gives a combined score for possible point groups. 
When X-rays or other short wavelength radiation is applied to any real crystal 
lattice, the resulting diffraction spots can be considered as forming a reciprocal 
lattice. The reciprocal space lattice contains imaginary points whose positions 
correspond to the normal of the real space planes, and the length of these vectors 
is equal to the reciprocal of the real interplanar distance. Reciprocal space is the 
Fourier transform real space, so it is also known as Fourier space. A diffraction 
pattern of a crystal is generated by the diffraction of the atomic components at 
the crystal lattice points. 
1.4.2 Data reduction – scaling and merging 
There are many physical factors affecting the diffraction intensities measured by 
integration of the recorded reflections thus the intensities are not all on the same 
scale. For example, the intensity of a spot measured at the start of an experiment 
could be very different from the measurement of the same spot made later due 
to crystal shape and radiation damage. Therefore it is very important to correct 
for these factors before the averaging of the intensities of the symmetry-related 
reflections is carried out. This process is referred to as scaling which, by fitting a 
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scaling model (e.g. a scale factor and a temperature factor for each diffraction 
image) puts all observations on a common scale (Evans, 2006). The quality of 
scaling, in other words the data quality, is assessed by the inspection of a few 
parameters based on the internal consistency and comparison of the corrected I 
and σI (Evans, 2006). 
When the data have been scaled, the multiple observations for each reflection 
are then merged into an average intensity. Those observations with large 
deviations from the mean are rejected during the merging step because they 
always contain significant errors due to spurious spots resulting from ice and salt 
diffraction, or from sudden fluctuations in the beam intensity. Programs such as 
Scala (Evans, 2006), Aimless (Evans and Murshudov, 2013a) and XSCALE 
(Kabsch, 2010) can be used to perform scaling and merging tasks. 
The Rmerge (also known as Rsym, equation 1.2) indicates how well the different 
observations agree. An overall Rmerge values of < 5%, 5-10%, 10-20% and > 20% 
indicate very good, usable, marginal and questionable data quality (McRee, 
1999). However, Rmerge is not always reliable because it inherently depends on 
multiplicity, so better indicators such as the Rmeas was introduced. The Rmeas (also 
referred to as Rr.i.m., equation 1.3) is the redundancy-independent version of the 
Rmerge (Diederichs and Karplus, 1997). Another data quality indicator is the CC1/2 
(referred to as half-dataset correlation coefficient, equation 1.4), which measures 
the Pearson correlation coefficient of the averaged intensities between two 
randomly split half subsets of each unique reflection in an unmerged dataset 
(Karplus and Diederichs, 2012). This is a very good indicator and is commonly 
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Where Ihkl,j is the intensity for the j th reflection, <Ihkl> is the averaged intensity, Nhkl is the 
number of reflections, Ix,j is the intensity for the j th reflection in the random dataset x, <Ix> is 
the averaged intensity for the random half subset x, and so forth. 
1.4.3 Calculation of structure factor amplitudes from intensities 
Since calculation of the electron density function requires structure factors, Fhkl, 
it is necessary to obtain the Fhkl for each reflection. The structure factor Fhkl is 
composed of the structure factor amplitude |Fhkl| and its phase. However, the 
phase cannot be determined directly yet, which forms the well-known ‘phase 
problem’ in macromolecular X-ray crystallography. The ‘phase problem’ can be 
solved by other methods which will be mentioned in the next section. The 
structure factor amplitude is calculated from the corresponding intensity 
according to equation 1.5 shown below (in real practice, one needs to consider 
the geometry and polarization factor as well as the absorption correction factor): 




1.4.4 Space group determination 
The possible Bravais lattice types are examined in the indexing step and the Laue 
group is usually indicated by using programs like Pointless. By detecting the 
translational symmetry operators, which are indicated in the diffraction pattern as 
systematic absences, we can determine the possible space group which defines 
the symmetry in space. However, since these indicators are not always reliable, 
we should bear in mind that the space group is only a hypothesis until the 
structure has been solved (Evans, 2011). 
1.4.5 Data quality assessment 
Besides those data quality indicators, such as the Rmerge and CC1/2 mentioned in 
the previous sections, there are still a few things that should be checked before 
any structure determination is carried out. The completeness tells us the 
percentage of unique reflections that have been measured to a given resolution, 
and should ideally be above 90-95%. The I/σI value indicates the signal-to-noise 
ratio and an acceptable value was considered to be 2 or higher in the outer 
resolution shell, but much lower values are acceptable nowadays since 
refinement programs are able to handle weak data better than before. Sometimes 
the crystal order is anisotropic which means there is a directional dependence in 
diffraction quality. This may lead to high R-factors during refinement and give 
blurred electron density maps which make model building difficult or impossible. 
The presence of translational non-crystallographic symmetry (NCS) and/or 





1.5 Solving the phase problem 
1.5.1 The structure factor, electron density and Fourier transforms 
In X-ray crystallography, the structure factor Fhkl is a mathematical description of 
how the crystal diffracts the incident radiation producing a reflection on the 
detector. The structure factor encapsulates the amplitude and phase of the X-
rays scattered by the electrons distributed within the crystal, or specifically within 
the unit cell because the crystal is composed of a great number of unit cells all 
scattering in phase. 
The result from a protein X-ray crystallography experiment is an electron density 
map into which a structural model of the protein can be fitted. Both the structure 
factor and the electron density are related by Fourier transforms. The Fourier 
transform of the structure factor is the electron density and the Fourier transform 
of the electron density gives the structure factor. This is one of the important 
properties of the Fourier transform, known as the Fourier inversion theorem. So 
by taking an inverse Fourier transform of the structure factor equation (1.6), the 
electron density equation is obtained as shown in equation 1.7. 
2 ( )( , , )     
hx ky l
hkl
zρ x y z e dxdF ydzV πi                (1.6) 
     2 ( )
1
( , , ) i hx ky lzhkl
h k l
x y z F e
V
               (1.7) 
where V is the unit cell volume. 
Because the structure factor Fhkl is a complex number, equation 1.7 can be 
rewritten as equation 1.8. 
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1.5.2 The phase problem 
From equation 1.8, we know that in order to calculate the electron density we 
need to know both the structure factor amplitude |Fhkl| and the phase ϕhkl for all 
the structure factors. As mentioned before, the |Fhkl| can be determined from the 
Ihkl according to equation 1.5, while the ϕhkl cannot be determined directly which 
constitutes the ‘phase problem’. This is shown in the Argand diagram below in 
Figure 1.11. 
 
Figure 1.11 The phase problem. The structure factor can be illustrated by an Argand diagram 
in which the complex number Fhkl is represented by its length |Fhkl| with the angle ϕhkl. The 
amplitude |Fhkl| is directly observed but if the phase angle ϕhkl is not known, Fhkl can be any 
straight line from the origin O to the circle of radius |Fhkl|. 
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1.5.3 The Patterson function and Patterson map 
The Patterson function is the Fourier transform of the relative intensities and does 
not require phase information, as shown below: 
2 2 ( )1( , , ) | |     i hu kv lwhkl
h k l
P u v w F e
V
             (1.9) 
A Patterson map (Figure 1.12) is a vector map derived from the relative Patterson 
function and represents all interatomic vectors between pairs of atoms. It contains 
not only intramolecular vectors within a molecule but also intermolecular vectors 
due to the presence of crystallographic and non-crystallographic symmetry. For 
a cell containing N atoms, there will be N(N-1) peaks in the Patterson map at 
points other than the origin and a huge peak at the origin corresponding to the 
vectors between each atom and itself. So as the number of atoms in the cell 
increases, it becomes difficult to interpret the Patterson map. However, in protein 
X-ray crystallography, it can be used in locating certain heavy atoms within the 
unit cell which is a useful technique in experimental phasing methods. In addition, 
the Patterson map of the known structure may be used to interpret the Patterson 
map of the unsolved homologous structure, which is used in some of the 




Figure 1.12 The 2D Patterson map for 4 atoms. a) The positions of the 4 atoms. b) The 
corresponding Patterson map showing the peaks representing all interatomic vectors relative 
to the origin. These four atoms in the unit cells give rise to 12 [N(N-1)] Patterson peaks at 
points other than the origin. 
1.5.4 Molecular replacement 
The molecular replacement (MR) method uses the phases calculated from a 
known structure as initial phase estimates for the unsolved structure (target 
structure) which is similar (homologous) to the known structure. The target and 
the search molecules must have a reasonable ‘similarity’ (e.g. a reasonable 
amino acid sequence identity or RMSD value) to have a good chance of success. 
The known structure is used as the ‘search model’ to determine the orientation 
and position of the target molecule in the unit cell. This is performed in two steps, 
known as the rotation function and the translation function, by molecular 
replacement. With a successful solution, a preliminary model of the target 
molecule is obtained with a correct orientation and position in the unit cell. The 
phases are then calculated based on this model and used with the structure factor 
29 
 
amplitudes from the experiment to produce an electron density map. The search 
model can be rebuilt to fit into the electron density map followed by converting 
the amino acid sequence to that of the target molecule. 
The basic calculations of molecular replacement (simply illustrated in Figure 1.13 
in two-dimensional space) involve the determination of a rotation matrix [C] and 
a translation vector d. If the coordinates of the search model and the target 
structure are represented by the matrices x and x’, the transformation between 
them can be described by equation 1.10: 
' [ ] x C x d                          (1.10) 
 
Figure 1.13 The basic concept of molecular replacement. It is carried out by superimposing 
the search model x on the target molecule x’ in the unit cell. The transformation process can 
be describe by equation x’ = [C]x + d where [C] is the rotation matrix that defines the ‘new’ 
orientation and d is the translation vector which defines the ‘new’ position of the search model. 
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Due to more and more structures (search models) being available in the Protein 
Data Bank (PDB), the number of PDB X-ray depositions solved by molecular 
replacement has increased dramatically in the recent years. In total, around 60% 
of X-ray structures were solved by this method between 1970 and Feb 2013 
whereas over 70% were solved by this method from 2010 to Feb 2013, as shown 
in Figure 1.14 (Scapin, 2013). 
 
Figure 1.14 PDB deposition statistics. a) Number of X-ray structure depositions solved by 
molecular replacement in the PDB between 1970 and Feb 2013. b) The number of deposited 
structures solved by molecular replacement as a percentage of the total number of PDB 
X-ray depositions to Feb 2013. [Figure generated based on (Scapin, 2013), reproduced with 
permission of the International Union of Crystallography (http://journals.iucr.org)]. 
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1.5.4.1 The Patterson method 
1.5.4.1.1 The rotation function 
The rotation function (equation 1.11) exploits the fact that the intramolecular 
vectors depend only on the orientation of the molecule, not on its position in the 
unit cell. This function, which is required to determine the orientation of the search 
model, involves calculating its Patterson function and comparing it with that of the 
target molecule calculated from the experimental data. The Patterson function of 
the search model is then repeatedly rotated by small angles and compared with 
that of the target molecule within a limited radius in three dimensions. The 
unknown translation can be ignored by restricting the radius at this stage. The 
agreement of the two Pattersons is assessed by the rotation function. 
( ) ( )u   T SR P P u du                     (1.11) 
In the equation, PT (u) is the target molecule Patterson function given by the matrix u, ( )Ps u  
is the search model Patterson function which has been rotated by the matrix [C]. 
The rotation function can be calculated either in real space or in reciprocal space. 
The computational process can be speeded up by selecting the strongest grid 
points of the search model Patterson function and calculating the agreement with 
the target Patterson function using the equivalent grid points (Huber, 1965). The 
fast rotation function (Crowther, 1972), which is computationally efficient, 
calculates the rotation function from spherical harmonics and Bessel functions by 





1.5.4.1.2 The translation function 
Unlike the rotation operation, the intermolecular vectors are sensitive to 
translation operations while the intramolecular vectors are not affected. The 
translation operation is based on the crystallographic symmetry-related operators. 
The Patterson based translation function is defined as: 
( ) ( , ) ( )  c oT t P u t P u du                     (1.12) 
where Pc (u,t) is the Patterson function of the search model and Po (u) is the target structure 
Patterson function. 
The translation search involves moving a correctly oriented search model on a 
grid and inspecting the agreement between the calculated target Patterson 
function and the Patterson function of the search model at each step (Fujinaga 
and Read, 1987). The translation operation can be performed in both real and 
reciprocal space and it can be calculated by the FFT (Harada et al., 1981; Tickle 
and Driessen, 1996). 
1.5.4.2 The maximum likelihood method 
The basic theory supporting the maximum likelihood method is quite simple: the 
best model has the best match with the observed data. The consistency with the 
observations is assessed statistically by the probability that the observations 
would have been measured given the model that is being tested. In other words, 
having the model in the correct orientation and position, there should be a high 
probability that the data as measured would have been observed. So the 
likelihood goes higher if changing the model makes the observations more 
probable, which means the model is getting better. The log of the likelihood is 
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commonly used in this method because it is easier to deal with. The likelihood 
function is expressed by: 
log (| |;| |)
hkl
P F F  o c                    (1.13) 
In real cases, what is needed is actually the probability distribution of the 
measurements, given as a function of model parameters and sources of errors. 
Sources of errors are measurement errors and errors in the model. However, 
measurement errors are less significant than those of the model. The effect of the 
errors in the model is estimated by introducing a parameter σA (Srinivasan and 
Ramachandran, 1965), which estimates the agreement between the observed 
and calculated normalised structure factors. 
1.5.4.3 Molecular replacement programs 
The Patterson method is widely used by molecular replacement programs such 
as Molrep (Vagin and Teplyakov, 2010) and AMoRe (Navaza, 1994; Navaza, 
2001). In addition to the standard searches, real space searching is also possible. 
Partial solutions can be used as fixed models to search for more monomers in 
one more runs. For example, if one molecule (A) is found in the ASU which 
actually contains two molecules (A and B) in Phaser MR (McCoy et al., 2007), 
the program can accept the input coordinates of molecule A without modification 
and skip to searh for molecule B. 
Phaser, based on the maximum likelihood method, is an efficient molecular 
replacement program. Both the CCP4 (Winn et al., 2011) and the PHENIX 
(Adams et al., 2010) program suites have Phaser included. It has been proved 
that Phaser is significantly better than traditional methods especially in difficult 
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cases (McCoy et al., 2007; Scapin, 2013). Things such as anisotropy and 
translational NCS corrections can be performed automatically. A very good 
feature of Phaser and Molrep is that it allows possible (or selected) space groups 
to be searched when there is ambiguity about the crystal symmetry. Also, multiple 
ensembles can be used as search models. An overview of Phaser is shown in 
Figure 1.15. 
 
Figure 1.15 An overview for automated molecular replacement in Phaser. (Figure is originally 
from http://www.phaser.cimr.cam.ac.uk/index.php/File:Phaser_MR_auto.gif). 
Molecular replacement pipelines such as MrBUMP (Keegan and Winn, 2008) and 
BALBES (Long et al., 2008) are available as both computer programs and online 
services. They start with a structure factor file and a target sequence and produce 
refined models and phased structure factors sorted by scores. Model selection 




1.5.5 Experimental phasing 
The phase problem may be solved by purely experimental means without 
borrowing the phase from a homologous structure and this is referred to as 
experimental phasing. Chemical modifications of the molecules within the crystal 
are usually required so that the diffraction intensities are altered. In X-ray 
crystallography, anomalous scattering is a change in the phase of a diffracted X-
ray, caused by certain atoms due to strong X-ray absorbance, which is different 
from that caused by the other atoms in the crystal. This can be achieved by the 
introduction of electron-rich ‘heavy’ atoms because atoms such as carbon, 
nitrogen and oxygen do not contribute to anomalous scattering. Atoms such as 
Hg or Pt are good candidates to make heavy metal derivatives for experimental 
phasing. In addition, replacing methionine residues with selenomethionine in a 
recombinantly expressed protein is also a good way. The development of 
technology has made it possible to perform experimental phasing with ‘not so 
heavy’ atoms such as S and Ca2+ (Mueller-Dieckmann et al., 2007), which may 
be naturally present in the protein already. The anomalous signal from these 
‘heavy’ atoms allows for estimation of the phases of diffraction spots by several 
methods known as single isomorphous replacement (SIR), multiple isomorphous 
replacement (MIR), multi-wavelength anomalous dispersion (MAD) or single-
wavelength anomalous dispersion (SAD). The wavelength of the X-ray beam 






1.5.5.1 Characteristics of anomalous scattering 
Anomalous scattering happens when the energy of the incident X-ray equals that 
which is required to promote an electron of an atom to a higher energy orbital. 
This energy is referred to as the absorption edge. The gained energy is then re-
emitted as the excited electron goes back to its original energy level. When 
anomalous scattering happens, the scattered wave (X-ray) has a component that 
is phase-shifted by 90, and each reflection will therefore possess an anomalous 
component. 
1.5.5.2 Friedel’s law 
A Friedel pair is a couple of Bragg reflections: h, k, l and h̄, k̄, l̄. Friedel’s law 
states that the two members of a Friedel pair have the same amplitude but 
opposite phase: |Fhkl| = |Fh̅k̅l̅|, ϕhkl = - ϕh̅k̅l̅ (Figure 1.16a). 
Friedel’s law is broken whenever there is anomalous scattering. Two parameters 
f’ and f’’, known as the anomalous scattering coefficients, are introduced to modify 
the structure factors. These two values are dependent on scattering angle and 
wavelength. As is illustrated in Figure 1.16b, the structure factors are no longer 
the same since f’’ is always 90° ahead in the Argand diagram. The difference 
between the amplitudes of such structure factors is named a Bijvoet difference 
(Blow, 2003) and these measurements are fundamental to experimental phasing 
methods such as SAD or MAD. 
Data are usually collected at three different wavelengths in a MAD experiment: a 
peak wavelength at the absorption edge where f’’ is maximum; an inflection point 
wavelength where f’ is at a minimum; and a remote wavelength where f’’ is at a 
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low value. These wavelengths as well as the f’ and f’’ values should be 
determined by an X-ray fluorescence experiment prior to the MAD data collection. 
In a SAD experiment, data are collected at the peak wavelength only but with a 
high redundancy (Dauter and Adamiak, 2001). 
Experimental phasing can be seen as a divide-and-conquer process which is 
divided into two steps: solving the substructure (e.g. locating heavy atom sites) 




Figure 1.16 Normal and anomalous scattering. a) A Friedel pair composed of F+ and F- from 
a normal scattering. The vectors F+ and F- (red) are of identical amplitudes but opposite 
phase angles, this is due to the contributions of the atomic vectors which have identical 
amplitudes but opposite phases in each pair (green, purple and yellow). b) A description of 
the structure factors in anomalous scattering. F + P  and F
 - 
P  indicate a Friedel pair without any 
anomalous contribution while they are modified (by f’ and f’’) to give F + PH and F
 - 
PH when there 
are anomalous contributions. 
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1.5.5.3 Identification of heavy atom locations based on the difference 
Patterson  function 
If we calculate a Patterson function for a structure containing heavy atoms (H), 
the Patterson peaks will correspond to interatomic vectors between: non-H & non-
H pairs, non-H & H pairs and H & H pairs. Since vectors between any non-H & 
non-H pairs are the same in the native (P) and derivative (PH) crystals, they can 
be cancelled out by calculating a difference Patterson function (equations 1.14 
and 1.15) which only has peaks arising from vectors between non-H & H as well 
as H & H pairs. 
PH PP P P                            (1.14) 
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It is more common to calculate the difference Patterson function from the 
isomorphous differences (Δiso) according to equations 1.16 and 1.17, which gives 
the heavy atom peaks with little contaminating noise. 
| | | |iso PH PF F                         (1.16) 
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The difference Patterson function significantly reduces the peak numbers and 
makes the Patterson map much less complex to interpret. A Patterson function 
calculated with anomalous differences also gives information on the heavy atom 
vectors. The anomalous difference is expressed as equation 1.18 and the 
corresponding anomalous difference Patterson is referred to as equation 1.19. 
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Where F
 ’’ 
H  corresponds to the imaginary component of the heavy atom scattering. 
1.5.5.4 Direct methods for locating heavy atom sites 
Direct methods are commonly used for determining phases of chemical 
molecules or small macromolecules (e.g. < 2000 atoms) diffracting to atomic 
resolution. However, they can also be used for locating heavy atom sites in 
experimental phasing. Based on how the structure factor magnitudes are 
compared, direct methods may be classified as: (i) inequalities, (ii) equalities and 
(iii) probabilities. To be concise, only the third one is going to be described here 
because its use is more general. The basic theory of the third class is that given 
a small set of starting phases, such as might be derived from the origin-fixing set 
or just random phases, a more complete phase set can be constructed by 
applying phase probability relationships. These relations are based on the 
tangent formula shown in equation 1.20, as described by Karle and Hauptman 
(Karle and Hauptman, 1956). An electron density map can be generated with the 
expanded phase set. 
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             (1.20) 
Where |E| is the normalised structure factor amplitude and hkl is represented for brevity as 
h. <…>h’ means that an average is taken over all values of h’. The formula assumes that h is 
the new set of planes whose phase need to be assigned from the ‘known’ set h’. 
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It is difficult to perform this method on a large macromolecule since there are too 
many probabilities to handle, but it can be applied to finding heavy atoms by use 
of Δiso or Δano which give the positions of heavy atoms. 
1.5.5.5 Phase calculation from heavy atoms 
Once the heavy atom sites have been determined, the phases for the protein 
molecule can be determined followed by calculation of the electron density map. 
In the isomorphous replacement method, the phases of the protein molecule are 
obtained by using phasing circles as shown in Figure 1.17. After the heavy atoms 
sites have been determined, the phases and the amplitudes of FH can be 
calculated whilst the amplitudes of FPH and FP are already known. To determine 
the phases of FP and FPH, the FH is drawn firstly from the origin on an Argand 
diagram. Then a circle of radius |FP| is drawn centred at the origin. Another circle 
is drawn of radius |FPH| with its centre at the head of FH. The two circles intersect 
at two points representing possible solutions of the unknown protein phase in the 
SIR method (Figure 1.17a). This ambiguity is solved by the introduction of more 
heavy atom derivatives and this is referred to as the MIR method. In the MIR 
method (Figure 1.17b), all the derivatives are treated in the same way as just 
described for the SIR method. Different derivatives will have different intersection 
points but one of them should be the same for all derivatives within a reasonable 
margin of error. The phase ambiguity is solved by applying this and the phase 




Figure 1.17 Harker construction for SIR and MIR. a) In the SIR method, the red circle is 
drawn centred at the origin with a radius of |FP|. A second circle (green) of radius |FPH| is 
drawn centred at the head of FH. The two circles intersect at two points which gives two 
possible phases for vectors FP and FP’. b) In the MIR method with two derivatives, the same 
circles (red and blue) for the second derivative can be drawn and both circles intersect at 
one point which solves the phase ambiguity. 
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In single isomorphous replacement with anomalous scattering (SIRAS), the 
phase ambiguity can be solved by the introduction of anomalous information. 
Similar to the SIR method, a circle of radius |FP| can be drawn with its centre at 









H. Only one of the FP estimates is consistent in these two diagrams as well 
as in the SIR one, thus breaking the ambiguity. 
 
Figure 1.18 Harker construction for SIRAS. The phase possibilities without anomalous 
effects is represented by the circle centred at the origin with a radius of |FP|. Anomalous 
effects are represented by +F ’’ H  and –F
 ’’ 
H  which give rise to two vectors with circles of radii  
|F + PH| and |F
 - 
PH|. Each of them produces two phase possibilities but only the phase represented 
by vector FP is consistent when considering all the effects. 
In a SAD experiment, two circles (Figure 1.19) can be drawn according to the 
method described in anomalous scattering. They interact at two points, giving two 
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possibilities of the phases of FP. Because FP is unknown in terms of both phase 
and amplitude, this ambiguity cannot be broken at this stage, but instead it may 
be solved by density-modification (mentioned briefly below). 
 
Figure 1.19 Harker construction for SAD. Two circles are drawn according to the method 
described in anomalous scattering, leaving two possible phases for FHP indicated by vectors 
FP and FP’. This ambiguity needs to be solved later by density-modification. 
In a MAD experiment, changes in the heavy atom structure factor are induced by 
different X-ray energy levels (wavelengths), so it is treated as the combination of 
different SAD experiments. However, the data from different wavelengths can be 
treated as ‘derivative’ structure factors or, in other words, as a ‘pesudo-MIR’ with 
one of the data sets being chosen as the ‘native’. 
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The initial map from SIR, MIR, MAD and SAD will contain noise due to errors in 
the phases, such as negative electron density, strong electron density in solvent 
regions and differences between the electron density for NCS related copies. 
Density-modification recognises and reduces the noise and this should improve 
promising phases and potentially turn good phases into very good ones. However, 
this approach cannot turn bad phases into good ones. By applying this method, 
the phase ambiguity which arises in SIR or SAD may be resolved and/or an 
improved electron density map may be obtained. 
The experimental phasing quality is commonly indicated by the mean Figure of 
Merit (FOM, equation 1.21), which will be higher given a better solution. However, 
it can be artificially high if the rms lack-of-closure error is underestimated. Other 
parameters include the phasing power (Ph.P, equation 1.22) and the Cullis 
R-factor (equation 1.23) (Cullis et al., 1961). Ph.P values of 0.5-1.0, >1.5, 
and >2.0 indicate usable, very good and excellent quality. The Cullis R-factor 
should always be significantly less than 90%, values below 70% indicate very 
















                  (1.21) 
Where ϕbest is the centroid phase (Blow and Crick, 1959) which minimises the rms error. 








                    (1.22) 
Where <…> means the rms value. εϕ is the lack-of-closure error for ϕ. 
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1.5.5.6 Phasing with maximum likelihood 
As mentioned in section 1.5.4.2, the likelihood method measures the consistency 
between the model and the observations. This can also be used in SAD. Given 
the calculated heavy atom structure factors F
 +
 H and F
 -
 H, this method describes a 
probability distribution PSAD (which is also a Gaussian distribution) of the model 
structure factor amplitudes |F+| and |F-| and finds the best match (McCoy et al., 
2004). 
(| |,| |; , )SAD H HP P F F F F
                      (1.24) 
There are many highly automated programs and online services that can be used 
to carry out experimental phasing including programs SHELX (Sheldrick, 2008) 
and Autosol (Terwilliger et al., 2009) as well as online services SHELX (Sheldrick, 
2010; Skubák and Pannu, 2013a) and CRANK2 (Skubák and Pannu, 2013a). 
1.6 Model building and refinement 
1.6.1 Obtaining the trial structure model 
With the phased structure factors obtained, an electron density map can be 
generated from equation 1.7: 
     2 ( )
1
( , , ) i hx ky lzhkl
h k l
x y z F e
V
               (1.7) 
It reveals the features of the real structure but is also far away from accurately 
representing these features. This is because the structure factors contain errors 
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raising from different sources, e.g. experimental errors and errors from the 
difference between the search model and the target molecule. A molecular model 
can be fitted into this raw electron density map either manually or automatically 
by the use of various computer programs. In the case of a molecular replacement 
solution, since an initial model with the correct orientation and position has 
already been obtained, rebuilding is usually performed with graphics programs 
such as Coot (Emsley and Cowtan, 2004; Emsley et al., 2010). When 
experimental phasing has been performed, it is better to run auto-building 
programs such as Buccaneer (Cowtan, 2006) or AutoBuild (Terwilliger et al., 
2008b). The model obtained at this stage often does not represent the true 
structure accurately so several rounds of rebuilding and refinement are usually 
needed. 
1.6.2 Refinement 
The purpose of refinement is to improve the phases as well as the interpretation 
of the electron density map. This is achieved statistically by fitting the atomic 
model better with the diffraction data. Fourier transforms allow the refinement to 
move forward and backward between real and reciprocal space because the 
model is in real space while the data is in reciprocal space. 
1.6.2.1 Least-squares refinement 
In general, the least-squares method minimises the sum of the squares of the 
errors between observed and calculated data. In protein crystallographic 
refinement, this is specifically to minimise the sum of the weighted squares of the 
differences between the observed and the calculated structure factor amplitudes. 




2(| | | |)w F F   o c                      (1.25) 
Where ϕ is the sum of squared differences between the observed and the calculated 
structure factor amplitudes and whkl is the weighting factor which is an estimate of the 
precision of the measured intensities. 
A new set of Fc values is calculated after each cycle of refinement and the shifts 
in the atomic parameters are computed until there is no significant shift compared 
with the previous cycle if the function has reached its minimum where the 
refinement converges. The refinable parameters can include the atomic 
coordinates (x, y, z), the occupancy and the temperature factor (B-factor) for each 
atom. Least-squares calculations require the data to parameter ratio to be at least 
2:1, and this ratio can be increased by introducing known rules of stereochemistry 
for amino acids. Constraints are rigid mathematical rules that can fix the values 
derived from the parameters (e.g. bond length) of the model during refinements, 
others (e.g. dihedral angles) are allowed to vary. Restrained refinement allows 
the derived values (e.g. bond lengths and bond angles) to vary within a certain 
range based on additional information. NCS, if present, can also be used as 
constraints or restraints. TLS (translation, libration and screw) refinement 
approximates anisotropy with much fewer parameters. Simulated annealing, 
which is performed by computationally heating and slowly cooling the structure, 





1.6.2.2 Refinement based on maximum likelihood 
The maximum likelihood method optimises the model such that the probability of 
having obtained the experimental dataset is maximised. Errors in the search 
model arise from Gaussian errors in the atomic positions, which give rise to 
Gaussian errors in the amplitudes and phases of the atomic structure factor 
contributions. The total structure factor is obtained by summing up the atomic 
structure factor contributions and their errors and the resulting distribution is a 
two-dimensional Gaussian centred on DFc with a variance of σ
2 
Δ . The probability 
distribution can be expressed as function 1.26. Since the phase of the observed 
structure factor is not known, the probability functions need to be converted to 
‘integrate out’ the phase information (known as a nuisance variable). Removal of 
this nuisance variable gives a Rice distribution (Read, 1990; Sim, 1959) and the 
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Where D is the Luzzati weighting factor which is the fraction of the calculated structure factor 
that is correlated to the true structure factor. I0 is the modified Bessel function of order [for 
details of these parameters see (McCoy et al., 2004)].Constraints and restraints described in 
section 1.5.6.2.1 can also be used in refinement based on this method. 
The quality of refinement is assessed by an ‘Rfactor’ which measures the difference 
between each calculated structure factor amplitude and the observed one. It is 
defined by the following equation: 
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                     (1.28) 
The Rfactor may not be the best indicator of convergence since the model can be 
over-fitted. Therefore another parameter ‘Rfree’ is introduced to avoid the over-
fitting problem. This value is generally calculated in the same way as the Rfactor 
but from 5% of the reflections that have been excluded from the refinement. The 
Rfree value is often slightly higher than the Rfactor value but they should drop in a 
similar way during a refinement. 
Refinement based on maximum likelihood is used most often these days, such 
as with the computer programs Refmac5 (Murshudov et al., 2011) in CCP4 (Winn 
et al., 2011) and Phenix.refine (Afonine et al., 2012). 
1.7 Structure validation and deposition 
It is always important to validate the structure after refinement to avoid any 
improper stereochemistry. Parameters such as bond lengths, bond angles, van 
der Waals contacts and torsion angles need to be monitored carefully. The 
Ramachandran plot (Fig 1.20) allows the visualisation of the main chain torsion 
angles and any unfavourable regions or outliers can be identified immediately. 
Many programs or online services can be used to validate refined structures 
including MolProbity (Chen et al., 2010), PDB_REDO (Joosten et al., 2014) and 
ProCheck (Laskowski et al., 1993). Note that glycine is more flexible while proline 
is more rigid compared with other amino acid residues. Side chains may adopt 
different conformations so they should be checked visually. Loop regions may be 
flexible giving them poor electron density which makes it difficult to interpret the 
map, and in addition they may adopt different conformations. The B-factor is a 
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good indicator since the disordered regions tend to have high B-factors while the 
more ordered buried regions have low values. High B-factors in a buried region 
almost certainly indicates errors. 
 
Figure 1.20 A Ramachandran plot. The red, yellow and light yellow regions represent the 
favoured, allowed, and ‘generously allowed’ regions. Glycine residues are indicated by 
crosses while others are indicated by boxes. (Figure generated by using ‘The Structure 
Analysis and Verification Server’ from University of California, Los Angeles). 
The structures can finally be deposited in the PDB and will be validated again 
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2.1  Introduction 
2.1.1 Norovirus and gastroenteritis 
Gastroenteritis is inflammation of the gastrointestinal tract involving the stomach 
and small intestine and causes diarrhoea and vomiting. It is a common cause of 
morbidity and mortality among people of all ages but particularly in young children. 
For example, it accounts for the death of 2,195 children every day worldwide 
which makes it the second leading cause of death among children under the age 
of 5, more than the combination of AIDS, malaria and measles (Liu et al., 2012). 
Gastroenteritis can be traced back to the 1930s, when Zahorsky first described a 
‘winter vomiting disease’ or ‘hyperemesis hemis’ that is characterised by the 
sudden outbreak of vomiting and diarrhoea which peaks in winter (Zahorsky, 
1929). Almost about 40 years later in 1972, through immune electron microscopic 
(IEM) examination of stools of volunteers treated with a faecal filtrates of students 
affected by gastroenteritis during an outbreak in Norwalk, Ohio in 1968 (Kapikian 
et al., 1972), it was identified that this syndrome was caused by ‘Norwalk virus’. 
It is now known that many things can cause gastroenteritis including parasites, 
bacteria and viruses, however, human caliciviruses have been recognised as the 
leading cause of gastroenteritis worldwide among people of all ages. The 
Caliciviridae family contains five genera know as norovirus, vesivirus, nebovirus, 
sapovirus and lagovirus (Clarke et al., 2012). While among all the members in 
this family, norovirus is the most common cause of disease in human (Lambden 
et al., 1993). 
The clinical symptoms of norovirus infection include vomiting, fever, headache, 
watery diarrhoea, abdominal cramps, chills, myalgia and the presence of mucus 
in stools which often appear after a 12-48 hours incubation period. A sudden 
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onset of vomiting may occur on the first day of the infection which, as was 
suggested by Meeroff et al. (1980), is because of a delay in gastric emptying. The 
most frequent symptom of norovirus infection is diarrhoea and virus shedding in 
faeces begins 18 hours after infection (Atmar et al., 2008). The mechanism of this 
is not fully understood but it may be attributed to dysfunction of the epithelial 
barrier during infection which was observed in ex vivo culture of biopsies from 
infected humans (Troeger et al., 2009). Different genotypes (see section 2.1.3 for 
details) of norovirus may be different in pathogenic strains, e.g., GII.4 which is 
more often associated with vomiting, a longer duration of diarrhoea and a greater 
number of diarrhoea stools compared with others (Desai et al., 2012; Friesema 
et al., 2009; Huhti et al., 2011). 
Several features make noroviruses highly transmissible. 1) The infectious dose 
is low; as few as 10 viral particles are enough to cause infection in some cases 
(Teunis et al., 2008). 2) The viral shedding can last for years which increases the 
risk of secondary spread. 3) The viruses are genetically diverse which limits 
cross-protection and long-term immunity. 4) Also they have high stability against 
nearly all active elements in cleaning products such as chlorine, detergent and 
alcohol, and are resistant to a wide range of temperatures from freezing to 60 °C. 
Generally, faecal-oral transmission is the most important route. Transmission 
happens through stools, infectious vomit, contaminated environmental surfaces 
and aerosolisation in closed settings such as hospitals, cruise ships, hotels and 
day-care centres (Widdowson, 2005). Another important mode is foodborne 
transmission, e.g. seafood near coastal areas may be contaminated by faecal 
discharge (Le Guyader et al., 2012) or food products may be contaminated by 
infected personnel during handling. Foodborne transmission has the potential to 
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transmit viruses worldwide, given the globalisation of the food chain and thus 
increases the chance of viral infection. 
While norovirus infections are self-limiting in healthy adults, they can be much 
more severe in young children, elderly people and those who have impaired 
immunity. Patients with impaired immune function may be chronically infected 
which, in some cases, lasts for longer than a year (Siebenga et al., 2008). Chronic 
infections have been reported in people of all ages who are undergoing 
chemotherapy, infected with HIV and those who have inherited immune 
deficiencies (Green, 2014; Siebenga et al., 2008). In younger children with 
congenital immunodeficiencies, noroviruses are frequently detected and the 
infections usually last for more than 9.5 months (Frange et al., 2012). The most 
frequently reported norovirus infection-associated deaths is pneumonia and other 
causes of death include gastroenteritis, acute gastrointestinal bleeding, 
malnutrition, cardiac complications, necrotizing enterocolitis, sepsis and colon 
perforation (Trivedi et al., 2013). In countries with limited resources, 
gastroenteritis is an important cause of morbidity and mortality. 
Noroviruses account for more than 50% of gastroenteritis and at least 90% of 
nonbacterial acute gastroenteritis worldwide, as reported by the Centers for 
Disease Control and Prevention in the US (2011). Studies have shown that in the 
United States alone, noroviruses cause on average 19-21 million acute 
gastroenteritis cases, 1.7-1.9 million outpatient visits, 400,000 emergency 
department visits, 56,000-71,000 hospitalisations and 570-800 deaths annually. 
Scallan et al. (2011) estimated that 99% of all viral foodborne illness incidents are 
caused by noroviruses which corresponds to 5.5 million per year in the US. Also 
from 2009 to 2013, around 62.5% of norovirus cases needed long-term care 
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facilities in order to control the transmission (Vega et al., 2014). Statistics are 
generally similar in Europe (Baert et al., 2009; Phillips et al., 2010). Globally, 
noroviruses lead to a total of $4.2 billion in direct health system costs and $60.3 
billion in social cost per year (Bartsch et al., 2016). 
Clinical treatments and interventions have been hampered because no licensed 
vaccine or antiviral is available at the moment. Treatment with human 
immunoglobulin did show some benefit, but did not result in clearance of the virus 
(Florescu et al., 2008). Despite the fact that discovery of a vaccine is hindered by 
the lack of small-animal models and cell culture systems, the first norovirus 
vaccine have now passed phase I and II clinical trials. Intramuscular vaccination 
did reduce the incidence and severity of vomiting and diarrhoea, however, the 
incidence of protocol-defined illness was not significantly reduced (Bernstein et 
al., 2015). Treatment with a small antimicrobial compound nitazoxanide resolved 
the acute gastroenteritis in a patient, but asymptomatic shedding was still 
observed (Siddiq et al., 2011). Oral treatment with another compound ribavirin 
gave both successful and unsuccessful cases (Woodward et al., 2015). 
Intervention with natural human interferon-α in gnotobiotic pigs reduced virus 
shedding which was later return to normal level after the termination of the 
intervention (Jung et al., 2012). 
2.1.2 Norovirus classification 
Noroviruses cannot be classified according to their serotypes since they cannot 
be cultured in vitro, except for the murine strains. For this reason, they are 
genetically classified into 7 established genogroups, known as GI to GVII (Figure 
2.1), based on amino acid sequence in the complete VP1 capsid protein. They 
are further segregated into at least 40 genotypes which have 9, 21 or 22, 3, 2, 2, 
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2 and 1 members in genogroups GI, GII, GIII, GIV, GV, GVI and GVII, respectively 
(Vinjé, 2015). Noroviruses from groups GI and GII infect humans except for GII.11, 
GII.18 and GII.19, which infect pigs. Members of GIV.1 subgroup are also 
involved in human diseases, while GIV.2 have been detected in feline and canine. 
GII viruses are the most frequently detected (89%) with GII.4 are the major cause 
of norovirus outbreaks worldwide (Siebenga et al., 2009). 
Many noroviruses have been reported such as Norwalk virus (Jiang et al., 1993), 
Hawaii virus (Lew et al., 1994a), Snow Mountain virus (Lochridge and Hardy, 
2003), Desert Shield virus (Lew et al., 1994b), Southampton virus (Clarke and 
Lambden, 1997) and Lordsdale virus (Lambden et al., 1993). 
 
Figure 2.1 Genogroups and genotypes of noroviruses. The arrow reflects GII.4 viruses which 
constitute the majority of norovirus infections all over the world. GII.15 may be reclassified 
into a separate group but further approval is required. The scale bar indicates the number of 
amino acid substitutions per site. [Figure from (Vinjé, 2015)]. 
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2.1.3 Susceptibility and resistance to norovirus infection 
Since it is not possible to cultivate human noroviruses and there has been no 
animal model until now, most of the immunology and pathogenesis data are from 
human volunteer studies (Johnson et al., 1990; Parrino et al., 1977). Wyatt and 
co-workers (1974) indicated that individuals recovering from norovirus infection 
showed a 6-14 weeks resistance to further infections, suggesting the 
development of at least partial protection against noroviruses. However, other 
conflicting studies showed that, in some cases, people possessing higher levels 
of antibody had a higher susceptibility to norovirus infection compared with those 
with lower levels or no antibody (Parrino et al., 1977), which indicated the 
infection is complicated. Interestingly, in their long term norovirus infection 
resistance experiments, 50% of the volunteers never became infected in the initial 
and further tests, while the others who displayed symptoms initially were re-
infected after re-exposed to noroviruses 27-42 months later. This suggested that 
some individuals possess an innate resistance to norovirus infection but the 
reason was not clear at that time. 
Such individuals appeared in familial clusters (Koopman et al., 1982) and recent 
studies revealed that noroviruses bind to specific human histo-blood group 
antigen (HBGA) receptors in the gut of hosts and the infection is correlated with 
the host genotype (Lindesmith et al., 2003). HBGAs are complex carbohydrates 
expressed on the surface of specific cells. They participate in cell to cell 
interactions, self and non-self recognition, as well as the binding of viral particles 
to host cell surfaces which cause viral internalisation and infection (Hutson et al., 
2004). They are determinants of the ABO blood group and Lewis blood group 
system (Marionneau et al., 2001). H HBGAs, the precursors of HBGAs, are 
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generated by the reactions catalysed by α(1,2)-fucosyltransferase 2 (FUT2) and 
are then converted to A and B HBGAs. The VP1 of different noroviruses bind 
specifically to different HBGAs, resulting in different susceptibilities of humans to 
specific strains of norovirus (Lindesmith et al., 2003; Thorven et al., 2005). Some 
people who do not have A, B and H HBGAs in their body, because of the lack of 
FUT2, are known as non-secretors. In contrast, those who do possess a FUT2 
gene are secretors (Le Pendu et al., 2006). About 20% of Northern Europeans 
are non-secretors (Thorven et al., 2005). The ABO blood group system is 
independent of secretor status because it is FUT1 rather than FUT2 which does 
HBGAs synthesis on the surfaces of erythrocytes (Shirato et al., 2008). However, 
individuals with blood type A or O have shown higher susceptibilities to norovirus 
infection compared with the other two blood types (Hutson et al., 2002; Thorven 
et al., 2005). 
A human challenge study in healthy adults showed that 70% of the secretors 
were infected while only 6% of the non-secretors were infected and displayed 
minimal disease (Frenck et al., 2012), confirming that HBGAs have a major effect 
on the susceptibility of individuals to norovirus infections. The host-specificity may 
explain why some volunteers with high levels of antibody had an increased 
chance of developing illness. Also, the variable host susceptibility observed in 
volunteer studies as well as in norovirus outbreaks may be explained by the 
varying expression of the HBGA receptors and the strain-specific binding. 
2.1.4 Genome structure 
The norovirus genome (Figure 2.2) consists of a single-stranded positive-sense 
RNA of 7.5-7.7 kb in length and contains three open reading frames (ORFs) 
(Lambden et al., 1993), except for the murine norovirus which has a fourth 
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alternative ORF (McFadden et al., 2011). ORF1 encodes a 200 kDa non-
structural polyprotein which is co- and post-translationally cleaved into six or 
seven non-structural proteins by the viral 3C-like protease (NS6). The products 
of the proteolysis are shown in Figure 2.2, from N-terminus to C-terminus: a p48 
protein (NS1-2), an NTPase (NS3), a 3A-like protein (p22, NS4), a viral genome-
linked protein (VPg, NS5), a 3C-like protease (3CLpro, NS6) and an RNA-
dependent RNA polymerase (RdRp, NS7) (Blakeney et al., 2003). ORF2 and 
ORF3 encode the capsid protein VP1 and the minor structural protein VP2, 
respectively. 
 
Figure 2.2 Diagrammatic representation of norovirus genome structure. 
2.1.5 The 3C-like protease 
Noroviruses encode a single protease named 3C-like protease (3CLpro) because 
of its similarity to the picornavirus 3C protease. As mentioned before, norovirus 
3CLpro cleaves the polyprotein and generates several non-structural proteins 
including the 3CLpro itself. The protein is a cysteine protease which shows a 
typical chymotrypsin-like fold containing two domains: a β-barrel domain and a β-
sheet domain separated by a groove where the active site is located (Bazan and 
Fletterick, 1988; Boniotti et al., 1994). The active site is characterised by a 
catalytic dyad (Cys139-His30) (Someya et al., 2002) or triad (Cys139-His30-
Glu54) (Tiew et al., 2011) and shows a strong preference for a –D/E-F/Y-X-L-Q-
G-P- (X can be H, Q or E) sequence corresponding to the subsites S5-S4-S3-S2-
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S1-S1’-S2’ (Tiew et al., 2011). Studies have indicated that norovirus 3CL 
proteases have a preferential order of processing the polyprotein, for example, 
the Southampton virus 3CLpro has a preference for cleavage at LQ-GP and 
LQ-GK, but it can also cleave at ME-GK, FE-AP and LE-GG (Hussey et al., 2011). 
Although several structures of norovirus 3CL proteases have been determined 
(Hussey et al., 2011; Nakamura et al., 2005; Zeitler et al., 2006), the structural 
basis of how these enzymes recognise different sites with different affinities is still 
unknown. The key role of norovirus 3CLpro in the processing of the polyprotein 
and its requirement for viral replication make it an excellent target for antiviral 
drug discovery. 
2.1.6 Viral structure 
The first 3-dimensional structure of norovirus (Norwalk virus) capsid (VP1) was 
determined by cryo-electron microscopy in 1994 (Prasad et al., 1994) and X-ray 
crystallography in 1999 (Figure 2.3a) (PDB ID: 1IHM) (Prasad et al., 1999). The 
capsid is composed of a single structural protein of approximately 58 kDa (Figure 
2.3b). The viruses are 405 Å in diameter and show T=3 icosahedral symmetry. 
The 3-dimensional structure has 32 large surface hollows (90 Å in width and 50 
Å in depth) surrounded by 90 distinctive arch-like capsomeres, each of which is 
formed by a dimer of the capsid protein VP1. VP1 is composed of the shell (S) 
domain and the protrusion (P) domain which is further divided into the P1 and P2 
sub-domains. The S domain is related to the formation of viral structure and is 
highly conserved. The P1 sub-domain is moderately flexible and links the S 
domain and P2 sub-domain together. The P2 sub-domain is highly variable and 
is located on the surface. It has been suggested that this sub-domain contains 
specific antigenic determinants, i.e. receptor- and neutralising antibody-binding 
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sites, and is involved in the up-regulation and stabilisation of VP1 in norovirus 
(Bertolotti-Ciarlet et al., 2003). The high stability of noroviruses to acidic 
conditions, such as in the stomach, may be explained by the lack of a capsid 
envelope. Capsid envelopes are generally degraded in the acidic conditions in 
the stomach so that those rely on a capsid envelope cannot survive in stomach 
(Maillard, 2001). 
 
Figure 2.3 Crystal structure of the Norwalk virus capsid. a) Overall X-ray structure of the 
capsid containing 180 molecules of VP1. b) Structure of the VP1 subunit with the S, P1 and 
P2 domains showing in red, yellow and blue, respectively. 
2.1.7 The VP2 protein 
The function of the VP2 protein is not well-understood. Based on its basic nature 
and internal location in the virion, VP2 is predicted to be involved in RNA binding 
and genome packaging into progeny virions (Vongpunsawad et al., 2013). In 
addition, it is suggested to contribute to virion and the VP1 stabilities (Bertolotti-
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Ciarlet et al., 2003; Sosnovtsev et al., 2005). Also, it negatively regulates the viral 
RdRp (Subba-Reddy et al., 2011). 
2.1.8 Viral proteases as targets for antiviral drug discovery 
Therapeutic agents targeting viral replication had not developed much for a few 
decades since the first one targeting on vaccinia virus was identified almost 70 
years ago (Hamre et al., 1950). With a better understanding of the viral life cycle 
in the early 1990’s, many key enzymes have been identified to play vital roles in 
viral replication including viral proteases. Most viruses which infect humans 
encode at least one viral protease (Jaeger et al., 2012) which is responsible for 
the processing of viral non-structural polyproteins in order to produce functional 
viral proteins. Viral proteases have attracted great interest as therapeutic targets 
and many compounds targeting these proteases have been approved for clinical 
use (Courter et al., 2008; Kim et al., 2012a). 
2.1.8.1 HIV protease inhibitors 
HIV protease belongs to the aspartic protease family and is involved in the 
processing of the Pol polyprotein to yield 3 non-structural proteins and in the 
processing of the Gag polyprotein to yield 4 structural proteins (Kohl et al., 1988). 
Saquinavir was the first approved HIV protease inhibitor in 1995, which is built on 
a peptidomimetic scaffold that has a non-hydrolysable amide bond between 
residues that are at the S1 and S1’ recognition sites of the protease (Martin, 1992). 
Several inhibitors based on the same mechanism have been approved since then 
including ritonavir, indinavir, nelfinavir, amprenavir, lopinavir, atazanavir, 
fosamprenavir and darunavir. Other inhibitors, such as tipranavir, have a 
coumarin scaffold instead (De Clercq, 2013). 
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2.1.8.2 Hepatitis C virus NS3-4A protease inhibitors 
Unlike the noroviral and HIV proteases, processing of the polyprotein in hepatitis 
C viruses (HCVs) relies on several proteases: the signal peptide protease (Hüssy 
et al., 1996), the NS2/3 (Grakoui et al., 1993) protease and the NS3-4A protease 
(Bartenschlager et al., 1994). Many efficient HCV NS3-4A protease inhibitors are 
now on the market including asunaprevir, paritaprevir, simeprevir, vaniprevir and 
grazoprevir. All the approved NS3-4A protease inhibitors are used for the 
treatment of HCV genotype 1 infections, which is the most prevalent genotype 
(Messina et al., 2015). In addition to the approved ones, other NS3-4A protease 
inhibitors, such as danoprevir, faldaprevir, vedroprevir, sovaprevir and narlaprevir 
are under clinical development (De Clercq, 2014, 2015). 
2.1.8.3 Norovirus 3CLpro inhibitors 
There is currently no approved norovirus 3CLpro inhibitors available but several 
products have been reported to have inhibitory activity against Norovirus 3CL 
proteases in vitro such as transition state (TS) mimics (Mandadapu et al., 2013a), 
peptidyl TS inhibitors (Mandadapu et al., 2012) and macrocyclic inhibitors 
(Damalanka et al., 2017). 
These transition state related peptidyl inhibitors were designed based on a 
structure incorporated with a recognition element (a peptidyl fragment) and a 
warhead or transition state mimic (Kankanamalage et al., 2015). Peptidyl 
aldehydes (Figure 2.4 GC373) and α-ketoamides (Figure 2.4 GC375) are TS 
inhibitors which showed great inhibition against not only norovirus 3CLpro, but also 
the 3C or 3C-like proteases in picornaviruses and coronaviruses in cell-based 
assays (Kim et al., 2012b). The aldehydes and α-ketoamides act as warheads 
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which form a reversible adduct with the catalytic residue Cys139 in the active site. 
The crystal structure of norovirus 3CLpro complexed with an aldehyde bisulphite 
adduct (Figure 2.4 GC376) showed that the bisulphite group seemed to be 
removed and the compound was converted to the aldehyde form that is covalently 
linked to Cys139 (Kim et al., 2012b). These compounds are named as latent TS 
inhibitors. TS mimics, such as α-hydroxyphosphonate, are converted to the 
aldehyde form either with or without catalytic action of the enzyme and form a 
tetrahedral adduct with the Cys139 residue (Kankanamalage et al., 2015). 
 
Figure 2.4 Structures of norovirus 3CLpro dipeptidyl inhibitors. The dipeptidyl fragment is 
shown on top. The warhead (R) is replaced by an aldehyde, an α-ketoamide or an aldehyde 
bisulphite adduct sodium salt for inhibitors GC373, GC375 and GC376, respectively. 
Macrocyclic inhibitors against 3C or 3CL proteases from different viruses have 
also been reported (Damalanka et al., 2017; Mandadapu et al., 2013b). The basic 
theory was to design macrocyclic molecules (Figure 2.5) that are able to 
1) maintain the favourable interactions which have been identified from the known 
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protein-inhibitor complex structures of noroviral 3C proteases and 2) have a 
flexible diversity site that can form hydrogen bonds and hydrophobic interactions 
with the S3 and S4 sub-sites. As for the inhibitors mentioned above, each of these 
also possessed an aldehyde or an aldehyde bisulphite adduct (α-ketoamides 
diminished activity) which forms covalent bond with the Cys139 residue. However, 
macrocyclic molecules have their own advantages including higher 
pharmacological activity and selectivity, improved permeability and stability (Bhat 
et al., 2015; Marsault and Peterson, 2011). 
 
Figure 2.5 General structure of norovirus 3CLpro macrocyclic inhibitors. R1 and R2 groups 
are replaced by different chemical and amino acid structures, respectively. The letter m 
indicates different numbers of -CH2- group in the square brackets. X is the warhead that 
stands for an aldehyde or an aldehyde bisulphite adduct. [Figure generated based on 
(Damalanka et al., 2017)]. 
Hussey et al. (2011) reported an X-ray complex structure of the Southampton 
norovirus 3CL protease (SV3CP) with an inhibitor (Figure 2.6) composed of part 
of the preferable substrate (EFQLQ) and a Michael acceptor moiety which is 
linked to the S1 residue Gln. This bond is attacked by the enzyme and a covalently 
bound complex is formed. Interestingly, His30 is pushed away by the inhibitor to 
some distance which disrupts the catalytic triad. 
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Finally, it is possible to develop broad spectrum inhibitors targeting 3C or 3CL 
proteases since the substrate specificity of many of these enzymes is quite similar 
(Kim et al., 2012b). 
 
Figure 2.6 Structure of the Michael acceptor peptidyl inhibitor (MAPI) for SV3CP, designed 
by Hussey et al. The arrow indicates the nucleophilic attack site by the Cys139 residue. 
2.2 Project aim 
1. To express, purify and crystallise SV3CP and determine its ligand-free 
structure for crystal-based fragment screening. To find out the differences 
between the ligand-free and the ligand-bound (PDB ID: 2IPH) structures and 
whether there is any domain movement. 
2. To perform crystal-based fragment screening with both covalent and non-
covalent fragment libraries which will allow fragments that bind in the active site 
to be identified and to find ways to develop these hits into good inhibitors. 
3. Since the 2IPH complex structure has only part of the substrate polypeptide 
bound in the active site of SV3CP, to try to find out how the other part binds in 





2.3.1 Mutagenesis, expression, purification and crystallisation 
Mutagenesis of SV3CP, in which the catalytic residue Cys139 was mutated to 
Ala, was carried out by a project student Nat Tan. The presence of the mutation 
was confirmed by gene sequencing and expression of the mutated enzyme was 
verified by Western blot. 
The same methods were used for DNA transformation, protein expression and 
purification for both the wild-type (WT) and the mutated proteins (C139A). For 
each protein, DNA transformation was undertaken according to the method 
described in Method i of the appendices, protein expression was performed 
following Method ii of the appendices using the standard method without heat 
shock. Protein purification was achieved firstly by using an SP Sepharose (GE 
Healthcare, Buckinghamshire, UK) cation-exchange column (binding buffer: 10 
mM Na2HPO4, 5 mM β-mercaptoethanol, pH 7.5, eluted with a gradient up to 1 
M NaCl in binding buffer), followed by use of a Superdex 75 (GE Healthcare, 
Buckinghamshire, UK) gel-filtration column (buffer: 100 mM NaCl in cation-
exchange binding buffer). 
Screening for crystallisation conditions for both the WT and C139A proteins was 
accomplished using the sitting-drop method at 21 °C with the screening kits 
Structure Screen 1 & 2, JCSG-plus, PACT premier, MIDAS and Morpheus from 
Molecular Dimensions (Suffolk, UK) . A TTP Labtech Mosquito crystal screening 
robot (TTP Labtech, Hertfordshire, UK) was used to dispense 400 nl of each 
protein, at 5 mg/ml along with 10 mg/ml, plus 400 nl of the corresponding well 
solution into each drop. Two different crystal forms for each protein (Figure 2.7) 
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appeared in many conditions in different kits and further optimisation revealed the 
optimal conditions (table 2.1). 
In order to obtain a complex structure of SV3CP and the substrate (DEFQLQGK), 
co-crystallisations were carried out with the C139A protein and the substrate (1×, 
5×, 10× and 20× in molar excess) with both crystal forms. 
 
Figure 2.7 Different crystal forms of SV3CP WT and C139A proteins. One small unit on the 







Table 2.1 Optimal crystallisation conditions for the WT and C139A SV3CPs. 
Protein Crystal form Conc. (mg/ml) Crystallisation condition 
WT 
C2 4  
0.2 M Ammonium citrate dibasic, 
12% (w/v) PEG 3,350 
P61 5 Morpheus C6* 
    
C139A 
P21 5 30% (w/v) PEG 1,500 
P61 5 
1.6 M Ammonium sulphate, 0.1 M 
MES pH 6.5, 10% (v/v) 1,4-Dioxane 
 
* Morpheus C6: for details see Gorrec (2009). 
2.3.2 Data collection, data processing and structure determination 
Selected crystals were cryo-protected in 30% glycerol and mounted in loops 
before flash-cooling. X-ray data were collected at beamlines I03 and I04-1 at 
Diamond Light Source (DLS, Didcot, England). Fine-sliced data were collected 
as guided by the strategies suggested by the program EDNA (Incardona et al., 
2009). Data were processed automatically by the program xia2 (Winter, 2010) at 
DLS, which revealed the space groups of the crystals, as shown in table 2.1. No 
twinning, tNCS or significant anisotropy was spotted by the analysis using 
Phenix.xtriage (Zwart et al., 2005). Solvent content (Table 2.2) for each crystal 
was estimated using Matthews_coef (Kantardjieff and Rupp, 2003). 
The C2 crystal structure of the WT protein was determined by use of the program 
Phaser MR (McCoy et al., 2007) using the protein structure from the published 
SV3CP-MAPI complex (PDB ID: 2IPH) as a search model. This refined structure 
was then used as the search model for the determination of the remaining other 
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three structures. Several rounds of manual rebuilding and correction were 
performed using Coot (Emsley and Cowtan, 2004) followed by restrained 
refinement using Refmac5 (Murshudov et al., 2011) in the CCP4 (Winn et al., 
2011) program suite. Since the C2 crystal diffracted to atomic resolution, a final 
round of anisotropic refinement was conducted using Refmac5, while for others, 
TLS refinement was performed instead. All the structures were validated using 
MolProbity (Chen et al., 2010). All the statistics for data collection, data 
processing and refinement are shown in table 2.2. 
Table 2.2 X-ray statistics for the SV3CP structures. Values in parentheses are for the high 
resolution shell. 
 WT C2 WT P61 C139A P21 C139A P61 
Beamline I04-1 I03 I04-1 I04-1 
Wavelength (Å) 0.9282 0.9762 0.9282 0.9282 
Space group C2 P61 P21 P61 
Unit-cell 
parameters 
    
a (Å) 63.1 130.2 37.8 130.5 
b (Å) 89.4 130.2 36.8 130.5 
c (Å) 61.6 120.0 112.7 121.1 
α (°) 90.0 90.0 90.0 90.0 
β (°) 96.5 90.0 97.9 90.0 










Rmerge (%) 4.4 (130.5) 13.2 (421.2) 8.3 (54.9) 6.5 (20.0) 
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Rmeas (%) 4.8 (143.0) 13.5 (431.4) 9.6 (72.6) 7.0 (224.6) 
CC½ (%) 100.0 (55.0) 99.9 (54.7) 99.8 (96.5) 99.9 (54.0) 
Completeness (%) 99.9 (98.7) 100.0 (100.0) 98.3 (97.9) 100.0 (100.0) 
Average I/σ(I) 13.6 (1.0) 14.8 (0.8) 13.8 (2.9) 14.5 (1.1) 
Multiplicity 6.6 (6.1) 20.6 (21.4) 6.4 (6.8) 7.9 (7.9) 
No. of  
observed 
reflections 
544,844 606,221 52,785 239,338 
No. of  
unique reflections 
83,130 29,412 8,199 30,491 
Wilson plot 
B-factor (Å2) 
16.1 104.3 58.7 96.5 
Solvent content (%) 44.9 67.6 38.6 68.0 
No. of  
molecules per ASU 
2 4 2 4 
Rfactor (%) 16.4 19.3 19.8 18.7 
Rfree (%) 21.3 24.3 24.4 24.5 
RMSD bond 
lengths (Å) 
0.033 0.020 0.143 0.020 
RMSD bond angles 
(°) 
2.592 2.292 1.798 2.121 
No. of reflections 
in working set 
83,130 29,378 8,338 30,457 
No. of reflections 
in test set 





20.7 98.1 46.1 71.7 
 
2.3.3 Polymeric status determination 
The polymeric status of WT SV3CP protein was determined by gel filtration using 
a Superdex 75 column and the same buffer was used in purification. SV3CP (4 
mg) was loaded on the column together with two marker proteins known as 
ovalbumin (4 mg, 42.7 kDa) and ribonuclease (4 mg, 13.7 kDa) and the result 
was checked by SDS-PAGE. 
2.3.4 Fragment screening with crystals 
2.3.4.1 Crystal preparation 
The native C2 crystals were selected to perform fragment screening since, on 
average, they are of good quality and diffract well. Crystals were prepared in 
Swissci 3-drop crystallisation plates (Hampton Research, CA, USA) in 200 nl 
drops containing 100 nl of the protein (4mg/ml) and 100 nl of well solution. Since 
all of the fragments were dissolved in 100% DMSO and some of them were also 
dissolved in 100% ethylene glycol (EDO, the alternative option in case crystals 
could not survive in DMSO, but fewer fragments were available), crystal stability 
in these two solvents was tested in the range (v/v) of 0, 10%, 20%, 30% and 40%, 
and in time scales of 1h, 3h and overnight. In order to make the experiment more 
efficient, the crystals were also tested with and without additional cryo-protectant 
for data collection. It was found that these crystals could survive in up to 40% of 
both solvents for many hours and additional cryo-protection other than DMSO or 
EDO was not required. 
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2.3.4.2 Fragment soaking, crystal harvesting and data collection 
The plates containing crystals were scanned using a Desktop Minstrel UV 
instrument (Rigaku Automation, CA, USA) for crystal imaging. All the crystals 
were then ranked manually by use of the program TeXRank (Ng et al., 2014) 
which also gave the coordinates of a target position for the fragment to be ejected 
to. Each fragment from the DSLP library (non-covalent, 776 fragments) (Cox et 
al., 2016), the Maybridge Ro3 core set (non-covalent, 68 fragments used) (Fisher 
Scientific UK Ltd, Loughborough, UK) and a covalent library (1000 electrophiles, 
offered by Dr Nir London, Weizmann Institute of Science, Israel) was ejected into 
a single drop in series of 2.5 nl droplets by acoustic dispensing using a Labcyte 
Echo 550 liquid handler (Labcyte Inc, CA, USA) which gave a final concentration 
of 200 mM and 8 mM for the non-covalent and covalent fragments, respectively, 
in each drop (Collins et al., 2017). Fragment soaking was conducted in batches 
to give an average soaking time of approximately 2.5 hours. Crystal fishing 
(harvest) was manual but significantly efficient with the help of an OLT Crystal 
Shifter (Oxford Lab Technologies, Oxford, UK). All the crystals were mounted in 
loops which were about the same size or slightly smaller than the crystals, this 
allowed for highly automated, unattended data collection aiming for the centre of 
the loops. Since the crystals belong to the C2 space group, 180° of data were 
collected for each crystal which only took approximately 60 seconds. 
2.3.4.3 Fragment screening by LC/MS and co-crystallisation with the 
covalent library 
Since soaking with the covalent library damaged most of the crystals and resulted 
in poor diffraction, optimisations were undertaken with different soaking time 
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scales and fragment concentrations. It was finally identified that the crystals could 
only survive in 8 mM fragments for 15 min or 2 mM fragments for 15 h. Attempts 
for both conditions with a few fragments did not give any hit. 
It was then decided to carry out co-crystallisation experiments with the covalent 
library. To make the experiment time and cost effective, an initial screening with 
LC/MS was performed followed by co-crystallisation using the top 100 hits from 
the LC/MS screening. LC/MS screening was accomplished in collaboration with 
Dr Nir London from Weizmann Institute of Science, Israel. In brief, each protein 
sample at a final concentration of 2 μM was incubated with a pool containing 5 
electrophiles at a final concentration of 6 μM each at 4 °C for 24 h. The sample 
was then applied to LC/MS and 200 hits were detected with measurable labelling. 
The protein was incubated separately with the top 100 hits from LC/MS overnight 
at 4 °C with protein to fragment ratios of 1:1 and 1:3 (in molar excess). The 
incubated samples were then subjected to co-crystallisation with and without 
seeding. We are currently waiting for crystal growth. 
2.3.4.4 Data processing, analysis and hit identification 
All the 4 datasets were processed automatically by xia2 (Winter, 2010) at DLS 
and the processed data were subjected to XChemExplorer (Krojer et al., 2017) 
and PanDDA (Pearce et al., 2016) for further analysis and hit identification. In 
brief, these two programs perform averaging on approximately 2000 datasets 
collected during the experiment, revealing clear electron density for only the 
changed state, given that most datasets do not have a ligand bound and are very 
similar. Even weak ligands with low occupancy can be identified by applying the 
analysis. All the hits were checked visually which was facilitated by using the 
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program Pandda.inspect in the PanDDA suite (Pearce et al., 2016). The 
interesting hits were further refined using Refmac5 (Murshudov et al., 2011) 
followed by further inspections using Coot (Emsley and Cowtan, 2004). Omit 
maps for the ligands were generated using the program Composite omit map 
(Terwilliger et al., 2008a) in the PHENIX program suite (Adams et al., 2010). 
Interactions between ligands and SV3CP were analysed using LigPlot+ (Wallace 
et al., 1995). All the figures in this thesis were prepared using programs 
MarvinSketch (ChemAxon, 2013), PyMOL (The PyMOL Molecular Graphic 
System, Schrödinger, LLC) and CueMol (Molecular Visualization Framework 
http://www.cuemol.org). 
2.4 Results 
2.4.1 Tertiary structure of SV3CP 
Figure 2.8 illustrates the overall structure of SV3CP which is composed of an N-
terminal and a C-terminal domain. The N-terminal domain contains an α-helix and 
a twisted 7-stranded antiparallel β-sheet forming an incomplete β-barrel. A typical 
N-terminal antiparallel β-barrel has been reported in many chymotrypsin-like viral 
3C or 3C-like proteases such as FMDV 3Cpro (Birtley et al., 2005), PV 3Cpro 
(Mosimann et al., 1997) and coronavirus 3CLpro (Anand et al., 2002). The C-
terminal domain is made up of 6 β-strands forming an antiparallel β-barrel. The 
catalytic triad C139-H30-E54 in the active site located in a cleft between the N-
terminal and the C-terminal domains. The β-hairpin formed by β9 and β10 adopts 
different conformations in the mutant P21 and 2IPH structures compared with the 
native C2 structure. 
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Figure 2.8 The overall structure of SV3CP with all β-strands labelled. The protein is 
composed of an N-terminal domain (red) containing a twisted 5-stranded antiparallel β-sheet 
and a C-terminal domain (green) consisting of a 6-stranded β-barrel. The catalytic triad is 
shown in ball-and-stick. 
2.4.2 Polymeric status 
Polymeric status of WT SV3CP (19.1 kDa) was determined by gel filtration with 
two marker proteins known as ovalbumin (42.7 kDa) and ribonuclease (13.7 kDa). 
Gel-filtration showed only two main peaks (Figure 2.9) with peak 2 being 
ribonuclease, as shown in Figure 2.10. Peak 1 contained both SV3CP and 
ovalbumin which were not separated, however, ovalbumin came out earlier than 
SV3CP, as indicated by the SDS-PAGE, suggesting SV3CP forms dimers in 
solution. This is consistent with some other noroviral 3C proteases that have been 
reported (Leen et al., 2012; Zeitler et al., 2006), however, analysis with the Pisa 
website (Krissinel and Henrick, 2007) suggested a tetramer is also stable in 
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solution. Indeed, the interface area between the A-B and C-D chains is 883.0 Å2 
while it is 692.3 Å2 between the A-D and B-C chains, indicating more stable 
complexes formed by the A-B and C-D chains compared with those formed by 
the A-D and B-C chains (Figure 2.11). 
 
Figure 2.9 Gel filtration for SV3CP. Two proteins known as ovalbumin and ribonuclease were 
used as markers. 
 




Figure 2.11 Polymeric status of SV3CP. The asymmetric unit (ASU) of the C2 WT SV3CP 
is composed of two dimeric structures shown as AB and CD. Less stable interfaces may form 
between chains A and D, B and C, as suggested by the Pisa website, resulting a possible 
tetrameric structure which makes up the ASU of the P61 WT and the C139A SV3CP 
structures. 
2.4.3 Crystal-based fragment screening with non-covalent libraries 
Most crystals used in the non-covalent fragment screening experiment diffracted 
to a resolution ranging from 1.5 to 1.8 Å with good crystallographic statistics, 
allowing accurate analysis of the results. Screening with the DSPL library and 
part of the Maybridge Ro3 library identified 19 hits in total, as illustrated in Figure 
2.12, which bind in five different sites. The protease active site (site A) is a long 
groove with the catalytic Cys139 residue locating in the middle. Two fragments 
(Figure 2.13, J01 and J02) were identified binding at different sides of the Cys139 
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residue in site A. Five hits (Figure 2.13, J03-J07) have been found to bind in the 
putative RNA binding site (site B) including one (J07) which also binds in site C. 
Site C lies in a pocket between chains A and B and the symmetry related chains 
A’ and B’, with 11 hits being identified (J07-J17) to bind here. Two other fragments 
were also spotted that bind at site D (J18) and site E (J19). For details of ligands 
J08-J19, see Figure A of the appendices. Presence of the ligands were further 
confirmed by calculating the omit maps, see Figure 2.14 for examples of J01 and 
J02. 
 
Figure 2.12 Fragment screening hits from the non-covalent libraries. All the ligands bind in 
five sites labelled as A, B, C, D and E. Site A is the active site of the protease and site B is 














Figure 2.14 2Fo-Fc and omit maps for fragments J01 and J02. 2Fo-Fc map and omit maps 
are coloured as blue and green, respectively. 
2.5 Discussion 
2.5.1 The important role of a β-hairpin in substrate recognition 
The N-terminal domain of ligand-free SV3CP and the ligand-bound enzyme is 
almost the same. Superimposition of the N-terminal domains by Cα atoms shows 
that most part for the C-terminal domain in these two structures is quite similar 
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as well, except for a β-hairpin (β9, β10) in the 2IPH structure having moved by 
7.5 Å, as indicated by the asterisk in Figure 2.15a. Binding of the MAPI inhibitor 
has pushed the β-hairpin back away from β11 and β12, which have also moved 
to some extent. These movements open up the channel A formed by the four β-
strands, suggesting a conformational change in response to inhibitor binding 
(Figure 2.15b and 2.15c). Interestingly, it has been reported that the equivalent 
β-hairpin in FMDV 3C protease is crucial for its catalytic activity (Sweeney et al., 
2007). Indeed, this β-hairpin folds over the active site of the protease and is 
characterised by significantly higher B-factors than the average in the ligand-free 
structure. In contrast, in the 2IPH structure, the B-factors for the residues forming 
this β-hairpin are similar to the other residues and the β-hairpin is stabilised by 
the contacts between the P2 to P4 positions of the MAPI and the protease. In the 
complex structure of human rhinovirus 3C protease (HRV 3Cpro) with a peptidyl 
inhibitor (PDB ID: 1CQQ), Leu127 in this β-hairpin makes hydrophobic contact 
with the P2 and P4 side chains, suggesting that it is very important for substrate 
binding (Matthews et al., 1999). An Ile residue is positioned at the equivalent site 
in the SV3CP structure, making it very likely to be a key residue for substrate 
recognition. 
Compared with the ligand-free structure, the binding pocket is 3 Å deeper in the 
2IPH structure in superposition. Interestingly, binding of the inhibitor also pushes 
the His30 residue away from the Cys139 and Glu54 residues, resulting in 
decomposition of the catalytic triad which further enhances the inhibitory activity. 
There is no electron density for the last 8 residues (ASEGETTL) at the C-terminal 
end of the 1.3 Å ligand-free structure, which is possibly due to proteolysis caused 
by the enzyme itself since the electron density is quite clear in the inactive 2IPH 
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structure. In this region, the C-terminus of the protein possesses a VQ-AS 
sequence at the P2-P1-P1’-P2’ positions, making it a less preferable cleavage site 
which may be cleaved during a relatively long-term proteolysis process, e.g. 
during crystallisation (Hussey et al., 2011; Kankanamalage et al., 2015). Whist 
the enzyme is inhibited by the MAPI in the 2IPH structure, leaving these residues 
un-cleaved. This may help to clarify the ambiguous question of where the enzyme 
cleaves the polyprotein between SV3CP and the RdRp. 
The P61 C139A protein has approximately the same structure as the ligand-free 
WT SV3CP protein, whilst in the P21 mutant protein structure the β-hairpin has 
moved even further back to a distance of 7.8 Å, as shown in Figure 2.15d. This 
confirms the flexibility of this β-hairpin which undergoes conformational changes 
in order to accommodate the substrate or inhibitor which is not caused by crystal 
contact. Interestingly, althrough it has been proved that the 3CLpro tend to form 




Figure 2.15 Comparison of different SV3CP structures. a) Superimposition for the ligand-
free SV3CP and the 2IPH structures. The ligand-free SV3CP structure is coloured as pale-
green with its C-terminal end labelling as C1. The 2IPH structure is coloured as light-orange 
with its C-terminus labelling C2. The asterisk indicates the ‘moved’ β-hairpin. b) The surface 
representation of ligand-free SV3CP with closed channel A. c) The surface representation of 
the 2IPH structure, in which channel A is opened in response to inhibitor binding. d) Structural 
superimposition of WT and P21 C139A proteins, the WT and C139A structures are coloured 
as pale-green and light-blue, respectively. 
2.5.2 Fragments bind in the protease active site 
As far as we know, all the noroviral 3Cpro inhibitors that have been reported are 
covalent inhibitors. In this experiment, two non-covalent fragments were identified 
that bind in the active site of the protease named as J01 and J02. Fragment J01 
binds in one part of the long active site and forms several hydrogen bonds, 
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through the carboxylic group, with the side chains of the neighbouring residues 
Gln110, Ile109 and Arg112 including those mediated by a water molecule 
HOH457 (Figure 2.16a, b). These residues reside at the tip of the functionally 
important β-hairpin that is involved in substrate recognition. The ligand –NH 
group (N1) is also within hydrogen bonding distance of the hydroxylic group of 
the Thr134 residue. In addition, J01 forms many hydrophobic interactions with 
the active site residues including Cys139, especially through the 5-methyl-2-
thienyl group. However, this group does not go deep into the binding pocket which 
is possibly occupied by a DMSO molecule, probably due to the higher affinity and 
smaller size of the DMSO molecule. The β-hairpin possesses the same 
conformation as the ligand-free SV3CP which seems to be held in place by the 
fragment. By holding the structure of the β-hairpin tightly by the fragment, the 
enzyme may not be able to adopt the ‘open’ conformation in order to 
accommodate the substrate, thus the activity is inhibited. 
J02 binds in the other part of the long active site on the other side of the Cys139 
residue. It does not seem to form any hydrogen bonds with the active site 
residues, as shown in Figure 2.16c and 2.16d. Instead, the benzoic acid ring is 
involved in a π-π interaction with the side chain of the His30 from the catalytic 
triad, and also forms a cation-π interaction with the Arg122 residue from the β-
hairpin. In addition, several hydrophobic interactions are formed between the 
fragment and the adjacent residues in the active site including Glu54 from the 
triad, and Arg112, Leu113 and Val114 which are all from the β-hairpin. The same 
as J01, J02 stabilises the β-hairpin through the interactions which makes it a good 
candidate for developing inhibitors. 
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In conclusion, J01 and J02 bind at different sides of the Cys139 in the long active 
site and both of them interact with the surrounding residues including those from 
the functionally important β-hairpin. J01 forms hydrophobic interaction with 
catalytic Cys139 while J02 forms hydrophobic and π-π interactions with Glu54 
and His30, which are also from the catalytic triad. Both J01 and J02 could 
potentially be developed into SV3CP inhibitors, however, a better ligand may be 
obtained by linking them together, given that the distance between the closest 





Figure 2.16 Interactions between SV3CP and the fragments J01 and J02. 3D (a, c) and 2D 
(b, d) representations of the interactions between fragments J01 (a, b), J02 (c, d) and the 
active site residues. The binding pocket is shown by a surface representation, fragments J01 
and J02 are coloured as purple and dark green, respectively. Hydrogen bonds are indicated 
by dashed lines in cyan. Hydrophobic interactions are indicated by eyebrow-like icons 
coloured as brown. 
2.5.3 Fragments bind in the putative RNA binding site 
In addition to the protease activity, studies on viral 3C proteases from different 
organisms suggested that 3C proteases or their larger precursors can bind 
specifically to the 5’-terminal nucleotides of the viral RNA (Leong et al., 1993a; 
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Nayak et al., 2006). The interaction occurs only on the plus strand which forms a 
ribonucleoprotein (RNP) complex that is necessary for the initiation of the plus 
strand synthesis (Andino et al., 1990). Viswanathan et al. (2013) suggested that 
SV3CP also has the ability to bind short RNAs and binding of RNA non-
competitively inhibited the ‘protease activity’ with an IC50 of 3-5 μM (Viswanathan 
et al., 2013). The RNA binding site has been studied by mutagenesis in other 
homologous 3C proteases, in which they identified a key arginine residue and a 
conserved sequence, KF/VRDI (F/V represents the amino acid could be an F or 
a V), which are required for the interaction with RNA (Bergmann et al., 1997; 
Leong et al., 1993b; Nayak et al., 2006). Structural comparison of SV3CP with 
HRV 3Cpro (PDB ID: 5FX5) (Kawatkar et al., 2016) and FMDV 3Cpro (PDB ID: 
2J92) (Nayak et al., 2006) identified the site around Arg65 to be the putative RNA 
binding site in SV3CP, which possesses a KIRPDL sequence that has similar 
properties with KF/VRDI. This putative RNA binding site for SV3CP is shown in 
Figure 2.13 (site B), which does not look like a typical RNA binding groove, 
however, the same trend is seen in the FMDV 3Cpro and only a shallow tiny 
groove is found in the HRV 3Cpro. In addition, these sites are in crystal contact 
areas and form deep channels with the neighbouring symmetry-related 
molecules in HRV, FMDV and SV3CP 3Cpro or 3CLpro. Inhibitors binding in the 
RNA binding site have the potential to inhibit both the RNA binding ability and the 
protease activity, which will give excellent antiviral activity. 
Interactions between J03-J06 and the residues in the putative RNA binding site 
are shown in Figure 2.17. All the fragments form hydrophobic contacts with Arg65 
and some other residues from the KIRPDL sequence, which may confirm the 
importance of this sequence. While J03 and J06 are mainly involved in 
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hydrophobic interactions, J04 and J05 also form many hydrogen bonds with the 
neighbouring residues, possibly making them stronger binders. The carbonyl 
group (O1) of J04 is involved in three hydrogen bonds formed, directly or 
mediated by a water molecule, with Thr10, Lys11 and Ser91 (from the symmetry 
related molecule). The N1 atom forms two hydrogen bonds with Ser7 and Pro3 
(also from the symmetry mate) with the participation of a water molecule. A weak 
hydrogen bond is also seen between the fluorine and the NE1 atom on the side 
chain of Trp19. J05 contributes to two hydrogen bonds, which are also mediated 
by a water molecule, formed with the symmetry related Ser91 and Glu93. Unlike 
the active site fragments which bind in different parts of the active site, these four 
fragments bind in the same position with their ‘heads’ overlapping at one place 
and their ‘tails’ pointing toward different directions. As it has been reported that 
binding of RNA also inhibits the protease activity of SV3CP (Viswanathan et al., 
2013), further analysis in solution are required to assess the binding ability and 
then inhibitory activity of these fragments which bind in an area that is involved in 
crystal contact in the complex structures obtained from the screening. 
Fragment J07 was found to bind in both the putative RNA binding site (B) and 
site C. Similarly, the main forces between the fragment and the neighbouring side 
chains are hydrogen bonds and hydrophobic interactions which are illustrated 




















Figure 2.17 Interactions between SV3CP and the fragments J03-J06. 3D (a, c, e, g) and 2D 
(b, d, f, h) representations of the interactions between fragments J03-J06 and the residues 
in the putative RNA binding site. The binding pocket is shown by a surface representation. 
Hydrogen bonds are indicated by dashed lines as cyan. Hydrophobic interactions are 
indicated by eyebrow-like icons coloured as brown. Protein chain ID is indicated by the letters 




Figure 2.18 Interactions between SV3CP and the fragment J07. The same 2D and 3D 
representations of fragment J07 which binds in both the putative RNA binding site (a, b) and 
site C (c, d). 
2.5.4 Other fragments 
Interestingly, the peptide bonds in fragments J11 and J18 (Figure A of the 
appendices) are cleaved for some reason and the resulting cleaved parts 
containing the thiadiazole ring from both J11 and J18 bind in sites C and D, and 
the other part from J11 binds in a different place near Glu93. Since both of the 
fragments possess a 2-ethyl-1,3,4-thiadiazole group and a peptide bond in their 
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structures, it is likely that these features can be recognised by the enzyme and 
compounds possessing them can be cleaved. This gives some clues for inhibitor 
design, for example, inhibitors may be developed by modifying the peptide bonds 
of these fragments so that they can be recognised but cannot be cleaved by the 
enzyme. However, analysis is required to make sure they have not broken down 
automatically before further development is performed. 
In addition, many other hits have been identified to bind in site C and some other 
sites, see section 2.4.3 for details. 
2.6 Future work 
1.The most important work in future is to evaluate the binding affinity and 
inhibitory activity of these fragments. 
2.Given any good hits, computer- and activity-based analysis needs to be 
performed to identify better homologous compounds. 
3.Chemistry as well as crystallography work is required to further develop the 












3. Chapter 3 
Structural and functional studies of 













Tetrapyrroles are a class of chemical compounds in which four pyrrole rings are 
linked together to form linear or cyclic molecules. These natural molecules are 
essential for living systems since they participate in key processes such as 
photosynthesis and respiration. Tetrapyrroles are only synthesised in small 
quantities and the synthetic pathways are tightly regulated. 
There are two pathways for tetrapyrrole biosynthesis which are similar in all living 
organisms. The first common intermediate in these pathways is 5-aminolaevulinic 
acid (ALA). Higher plants and many prokaryotes adopt the C5 or glutamate 
pathway (Figure 3.1) in which 5-ALA is generated from the carbon skeleton of 
glutamate (Kannangara et al., 1994; Kannangara et al., 1988). Mammals and 
other eukaryotic organisms produce 5-ALA from glycine and succinyl-CoA along 
the C4 or “Shemin” pathway which requires the enzyme 5-ALA synthase (ALAS) 
(Leeper, 1985; Li et al., 1989). 
The next stage includes transformation of 5-ALA into the common precursor for 
tetrapyrroles, uroporphyrinogen III, in three enzymatic steps which are common 




Figure 3.1 5-ALA synthesis pathways. Higher plants and prokaryotic organisms take the C5 
pathway whilst eukaryotes and mammals adopt the C4 pathway. 
In the first step, two molecules of 5-ALA are condensed by the enzyme 5-ALA 
dehydratase (ALAD, also known as porphobilinogen synthase, PBGS) to form the 
basic pyrrole building block porphobilinogen (PBG). In the next step, four 
molecules of PBG are condensed together to produce a highly unstable linear 
hydroxymethylbilane (HMB), which is also known as preuroporphyrinogen. This 
reaction is catalysed by the enzyme porphobilinogen deaminase (PBGD). The 
fourth pyrrole ring of the preuroporphyrinogen is then rearranged and connected 
with the first ring to form a uroporphyrinogen III in a reaction catalysed by the 
enzyme uroporphyrinogen synthase (UROS) (Warren et al., 1995), as shown in 
Figure 3.2. Uroporphyrinogen III acts as a branch point in the pathway that many 
tetrapyrroles, such as chlorophyll, haem, sirohaem, F430 and vitamin B12, are all 







Figure 3.2 Synthesis of uroporphyrinogen I and III from PBG. Uroporphyrinogen III is 
synthesised from the unstable intermediate preuroporphyrinogen under the catalysis of 
uroporphyrinogen synthase. Uroporphyrinogen I is produced when uroporphyrinogen 




Figure 3.3 Tetrapyrroles formed from Uroporphyrinogen III. 
3.1.2 Haem and haemoproteins 
Haem is a prosthetic group of proteins like myoglobin and haemoglobin, and 
consists of a ferrous ion (Fe2+) chelated in the centre of a large heterocyclic 
organic ring named a porphyrin. While the most common type of haem is haem 
B (Figure 3.4), other important types include haem A and haem C. As a regulatory 
molecule, haem mediates gene expression, translation, protein targeting, protein 
stability and differentiation (Chen and London, 1995; Karplus and Diederichs, 
2012; Lathrop and Timko, 1993; Schmitt, 1999; Wang et al., 1999). It also acts 
as a sink or source of electrons during electron transfer or redox chemistry. 
Haemoproteins are involved in many fields in oxidative metabolism including O2 
transport, O2 sensing, oxidative stress response, oxidative phosphorylation and 
oxygenation reactions. They also participate in transportation of diatomic gases, 
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chemical catalysis, electron transfer and sensing of diatomic gases such as nitric 
oxide and carbon monoxide (Rodgers, 1999). Haemoproteins are coloured since 
the conjugated double bonds absorb visible light. 
Most haem in humans is synthesised endogenously and each tissue produces 
haem to satisfy its own requirement. More than 70% of total haem in the body is 
synthesised in the bone marrow where haem is incorporated into haemoglobin 
for erythrocyte precursors. The liver, which is the second most important site in 
the human body for haem synthesis, accounts for about 15% of the total haem 
production. There is a high demand in the liver for haem to be incorporated into 
mitochondrial cytochromes as well as into cytochrome P450, catalase and 
cytochrome b5. 
 
Figure 3.4 Structure of haem B. The most common type of haem is haem B, other types 
include haem A and haem C. A ferrous ion is located in the centre of the porphyrin molecule. 
3.1.3 Porphobilinogen deaminase 
Porphobilinogen deaminase (PBGD), also referred to as hydroxymethylbilane 
synthase, uroporphyrinogen I synthase or preuroporphyrinogen synthase, 
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catalyses one of the early steps in the synthesis of tetrapyrroles (Warren and 
Smith, 2009). Several PBGDs have been isolated from different organisms of 
both prokaryotic and eukaryotic sources including Escherichia coli (Bugg et al., 
2011; Jordan and Warren, 1987), plants (Cooper et al., 2014) and mammals 
(Coates et al., 2006; Knight et al., 2006). The primary amino acid sequences of 
this enzyme from different sources have a conservation of at least 32%. There 
are two isoforms of PBGD, the erythroid specific enzyme and the housekeeping 
enzyme. Both originate from a single PBGD gene on chromosome 11 and arise 
by alternate splicing of the primary transcript (Erskine et al., 2006). PBGDs have 
molecular weights ranging from 34 to 44 kDa and pH optima in the range 8.0 - 
8.5. These enzymes from most organisms have great thermostability which has 
been exploited during their purification. Most of the proteins can be heated to 
60 °C or even higher temperatures for 10 to 120 minutes with no or very little loss 
of activity. 
3.1.4 The structure of PBGD 
A number of X-ray structures of PBGD have been reported including those from 
Escherichia coli, human, Arabidopsis thaliana and Bacillus megaterium (Azim et 
al., 2014; Gill et al., 2009; Louie et al., 1992; Roberts et al., 2013). E. coli PBGD 
was the first enzyme in the tetrapyrrole pathway to have its structure determined 
by X-ray crystallography (Louie et al., 1992). The polypeptide itself is folded into 
three domains (1 - 3) each of approximately the same size. Both domain 1 and 
domain 2 are composed of five-stranded mixed β-sheets and have similar overall 
topology to the type II periplasmic binding proteins, which have been reported to 
adopt “open ” and “closed” states in response to ligand binding (Louie, 1993; 
Louie et al., 1992). Domain 3, which possesses an open-faced anti-parallel β-
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sheet of three strands and three α-helices, is folded completely differently from 
the other two domains (Figure 3.5). 
 
Figure 3.5 X-ray structure of the PBGD from B. megaterium (BPBGD, PDB ID: 4MLV). A 
dipyrromethane (DPM) cofactor is covalently bound to Cys241 in the active site. The domains, 
α-helices and β-sheets are labelled according to the nomenclature of Louie et al (1992). 
[Figure generated based on (Azim et al., 2014), reproduced with permission of the 
International Union of Crystallography (http://journals.iucr.org)]. 
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There is a DPM cofactor (Figure 3.6) that is covalently attached to a cysteine 
(Cys241 in B. megaterium) in a loop which is located in the active-site. The two 
pyrrole rings of the cofactor are named C1 and C2, with C1 being attached to the 
protein. The presence of the cofactor can be confirmed by the treatment of PBGD 
with Ehrlich’s reagent which gives an absorbance at 565 nm and a subsequent 
shift to a λmax of 495 nm after 15 min (Williams et al., 2006). The cofactor can be 
generated in two different ways, 1) by slow assembly from two molecules of PBG 
or 2) by cleavage of the product, preuroporphyrinogen, which reacts rapidly with 
the apo-enzyme (Awan et al., 1997; Shoolingin-Jordan et al., 1997). 
 
Figure 3.6 Structure of the DPM cofactor. DPM is covalently linked to Cys241 through 
a thioether linkage. Four molecules of PBG are linked sequentially to the cofactor via 
the free α-position of each pyrrole and the tetrapyrrole product is then released from the 
cofactor [Figure from (Guo et al., 2017a)]. 
The DPM cofactor plays two different roles in the catalysis. Firstly, it acts as the 
primer in the active site in order to initiate the enzymatic reaction and to connect 
the substrate moieties to the enzyme during the elongation stage. This has been 
confirmed by 14C labelling experiments in which the enzyme containing a labelled 
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cofactor was incubated with unlabelled PBG. The final product contained no 
labelled compounds, indicating that the DPM cofactor was not affected by the 
catalytic turnover and remained permanently linked to the enzyme (Warren and 
Jordan, 1988). Secondly, the permanent connection between the cofactor and 
the enzyme may help to limit the maximum number of substrate molecules that 
can bind and make it precisely four. 
The cofactor adopts different conformations depending on its oxidation state. The 
C1 ring varies little between different states, while the C2 ring in the oxidised state 
(in which the cofactor is called dipyrromethenone) tends to occupy a space which 
is thought to be the position for the incoming substrate PBG (Louie et al., 1996). 
In this state, both rings of the dipyrromethenone factor are found to be coplanar 
whilst in the reduced dipyrromethane state, the cofactor adopts a conformation 
where the C2 ring occupies a more internal position in the active site cleft (Azim 
et al., 2014; Louie et al., 1996; Roberts et al., 2013). 
There is also an invariant aspartic acid (Asp82 in B. megaterium) that is located 
in a highly conserved region of the PBGD sequence, V-H-S-M-K-D-M-P, from 
residues 77 to 84 in the B. megaterium enzyme (Azim et al., 2014). The aspartate 
side chain forms two hydrogen bonds with the NH groups of the DPM and is 
thought to catalyse the tetramerisation reaction. 
3.1.5 Catalytic mechanism of PBGD 
During the catalysis, four molecules of the substrate PBG bind to the enzyme in 
a stepwise head-to-tail manner through the free α-position of the DPM cofactor. 
The catalytic reaction starts with the binding of the first substrate PBG (ring A), 
which is deaminated and forms an azafulvene. The azafulvene then 
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nucleophilically attacks the free α-position of the C2 ring of the cofactor to form a 
new C-C bond (Figure 3.7). The following rings B, C and D are added sequentially 
in the same way (Jordan and Woodcock, 1991). In summary, the formation of the 
linear tetrapyrrole preuroporphyrinogen is achieved from the sequential binding, 
deamination and condensation of four substrate molecules through a few stable 
intermediates known as ES, ES2, ES3 and ES4 (Figure 3.8) (Shoolingin-Jordan, 
1998). This was firstly identified by incubating the human erythroid enzyme 
deaminase with [3H]-PBG after which the labelled four complexes were detected 
(Anderson and Desnick, 1980). These intermediate complexes are more 
negatively charged than the original enzyme so that they could be separated by 
electrophoresis or ion exchange chromatography (Anderson and Desnick, 1980). 
ES4, which is actually a hexapyrrole composed of the cofactor and the 
tetrapyrrole bilin product, is then hydrolysed and the unstable product 
(preuroporphyrinogen) is released from the enzyme (Jordan and Woodcock, 
1991; Warren and Jordan, 1988). This is achieved by the protonation of the 
carbon in the α-position of the C2 ring followed by the cleavage of the C-C bond 





Figure 3.7 The mechanism for attachment of a PBG molecule. The PBG molecule can be 
attached to the cofactor or any of the subsequent intermediates through three steps known 
as: deamination of PBG, nucleophilic attack of the free α-position of the previous ring to be 
attached and deprotonation of the Cα atom. [Figure generated based on (Roberts et al., 2013), 

































































































































































































3.1.6 Mutagenesis studies of PBGD 
Comparison of the sequence of PBGDs among E. coli, human, B. megaterium 
and A. thaliana (Figure 3.9) identified that there are many highly conserved 
arginine residues at positions 11, 101, 131, 132, 149, 155, 176, 182, 206, 232 
and 277 in E. coli PBGD, several of which bind to the acetate and propionate 
groups of the cofactor. Site-directed mutagenesis of these arginine residues 
revealed that they play important roles in the catalytic mechanism (Jordan and 
Woodcock, 1991). The enzyme lost the ability to assemble the cofactor with 
mutations at R131 or R132, resulting in inactive mutants, while mutations at R149 
or R176 produced mutants with less activity and had the ability to accumulate 
intermediates. In addition, R11 or R155 mutated proteins were able to assemble 





Figure 3.9 Sequence alignment of PBGDs. PBGD from different organisms including 
B. megaterium, E. coli, A. thaliana and human are compared. The secondary structural 
elements based on the BPBGD are shown at the bottom. The amino acid residues are 
coloured as follow: cyan, basic; red, acidic; green, neutral polar; pink, bulky hydrophobic; 
white, Gly, Ala and Pro; yellow, Cys. [Figure generated based on (Azim et al., 2014), 
reproduced with permission of the International Union of Crystallography 
(http://journals.iucr.org)]. 
Site-directed mutagenesis was undertaken by Jordan and Woodcock (1991; 
1994) in which the Asp84 in E. coli PBGD (Asp82 in B. megaterium) was mutated 
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to Glu, Ala and Asn. The D84E mutant had a significantly reduced activity of less 
than 1% of that of the WT enzyme while the other two mutants, D84A and D84N, 
were completely inactive. It was found that the cofactor of the D84E mutant was 
more sensitive to oxidation and one reason might be that the hydrogen bond 
between the carboxylic group of Asp84 and the NH group of the C2 ring was 
weaker or lost due to the mutation (Lambert et al., 1994). 
3.1.7 Acute intermittent porphyria 
The porphyrias are a group of inherited disorders caused by enzyme defects in 
haem biosynthesis and the resulting accumulation of phototoxic intermediates. 
Acute intermittent porphyria (AIP) is an autosomal dominant metabolic disease 
resulting from diminished erythrocyte activity of PBGD. Onset of AIP typically 
occurs during puberty or later and symptoms include severe abdominal pain, 
vomiting, peripheral, central neuropathy and proximal motor weakness, which 
may well be due to the toxicity of excess 5-ALA that has a similar structure and 
may behave as an analogue of the inhibitory neurotransmitter γ-aminobutyric acid 
(GABA). The attacks may be precipitated by circumstances including the use of 
drugs (e.g. barbiturates and sulphur-containing drugs), alcohol and heavy metals 
as well as stress, poor diet, infections and hormonal changes (Wood et al., 1995). 
The reduced ability of the enzyme to fold and function is caused by many of the 
point mutations in PBGD, which affect the amino acid residues (mainly arginine 
residues in the active site) of the enzyme, as mentioned by before. In addition, 
some other mutations probably destabilise the three-dimensional fold by steric 
and electrostatic effects (Delfau et al., 1990; Jordan and Woodcock, 1991; Lander 
et al., 1991; Scott et al., 1989). 
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Biochemical tests can help the diagnosis of the AIP through estimating the PBGD 
activity in erythrocytes and/or cultured transformed lymphocytes, though 5% to 
10% of affected individuals exhibit normal erythrocyte PBGD activity. Another 
way is to measure the PBG and 5-ALA in urine, however, both of them are most 
clearly disturbed only during the acute attacks. In addition, some patients with 
AIP show normal red cell enzyme activity, but depletion in other tissues. Since it 
is an inherited disorder, family members of a patient with AIP should take suitable 
tests as well. It is important to undertake the diagnosis as soon as possible 
because acute episodes of AIP can be fatal (Moore and McColl, 1989). Treatment 
with large doses of haem can be effective through inhibition of the first reaction 
of the pathway, shutting down the flux and providing haem for the patient. 
Avoidance of precipitating factors is also useful in preventing the symptoms of 
AIP. 
3.2 Project aim 
The aim of this investigation was to use a combination of mutagenesis, X-ray 
crystallography, enzymology, computational analysis to explore how PBGD 
works, in terms of the substrate binding and domain movements during catalysis. 
Structural information gained from X-ray crystallography of mutants would be 
used to determine the domain movements and enzymatic assays would be 
performed to establish the kinetic behaviour and the role of the cofactor. 
3.3 Methods 
3.3.1 Mutagenesis and DNA transformation 
The WT BPBGD gene in a pET-14b expression construct, as previously reported 
by Azim (Azim et al., 2013), was applied to the QuickChange mutagenesis kit 
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(Agilent Technologies, Cheshire, UK) to introduce the required base changes. 
The primers were ordered from Yorkshire Bioscience (York Science Park, York, 
UK) with sequences as follows: 
D82A (GAT to GCT): 
Forward: 5'-GGCCGTTCATAGTATGAAAGCTATGCCGGC-3' 
Reverse:  5'-GCCGGCATAGCTTTCATACTATGAACGGCC-3' 
D82E (GAT to GAA): 
Forward: 5'-GGCCGTTCATAGTATGAAAGAAATGCCGGC-3' 
Reverse:  5'-GCCGGCATTTCTTTCATACTATGAACGGCC-3' 
D82N (GAT to AAT): 
Forward: 5'-GATATGGCCGTTCATAGTATGAAAAATATGCCGGCTG-3' 
Reverse:  5'-CAGCCGGCATATTTTTCATACTATGAACGGCCATATC-3' 
The base changes are coloured in red. 
Each mutagenesis reaction was undertaken using a Techne Progene thermal 
cycler (Techne, Staffordshire, UK) following the protocol provided in the kit. The 
nicked plasmid DNA was then transformed into ‘subcloning efficiency DH5α’ 
competent cells (Invitrogen, Thermo Fisher Scientific, Dartford, UK) for nick repair 
and DNA amplification, following the protocol described in Method i of the 
appendices. The plasmid DNA was then extracted and purified by use of an 
AxyPrep Plasmid Miniprep Kit (Axygen, Union City, California, USA). 
DNA sequencing, carried out at DNA Sequencing & Services (University of 
Dundee, Dundee, UK), confirmed that the base changes were introduced 
successfully (Figure B of the appendices) which could also be seen in the X-ray 
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structures determined later. Each of the mutated genes was transformed into 
Rosetta (DE3) pLysS E. coli cells (Novagen, Darmstadt, Germany) for protein 
expression. 
3.3.2 Protein preparation 
All the mutant proteins were expressed by using the heat shock method 
described in Method ii of the appendices. The His-tagged proteins were then 
purified initially by a HisTrap FF column, followed by the cleavage of the tag using 
thrombin. A HiTrap benzamidine column was then used to remove the thrombin 
and the proteins were finally desalted and purified by a Superdex75 gel-filtration 
column. All the columns used were purchased from GE Healthcare 
(Buckinghamshire, UK). 
3.3.3 Protein crystallisation 
Screening for crystallisation conditions for all the BPBGD mutant proteins was 
undertaken by use of the hanging-drop method with the Structure Screens 1 & 2 
kit from Molecular Dimensions (Suffolk, UK). 5 μl of each mutant protein (5 mg/ml) 
was mixed with 5 μl of the corresponding well solution on a siliconised coverslip 
and the plates were stored at 21 °C for crystallisation. Showers of small yellow 
crystals for the D82N protein started to appear after three days in Screen 1 
condition 2 (0.2 M ammonium acetate, 0.1 M sodium acetate pH 4.6, 30% PEG 
4,000). Subsequent optimisation revealed that better crystals for all the mutants 
could be obtained reproducibly in 0.2 M ammonium acetate, 0.1 M sodium 
acetate pH 3.5 - 4.0, 22 - 28 % PEG 4,000 (Figure 3.10). These crystals grew as 
clusters formed by thin plates and there was no significant difference among 
114 
 
crystals of the mutants. It seemed that all of the mutants preferred crystallising at 
a ‘final’ pH of around 5.7 in each hanging droplet. 
In order to get protein-substrate complex structures, co-crystallisation was 
undertaken for all BPBGD mutants with the substrate PBG ranging from 0.14 to 
1.4 mM (1-10 times in molar excess of the protein) using the same crystallisation 
condition. In addition, co-crystallisation of the mutants with the WT enzyme and 
PBG was also carried out with a ratio of WT:mutant:PBG = 1:50:500 (in molar 
excess). The idea behind this experiment was that the WT enzyme might make 
sufficient product which would then bind to the inactive mutants, given the 
evidence that the product is actually the precursor of the cofactor (Jordan and 
Warren, 1987; Mauzerall and Granick, 1956; Pluscec and Bogorad, 1970). 
 
Figure 3.10 Crystals of BPBGD D82N mutant from B. megaterium. A single fragment used 
for data collection was approximately 400 m in its longest dimension and 100 m wide. 
3.3.4 Crystal freezing, data collection and data processing 
Selected crystals were mounted in loops with approximately 30% glycerol as the 
cryo-protectant before flash-cooling in a nitrogen gas cryostream (Oxford 
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Cyrosystems Ltd., Oxford, UK) at 100 K or immersion in liquid ethane. Crystals 
were then stored in pucks in liquid nitrogen prior to exposure to X-ray beam. 
X-ray data collection was performed at stations I02, I03, I04 and I04-1 at DLS. 
190 degrees of data were collected for every crystal which yielded good 
diffraction with 1 s exposure times, 1° oscillation and 20% transmission. Data 
collection revealed that all the crystals for the mutants were orthorhombic and 
belonged to the space group P212121 which is the same as that of the WT protein 
(Azim et al., 2013) and the unit-cell dimensions are somewhat smaller for the 
mutants. 
Data processing was achieved through two different ways, either by use of the 
automatic processed data from xia2 (Winter, 2010) or by manual processing. For 
manual data processing, iMosflm (Battye et al., 2011; Leslie, 2006) was used to 
integrate the diffractions spots and produce the reflection .mtz file before Scala 
(Evans, 2006) was used to scale all the equivalent symmetry related reflections 
together. Ctruncate (Dauter, 2006; French and Wilson, 1978) was then used to 
obtain the structure factor amplitudes from the diffraction intensities. 
3.3.5 Structure determination, model building, refinement and validation 
Structure determination was undertaken by molecular replacement using Molrep 
(Vagin and Teplyakov, 2010) with the WT enzyme structure as the search model 
(PDB ID: 4MLV). Following one round of refinement of the solutions, manual 
rebuilding and the introduction of the mutant residues Ala, Glu and Asn, to replace 
Asp82 in the WT structure, was accomplished by use of the program Coot 
(Emsley and Cowtan, 2004). The structures were then refined by restrained 
refinement with Refmac5 (Murshudov et al., 1997; Winn et al., 2001; Winn et al., 
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2003). All the statistics for data collection, data processing, structure 
determination and refinement are shown in Table 3.1. 
Table 3.1 X-ray statistics for all the three mutant structures. Values in parentheses are for 
the outer resolution shell [Table from (Guo et al., 2017a)]. 
 D82A  D82E  D82N  
Beamline I03 (DLS) I03 (DLS) I02 (DLS) 
Wavelength (Å) 0.9763 0.9763 0.9795 
Space group P212121 P212121 P212121 
Unit-cell parameters (Å) 
a (Å) 49.1 49.2 49.0 
b (Å) 62.5 62.7 62.7 
c (Å) 91.4 91.8 91.3 








Rmerge (%) 12.8 (48.3) 4.8 (62.9) 6.9 (54.1) 
Rmeas (%) 15.1 (58.5) 5.3 (69.7) 8.2 (65.5) 
CC½ (%) 99.0 (79.7) 99.9 (76.6) 99.6 (78.8) 
Completeness (%) 99.6 (97.4) 99.9 (100.0) 98.9 (96.5) 
Average I/σ(I) 11.8 (3.2) 20.7 (2.6) 16.9 (4.0) 
Multiplicity 6.4 (5.6) 6.7 (5.8) 6.2 (5.7) 







No. of unique reflections 8,221 (579) 26,586 (1,907) 23,650 (1,679) 
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Wilson plot B-factor (Å2) 51.8 24.0 24.0 
Solvent content (%) 36.9 37.5 36.8 
Rfactor (%) 20.9 18.3 21.0 
Rfree (%) 23.9 22.6 25.3 
RMSD bond lengths (Å) 0.002 0.002 0.003 
RMSD bond angles (°) 0.479 0.560 0.515 
No. of reflections in 
working set 
8,186 26,585 23,589 
No. of reflections in test set 394 1,310 1,164 
Mean protein B-factor (Å2) 38.7 32.6 28.7 
All the mutant structures were validated by the program MolProbity (Chen et al., 
2010). 
3.3.6 Ehrlich’s reaction 
Modified Ehrlich’s reagent: 
4-dimethylaminobenzaldehyde   1g 
Glacial acetic acid              42 ml 
Perchloric acid (70%)            8 ml 
The reagent was made fresh every time and was kept in the dark. 
Ehrlich’s reaction to determine the status of the DPM cofactor in BPBGD WT and 
mutant enzymes was carried out as described by Jordan and Warren (1987; 
1988). In brief, an aliquot (500 μl) of each enzyme solution (1 mg/ml) was mixed 
with 500 μl of modified Ehrlich’s reagent at room temperature and any precipitate 
was removed by centrifugation. The absorbance for each sample was monitored 
by a wave scan between 380 nm and 600 nm after 1 and 15 min using an 
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Ultrospec 3000 UV/Visible Spectrophotometer (GE Healthcare, Buckinghamshire, 
UK). 500 μl of protein buffer (50 mM Tris, 100 mM NaCl, pH 7.3) was mixed with 
an equal volume of modified Ehrlich’s reagent as a blank. Observation of a peak 
at λmax = 565 nm which subsequently shifted to a λmax = 495 nm after 15 min 
confirmed the presence of the cofactor. 
3.3.7 Determination and classification of domain movements 
Relative domain movements were analysed using the DynDom website 
(Hayward and Berendsen, 1998; Hayward and Lee, 2002). The hinge and shear 
classification of the domain movements was determined using the Dynamic 
Contact Graphs (DCG) method described by Taylor et al. (2013; 2014). This 
method is based on the contact changes between residues from different 
domains as a result of the domain movements. There are five types of contact 
changes named as: ‘no contact change’, ‘new contact change’, ‘maintained 
contact change’, ‘exchange-partner contact change’ and ‘exchange-pair contact 
change’. PyMOL (The PyMOL Molecular Graphics System, Schrödinger, LLC) 
was used to visualise residues have contact changes and the Bioinformatics 
Toolbox in MATLAB (MATLAB 2014b, The MathWorks Inc, Natick, MA) was used 
to create the DCG when determining the classifications. The value of y(N) can be 







                           (3.1)                                           
Where y(N) is the logistic regression of the numbers of the four different types of contact 
changes and α = -0.2387Nmaint – 0.0356Nexchpart + 0.4249Nexchpair + 0.2122Nnew + 0.1467. 
The classification was determined as follow: 
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                       Shear motion: 0 ≤ y ≤ 0.45 
                       Mixed motion: 0.45 < y < 0.55 
                       Hinge motion: 0.55 ≤ y ≤ 1.0 
3.3.8 Kinetic assay 
BPBGD kinetic assay was conducted for WT and all mutant proteins according 
to the method described by Jordan et al (1997). A 25 μl aliquot of the enzyme 
(0.5 mg/ml) was pre-incubated with 75 μl of 20 mM Tris-HCl buffer, pH 7.2, at 
37°C in a water bath for 2 min. The reaction was initiated by the addition of 50 μl 
of a pre-warmed PBG solution ranging from 0.05 mM to 2.5 mM. 65 μl of 5 M HCl 
was added to stop the reaction after 5 min at 37°C, followed by the addition of 25 
μl of fresh benzoquinone solution [0.1% (w/v) in methanol] in order to oxidise the 
porphyrinogens to porphyrins. Each sample was then stored on ice in the dark 
for 20 min after which 50 μl of saturated sodium metabisulphite was added to 
decolourise any remaining benzoquinone. The sample was then diluted 10-fold 
with 1 M HCl and any precipitate was removed by centrifugation. The absorbance 
was determined at 405.5 nm (EM = 548000 M-1 cm-1) using a Ultrospec 3000 
UV/Visible Spectrophotometer (GE Healthcare, Buckinghamshire, UK) and the 
kinetic calculation and figure plotting were achieved using OriginPro 9.1 









3.4.1 Protein preparation 
Successful expression of each protein was suggested by a clear band slightly 
larger than 35 kDa on the SDS-PAGE gel, see Figure 3.11a for the D82N mutant. 
Heat shock at 42°C followed by incubating at 16°C was found to be necessary 
for producing soluble proteins. The initial purification was undertaken by nickel 
affinity chromatography which allowed his-tagged proteins to be purified under 
gentle and non-denaturing conditions. All the fractions from the column including 
the loading flow-through (L), the wash-through (W) and the eluted sample (E), 
were collected for SDS-PAGE analysis (Figure 3.11b). The strong band observed 
in the eluted sample indicated successful purification of the desired protein. The 
His-tag was then removed by thrombin digest and the cleaved protein (lane T) 
was found to be slightly smaller in molecular mass compared with the one in the 
eluted sample, suggesting that the His-tag plus a few residues (2 kDa) had been 
removed from the protein. Gel filtration was undertaken to further purify the 
proteins and to exchange the high salt wash buffer to Tris buffer (50 mM Tris, 100 
mM NaCl, pH 7.3). The purified proteins were concentrated to 5 mg/ml using a 
Vivaspin centrifugal concentrator (GE Healthcare, Buckinghamshire, UK) before 




Figure 3.11 SDS-PAGE for D82N expression and purification. Lanes M, N, I, S, P, L, W, E 
and T correspond to the marker, non-induced, induced, supernatant, pellets, loading flow-
through, wash-through, eluted and thrombin-digested samples. The D82N mutant of BPBGD 
protein is indicated by the arrows. 
3.4.2 Protein crystallisation 
It proved to be fairly difficult to crystallise the PBGD mutant proteins from different 
sources. Different screening kits, temperatures, additives and methods like 
proteolysis (Keegan et al., 2014), lysine methylation to reduce surface entropy 
(Sledz et al., 2010) were tried, but no crystal-like objects were obtained. By 
chance, a few small crystal-like needles of D82N mutants were obtained in 
condition 2 of the Structure Screen 1 kit (0.2 M ammonium acetate, 0.1 M sodium 
acetate pH 4.6, 30% PEG 4,000) from Molecular Dimensions and a thick yellow 
crystal (Figure 3.12) was obtained in condition 14 of the same kit (0.2 M 
ammonium sulphate, 0.1 M sodium cacodylate, pH 6.5, 30% PEG 8,000). 
Subsequent optimisation revealed that better crystals of all the mutant proteins 
could be obtained reproducibly in 0.2 M ammonium acetate, 0.1 M sodium 
acetate pH 3.5 - 4.0 and 22 - 28 % PEG 4,000. However, condition 14 was quite 
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difficult to reproduce. The optimisation of condition 2 showed that the mutants 
prefer crystallising at final pH values of around 5.7 in each drop. 
 
Figure 3.12 An unusual form of D82N crystal. The crystal was obtained in 0.2 M ammonium 
sulphate, 0.1 M sodium cacodylate, pH 6.5, 30% PEG 8,000, which was quite difficult to 
reproduce. One small unit on the scale is 10 microns. 
3.4.3 Data collection, data processing, structure determination and 
refinement 
All of the three mutant proteins diffracted reasonably well during data collection, 
but there were some differences. While D82E diffracted the best of all with a high 
resolution limit of 1.81 Å, D82A had the lowest resolution of 2.76 Å, leaving D82N 
in the middle with a resolution of 1.87 Å which was close to that of D82E. The 
same trend could be seen with the other parameters for the data collection, data 
processing and refinement such as the mosaic spread, Rmerge, Rmeas and I/σI. This 
might be because there was a big difference in the status of the cofactor. It was 
found that, by comparing the structures solved later, the D82E mutant has the 
cofactor bound tightly while the D82A has nothing observable in the active site. 
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In contrast, the D82N has only the C1 ring present (Figure 3.13). Residues from 
40 to 60 in D82A, D82E and from 40 to 59 in D82E were missing in the structure 
which might be due to proteolytic digest during the treatment with thrombin or the 
flexibility of these residues themselves. 
It was mentioned by Woodcock and Jordan that the mutant PBGD enzymes could 
bind to the substrate PBG to form stable enzyme-substrate complexes depending 
on the PBG concentration and these complexes could be separated by ion-
exchange chromatography (Woodcock and Jordan, 1994). All the mutant 
enzymes were co-crystallised with different concentrations of the PBG but, 
unfortunately, no crystal of any of the intermediate complexes was obtained. 
Table 3.2 The Ramachandran statistics for BPBGD mutant structures. 
 D82E D82N D82A 
Ramachandran  
favoured (%) 
97.5 97.6 99.3 




Figure 3.13 The electron density map for the DPM cofactors and a selection of the 
surrounding active-site residues in all the mutant structures. There is almost no density for 
the cofactor in D82A and for the C2 ring of the cofactor in D82N, while the D82E mutant 
shows good density for both rings of the cofactor [Figure from (Guo et al., 2017a)]. 
3.4.4 Ehrlich’s reaction 
The free α-position of the DPM cofactor of PBGD can react with Ehrlich’s reagent 
which initially gives a dark purple colour to the solution and has a λmax at 565 nm. 
This is because of the formation of a double bond between the para-
dimethylaminobenzaldehyde (DMAB) and the free α-position of the DPM cofactor, 
as shown in Figure 3.14. The colour changes to orange after 15 min which gives 





Figure 3.14 The reaction of the DPM cofactor with Ehrlich’s reagent [Figure from (Guo et al., 
2017a)]. 
All the WT and mutant BPBGD enzymes were treated with Ehrlich’s reagent and 
the absorbance of each sample was monitored at both 1 min and 15 min after 
initiation of the reaction. As shown in Figure 3.15, the WT BPBGD had a distinct 
peak at 565 nm at 1 min which shifted to 495 nm after 15 min, confirming the 
existence of the cofactor. The D82E mutant protein had the same peaks which 
also proved the presence of the cofactor. In contrast, the peaks were much lower 
in the D82A sample, which indicated that the occupancy of the cofactor was 
probably quite low in this mutant. The loss of the C2 ring in the D82N mutant 
actually didn’t affect the binding of the DMAB which can also bind to the C1 ring 
of the cofactor, as indicated by the peak at around 565 nm. However, the lower 
peak at 495 nm may indicate that less conjugated DMP is being formed because 




Figure 3.15 Absorbance spectrum of the products of the Ehrlich’s reactions. The column on 
the left indicates the spectrum after 1 minute and the column on the right corresponds to the 
spectrum after 15 minutes. W, E, N and A stand for the WT, D82E, D82N and D82A with the 
numbers after them representing 1 min and 15 min [Figure from (Guo et al., 2017a)]. 
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3.4.5 Domain movements 
The DynDom website was used to determine the domain movements, the screw 
axis and the bending residues during the domain movements. It was confirmed 
that domains 2 and 3 tend to move together as a rigid body except that there is 
an additional local movement of the α22-helix and the α32-helix in domain 2 
(Figure 3.16b). Superposition of domains 1 and 3 of the WT BPBGD structure 
individually with the counterparts in all the mutant proteins gave RMSD values of 
around 0.4 Å, which were not significant. However, there were bigger differences 
in domain 2 with RMSD values of all above 0.85 Å. RMSD values of all above 1.0 
were observed when considering the whole protein as a rigid body in the 
superpositions (Figure 3.16a, Table 3.3). 
When considering domains 2 and 3 as a rigid part, domain 1 in the mutants was 
found to rotate about 7° with negligible translation when compared with the WT. 
Thus a screw axis representing the rotation and translation movements between 
each pair of structures (WT and D82E, WT and D82N, WT and D82A) was 
generated using DynDom (see Figure 3.17 as an example for the pair between 
WT and D82A). The contact changes were determined using PyMOL and 
Dynamic Contact Graphs were produced using MATLAB (Figure 3.18 as an 
example of D82A). According to equations 3.1, D82A has a y(N) value of 0.921 
indicating that its domain movements can be classified as a pure hinge motion. 
D82N has a hinge motion as well, whilst D82E seems to have a mixed type with 
both hinge and shear motions as indicated by a y(N) value of 0.456. However, 
this is likely to be caused by the flexibility of a few side chains which are not well 






Figure 3.16 Superposition of BPBGD WT and mutant structures. a) Secondary structure 
superposition of the WT (green), D82A (red), D82N (yellow) and D82E (orange) BPBGD 
structures. b) Least-squares superposition of all the structures by domains 2 and 3 indicating 
a clear movement of domain 1 and some local movements of α22-helix and α32-helix in 
domain 2 [Figure from (Guo et al., 2017a)]. 
Table 3.3 Superposition RMSD values, rotation angles and translation distances between 
equivalent domains of the WT and mutant BPBGDs [Table from (Guo et al., 2017a)]. 





 All Cα Domain 1 Domain 2 Domain 3   
D82A 1.12 0.430 0.87 0.49 7.4 0.2 
D82E 1.04 0.37 0.86 0.49 7.2 0.1 






Figure 3.17 The inter-domain screw axis. Domain 1 rotates and translates along this axis 
which results in the ‘open’ (D82A, red) and ‘closed’ (WT, green) conformations of the protein 
[Figure from (Guo et al., 2017a)]. 
In addition, there is no structural difference between the D82N crystal obtained 
at a lower pH (5.7 in droplet ) and the one obtained at a higher pH (7.0 in droplet) 
which suggests that the domain movement is probably caused not by the lower 
pH, but by the mutation itself. This is consistent with Awan et al. (1997) who 
suggested that the E. coli PBGD crystal structure determined at pH 5.1 is likely 




Figure 3.18 The Dynamic Contact Graphs for the WT and D82A BPBGD structures. A blue 
square corresponds to a residue in domain 1 and a red square corresponds to a residue in 
domains 2&3 with the residue number labelled in the middle. 
3.4.6 BPBGD kinetic assay 
The substrate PBG is converted to preuroporphyrinogen by PBGD at a suitable 
pH. The product preuroporphyrinogen is highly unstable and will be converted to 
uroporphyrinogen I in the absence of the next enzyme uroporphyrinogen III 
synthase or converted to uroporphyrinogen III in the presence of this enzyme. 
Both uroporphyrinogen I and III can be oxidised to form uroporphyrin by the 
addition of benzoquinone. Uroporhyrin has a λmax at 405.5 nm and produces a 






Figure 3.19 Mechanism of the PBGD kinetic assay. Without the presence of 
uroporphyrinogen III synthase, the assay follows the pathway shown on the left, in which the 
preuroporphyrinogen is converted to uroporphyrinogen I which is then oxidised to 
uroporphyrin I that has a λmax at 405.5 nm. The reaction follows the pathway on the right if 





A range of PBG concentrations from 0.05 to 2.5 mM were assayed with both the 
WT and the mutant enzyme. Samples with higher concentrations of PBG turned 
pink after incubation with benzoquinone on ice in the dark for 20 min. The colour 
of the mutant samples disappeared after the addition of sodium metabisulphite 
while the colour of the WT samples did not, indicating the existence of porphyrin. 
The concentration of product was calculated from the OD405.5 values according 
to the Beer-Lambert law (equation 3.2) and the KM was calculated according to 
the Michaelis – Menten equation (equation 3.3). Figure 3.20 shows the kinetic 
curves for the WT and the D82E enzymes, which have KM values of 1.38 μM and 
7.71 μM and kcat values of 5.8 × 10-2 s-1 and 6.57×10-5 s-1, respectively. In 
conclusion, the D82E mutant showed a significantly reduced activity while the 
D82A and the D82N mutants were completely inactive. 












Figure 3.20 Michaelis–Menten kinetic curves for the WT and D82E BPBGDs. 
3.5 Discussion 
3.5.1 Domain movements 
Domains of multi-domain proteins are often linked by flexible regions that allow 
them to move relative to one-another. Since the catalytic mechanisms of many 
enzymes can be dependent on domain movements, static information that can 
be obtained by comparison of domains in open and closed crystallographic 
structures, such as those of ligand-bound and ligand-free forms or WT and 
mutant structures, is of great importance. Characterisation of domain movements 
134 
 
is important for understanding how a protein folds or reorganises its domains to 
attain its functional state and how it functions once it is there. 
When considering individually, superposition of WT BPBGD with the three mutant 
structures shows that there are small differences in domains 1 and 3 with RMSD 
values around 0.4 Å. In contrast, there are larger differences between them in 
domain 2 with RMSD values of all above 0.85 Å. This could be because of the 
local movements in the second and third α-helices (α22 and α32) (Roberts et al., 
2013) which can be found in all of the mutant structures and affect the shape of 
the active site cleft (Figure 3.16b). All of the RMSD values are appreciably lower 
than those obtained when the crystallographic structures are superposed as a 
rigid compilation of the three domains, which give RMSD values of all above 1.0 
Å (Figure 3.16a, Table 3.3). 
By comparison of domains 2 and 3 in the A. thaliana and E. coli PBGD structures, 
it revealed that the two domains move in a concerted manner with respect to 
domain 1 (Roberts et al., 2013). The same effect could also be seen when 
comparing the structures of WT and mutant B. megaterium enzyme. In addition, 
these mutant structures exhibit a marked local movement of α-helices α22 and 
α32 which further opens the active site cleft. The differences in the relative domain 
orientation are emphasized most clearly when the WT and mutant structures are 
superposed by domains 2 and 3, as shown in Figure 3.16b. This is also confirmed 
by a separate analysis using the protein domain motion website, DynDom, which 
automatically defines domains 2 and 3 as a fixed unit and domain 1 as the moving 
partner. Specifically, domain 1 has a rotation of more than 7.0 degrees about the 
inter-domain axis in all the mutant structures compared with the WT enzyme 
which leads to an opening of the active site cleft (Figure 3.21a). To date, as far 
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as we are aware, this is the largest domain rotation that has been reported for 
this enzyme family. It is stated by Chasles’ theorem that any rigid body 
displacement is a screw motion in which there is a translation along an axis 
followed by a rotation about the axis. In this case, there is quite a small translation 
of only 0.1 Å or 0.2 Å in the mutants which means that the domains move mainly 
in a rotation mode or as a hinge motion (Gerstein et al., 1994). Compared with 
more complicated shear or mixed motion, hinge movements are relatively simple 
and allow parts of the respective domains to approach each other perpendicular 
to the plane of the domain interface. This hinge motion of BPBGD has also been 
confirmed quantitatively using Dynamic Contact Graphs (Taylor et al., 2013; 
Taylor et al., 2014). Residues 99, 100 and 198, which reside in the linker region 
between domain 1 and 2, are recognised by DynDom as bending residues and 





Figure 3.21 BPBGD domain movements. a) Superposition of the WT (green) and D82A (red) 
structures via domains 2 and 3 emphasises the hinge movement of domain 1 about the screw 
axis which is shown in purple. b) A similar superposition made using a model of the missing 
residues in the active site flap of BPBGD which were built according to the structure of the A. 
thaliana enzyme. This suggests a possible route for substrate (shown as ball-and-stick model 
on the left) to gain access to the active site when the structure is in the more open state that 
is apparently adopted by the mutants [Figure from (Guo et al., 2017a)]. 
The amino acid residues from 40 to 60 are missing in the BPBGD WT and mutant 
structures. In the structure of the A. thaliana enzyme, these residues form two α-
helices and loop regions which altogether cover the active site of the protein 
(Roberts et al., 2013). The absence of this region in the B. megaterium enzyme 
could be due to proteolysis caused by the addition of thrombin to remove the His-
tag or by protease impurities during storage of the enzyme or crystallisation. It is 
reasonable to assume that this region of the enzyme is more ordered in vivo since 
it is highly conserved and forms many contacts with the DPM cofactor. Hence, 
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we modelled the missing residues of the B. megaterium enzyme based on the 
plant PBGD structure, as shown in Figure 3.21b. If this model is correct, then the 
movement of domains 2 and 3 away from domain 1 (which is also enhanced by 
the local movement of the helix α22 in domain 2) could be critical to let the 
substrate gain access to the active site. Once the substrate has gained entry, it 
would be quite close to both the free α-position of the C2 ring of the cofactor and 
the catalytic residue Asp82 of the enzyme, so that condensation can occur. 
Further substrate moieties can then get into the active site and bind in a large 
cavity close to the catalytic aspartate such that they become connected, one by 
one to ultimately form a hexamer. 
Although the structures of the three mutants are similar to each other, they do 
have some slight differences. In general, when they are superposed by domains 
2 and 3, there are small movements in domain 1. The D82E mutant has the most 
closed conformation while the D82A mutant has the most open one, leaving 
D82N as the intermediate of the three mutant structures. 
3.5.2 Active site and cofactor electron density 
The DPM cofactor is covalently attached to Cys241 in domain 3 in the WT 
BPBGD by a thioether link. It has been shown that there are a number of 
conserved amino acid residues, mainly arginine residues, which bind the acidic 
side chains of the cofactor through many ionic interactions (Wood et al., 1995). 
Additionally, the catalytic residue, Asp82 in domain 1, forms hydrogen bonds with 




Inspection of the electron density in the active site of the mutant structures shows 
that there is no electron density for the whole of the cofactor in the D82A mutant. 
In contrast, there is good density for only the C1 ring of the cofactor in the D82N 
mutant, but in the D82E mutant there is good electron density for both of the 
cofactor rings (Figure 3.13). This suggests that the whole cofactor in the D82A 
mutant and the C2 ring of the cofactor in the D82N mutant are missing, or at least 
highly flexible. This was also consistent with the result of Ehrlich’s reaction, which 
can be used to determine the DPM cofactor status in the active site of the enzyme. 
In the D82E mutant structure, the active site arginine residues are still in almost 
the same position as in the wild structure, keeping the cofactor firmly in place. In 
the D82N mutant structure, the arginine residues (129, 130 and 153) which are 
close to the side chain of the C1 ring can still form strong interactions (donor-
acceptor distances around 2.75 Å) with the C1 ring, but those which are close to 
the C2 ring in the WT structure are all moved back to some distance (> 3.15 Å), 
perhaps making it difficult for the C2 ring of the cofactor to bind firmly, as its lack 
of electron density would suggest. In addition to this, there are two conserved 
water molecules in the WT and D82E structures which mediate 4 hydrogen bonds 
between Arg174, Gln17 and the side chain of the C2 ring of the cofactor. These 
two water molecules are missing in the D82N structure which makes it impossible 
to form these hydrogen bonds. A similar trend can be seen in the D82A structure 
which completely lacks the cofactor and has the most open of all the mutant 
structures. 
Enzyme kinetic studies showed that the D82A and D82N mutants were 
completely inactive. In contrast, the D82E mutant enzyme was found to react 
much slower compared with WT enzyme. This mutant has a KM of 7.71 μM and 
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a kcat of 6.57×10-5 s-1 which compares with values of 1.38 μM and 5.8 ×10-2 s-1, 
respectively, for WT BPBGD. This is consistent with the structural information that 
has been obtained showing that the D82E mutant has the whole cofactor bound 
in a well-ordered manner, while the others either do not assemble the complete 
cofactor or are not able to bind it sufficiently tightly to allow the electron density 
for both rings to be resolved. 
3.6 Future work 
1. Woodcock et al. (1994) found that the mutant PBGD enzymes could bind to 
the substrate PBG to form stable enzyme-substrate complexes. These 
complexes could be separated by ion-exchange chromatography (Woodcock and 
Jordan, 1994). Previous studies on co-crystallisation of the substrate and mutant 
enzymes failed to get crystals of any of the complexes. It would be worth trying 
to get stable complexes first and then crystallise them directly to see if their 
structures could be obtained. 
2. In the substrate analogue α-bromoporphobilinogen, the reactive α-position of 
porphobilinogen is blocked by a bromine atom (Figure 3.22). Hence this 
compound acts as a chain terminator and suicide substrate in the polymerisation 
reaction. It has been used to investigate the catalytic mechanism of PBGD during 
the tetrapolymerisation reaction. When α-bromoporphobilinogen was incubated 
with PBGD, not only was the enzyme inactivated, but the Ehrlich’s reaction was 
also inhibited. It reacts with all of E, ES, ES2 and ES3 and produces EBr, ESBr, 
ES2Br and ES3Br, respectively (Figure 3.23), where Br indicates 
bromoporphobilinogen. All of these complexes can also be isolated (Warren and 
Jordan, 1988). Thus, future work on this project includes synthesis of α-
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bromoporphobilinogen as well as α-iodoporphobilinogen and trying to get the 
complex structures to understand how the substrate moieties bind to the active 
site in the different intermediates. 
   
Figure 3.22 Structure of α-bromoporphobilinogen. The otherwise free α-position of the 

















Figure 3.23 Complexes formed between PBGD and α-bromoporphobilinogen. EBr, ESBr, 
ES2Br and ES3Br are formed through inhibition of the reaction of PBGD with the substrate 










4. Chapter 4 
Structural studies of a Kunitz-type 










This chapter is based on the work published by Guo et al. (2015). 
4.1 Introduction 
4.1.1 Protease inhibitors 
Proteases regulate the synthesis, activation and turnover of proteins. 
Uncontrolled proteolysis is harmful to cellular functions and is related to many 
diseases such as cancer (Bell-McGuinn et al., 2007), Alzheimer’s disease (De 
Strooper, 2010), emphysema (Greene and McElvaney, 2009) and pancreatitis 
(Kitagawa and Hayakawa, 2007). Nature has developed many strategies to 
control proteolysis, one of which is to produce polypeptides known as protease 
inhibitors (PIs). PIs inhibit the activity of their target proteases by forming 
protease-inhibitor complexes through their reactive-site loops and the active site 
of the target proteases (Rakashanda et al., 2012). PIs work as antibiotics and 
pesticides by targeting against hydrolytic enzymes of pests and microbes to 
prevent their growth, which is adopted by many plants (Satheesh and Murugan, 
2011). PIs are particularly abundant in plant storage tissues including fruits, 
seeds and tubers, for example, 50% of the total weight of the soluble proteins in 
potato juice is contributed by PIs (Pouvreau et al., 2001) and their expression is 
increased under environmental stress or during wound healing. PIs prevent plant 
seeds from being digested in a predator’s gut which acts as a defensive 
mechanism. In addition, it has been suggested that they also have anti-tumour 
effects in colon, breast, skin and prostate cancers (Correa, 1981; Li et al., 2009). 
4.1.2 Classification of PIs 
Based on the amino acid sequence homology, structure, reactive-site location, 
disulphide bridges and the proteases they inhibit, PIs can be classified into eight 
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distinct families known as: Kunitz, cereal, squash, potato, mustard, cystatin, 
Kininogen, and Bowman-Birk (Habib and Fazili, 2007). Kunitz-type protease 
inhibitors are mostly active against serine proteases but can also inhibit aspartic 
and cysteine proteases (Oliva et al., 2010). These inhibitors usually have a 
molecular mass of around 20 kDa and have a low cysteine content forming two 
disulphide bridges. The 3-dimensional structure is characterised with a β-trefoil 
composed of 12 antiparallel β-strands with long protruding loops, some of which 
act as the reactive sites for proteases (Figure 4.1). Single-headed Kunitz-type 
inhibitors (Khamrui et al., 2005) have only one reactive site while double-headed 
inhibitors (Azarkan et al., 2006) have two reactive sites which can bind two target 
molecules (Figure 4.1). Kunitz-type protease inhibitors bind tightly to their targets 
in competitive and non-competitive ways and the complexes dissociate fairly 
slowly (Migliolo et al., 2010; Ritonja et al., 1990). The reactive site of Kunitz-type 
trypsin inhibitors often possesses a Lys or Arg residue. 
Protease inhibitors can also be placed into four classes based on the targets they 
inhibit, known as serine protease inhibitors, aspartic protease inhibitors, cysteine 
protease inhibitors and metallocarboxy protease inhibitors. The serine protease 
inhibitor (SPI) family is the largest one among all the four families. Most SPIs 
have a molecular mass between 3 and 25 kDa and can inhibit trypsin and/or 
chymotrypsin. The two best characterised SPI families are the Kunitz-type and 
Bowman-Birk type inhibitors. They have different molecular masses, cysteine 
contents and numbers of reactive sites compared with other families (Richardson, 
1977) and their structures are stabilised mainly by hydrophobic interactions of 





Figure 4.1 Structure of a PI-protease complex. The tertiary structure of a Kunitz-type double-
headed arrowhead protease inhibitor A (API-A) complexed with two trypsin molecules (PDB 
ID: 3E8L) (Bao et al., 2009). API-A adopts a β-trefoil composed of 12 antiparallel β-strands, 
6 of which form the ‘bottom’ barrel (blue) covered by a ‘cap’ (red) composed by the other 6 
strands. API-A binds to the two trypsin molecules through the two reactive site residues 
Lys145 and Leu87. 
Aspartic protease inhibitors (APIs) contain only the Kunitz-type family. They are 
characterised by a molecular mass of 20-22 kDa and two disulphide bridges. It 
has been proved that APIs inhibit cathepsin D and may inhibit trypsin and/or 
chymotrypsin as well (Park et al., 2005). APIs are rare in nature and have been 
identified in plants such as tomato (Solanum lycopersicum) (Werner et al., 1993), 
potato (Solanum tuberosum) (Guo et al., 2015) and wheat (Triticum aestivum) 
(Galleschi et al., 1993). 
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4.1.3 Cathepsin D 
Cathepsin D (EC 3.4.23.5) belongs to the aspartic protease family and is 
ubiquitously distributed in lysosomes. Like other aspartic proteases, the catalytic 
process of cathepsin D depends on the protonation of the catalytic Asp residues 
in the active site and it can accommodate up to 8 amino acid residues in the 
active site. It is involved in the degradation of intracellular and internalized 
proteins, activation and degradation of polypeptide hormones and growth factors, 
it also participates in brain antigen processing and regulates programmed cell 
death (Benes et al., 2008). 
4.1.4 Potato cathepsin D inhibitor 
Potato cathepsin D inhibitor (PDI), isolated from Solanum tuberosum, is one of 
the natural cathepsin D inhibitors. It belongs to the Kunitz-type protease inhibitor 
family and has been reported to inhibit both bovine cathepsin D and trypsin with 
Ki values of 3.8 × 10-7 M and 8.6 × 10-9 M, respectively (Keilova and Tomášek, 
1976a; Keilova and Tomášek, 1976b; Mareš et al., 1989). It is highly homologous 
to many known serine protease inhibitors including potato serine protease 
inhibitor (PSPI, PDB ID: 3TC2) (Meulenbroek et al., 2012) and soybean trypsin 
inhibitor (STI, PDB ID: 1AVX) (Song and Suh, 1998). Previous studies showed 
that PDI is a single polypeptide consisting of 188 amino acids with a molecular 
mass of 20.6 kDa, and has high pH- and thermal-stability (Keilova and Tomášek, 
1976a; Keilova and Tomášek, 1976b). PDI is expressed in flower buds and potato 
tubers, and the expression is induced during wounding and treatment of leaves 
with the plant hormones abscisic acid and jasmonic acid (Hannapel, 1993; 
Herbers et al., 1994). Transgenic plants, which have been modified to over-
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express protease inhibitors, have shown improved resistance to pests, 
presumably due to the anti-nutritional effects on predatory insect larvae (Schluter 
et al., 2010; Srinivasan et al., 2005). 
There are six cysteine residues in PDI which form three disulphide bridges (Mares 
et al., 1989). It is a glycoprotein which contains 2 GlcNH2 residues and the -NH2 
group of the side chain of Asn19 acts as the attachment point for the carbohydrate 
moiety to form an Asn-linked oligosaccharide (Kornfeld and Kornfeld, 1985). 
Several isoforms of PDI have been identified from the genome sequence study 
of potato (Consortium, 2011; Hirsch et al., 2014) and they share a high sequence 
identity of above 90%. The isoform reported here is encoded by the aspartic 
protease inhibitor 8 gene, which also encodes an N-terminal pre-sequence (31 
residues) composed of a predicted endoplasmic reticulum (ER) secretion signal 
and a putative N-terminal vacuolar sequence determinant (NLIDL) separated by 
a cleavage site between residues 18 and 19. It is likely that the Kunitz-type 
protease inhibitors are primarily stored in the storage vacuoles of potato tuber 
cells (Jørgensen et al., 2011) and are finally secreted into the apoplast or 
extracellular space, where they inhibit proteases produced by predatory microbes 
in order to protect the plant cell wall (Jashni et al., 2015). The closest homologue 
of PDI, which shares 93% amino acid sequence identity, is encoded by the 
aspartic protease inhibitor 5 gene (Ritonja et al., 1990). It shows a much stronger 





4.2 Project Aim 
The aim of the project was to determine the crystal structure of PDI and then 
identify the reactive sites for cathepsin D and trypsin based on the structure. 
4.3 Methods 
4.3.1 Crystallisation 
A freeze-dried powder of PDI was a gift of Prof. Vladimir Kostka (Institute of 
Organic Chemistry and Biochemistry, Prague, Czech Republic) and had been 
purified as described by Keilova and Tomášek (1976b). It was dissolved in 50 
mM Tris, 100 mM NaCl pH 7.3 to a final concentration of 5 mg/ml. Screening of 
crystallisation conditions was performed with the same kits as described in 
section 2.3.1 by use of the hanging-drop method with a TTP Labtech Mosquito 
crystal screening robot (TTP Labtech, Hertfordshire, UK). All the 96-well plates 
were stored at 21 C and crystals started to appear after 7 days. Two crystals 
were harvested for data collection with crystal 1 (Figure 4.2a) being obtained in 
2.0 M NaCl and 10% PEG 6,000 and crystal 2 (Figure 4.2b) being obtained in 0.2 
M MgCl2·6H2O, 0.1 M Tris pH 8.5 and 20% PEG 8,000. These crystals were 
mounted in loops with 30% glycerol as a cryo-protectant and were flash-cooled 





Figure 4.2 Crystals of PDI. a) The cluster containing crystal 1 which belonged to the space 
group C2. b) The cluster containing crystal 2 which belonged to the space group C2221. Both 
of the crystals were separated into single pieces for data collection. [Figure originally from 
(Guo et al., 2015)]. 
4.3.2 Data collection, data processing, structure determination and 
validation 
X-ray data collection was undertaken at station I04-1 at DLS. Crystals 1 and 2 
diffracted to a resolution of 2.1 Å and 2.8 Å, respectively. Automatic data 
processing, performed at DLS, using xia2 (Winter, 2010) identified that crystal 1 
was monoclinic and belonged to the space group C2 while crystal 2 was 
orthorhombic and belonged to the space group C2221. The solvent contents, 
calculated with Matthews_coef (Matthews, 1968), suggested that both crystals 
had two molecules in the ASU. The recently solved structure for PSPI (PDB ID: 
3TC2, 73% sequence identity with PDI) (Meulenbroek et al., 2012) allowed the 
determination of the C2 structure by molecular replacement using the program 
Molrep (Vagin and Teplyakov, 2010) in the CCP4 suite (Winn et al., 2011). The 
refined C2 structure was then used as the search model for the analysis of the 
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C2221 structure by molecular replacement. Manual rebuilding and introduction of 
sugar moieties were carried out by use of the program Coot (Emsley and Cowtan, 
2004). The structures were refined using Refmac5 (Murshudov et al., 2011) and 
validated with MolProbity (Chen et al., 2010). All the statistics for data processing 
and refinement are shown in table 4.1. 
Table 4.1 X-ray statistics for the two PDI structures. Values in parentheses are for the outer 
resolution shell [Table from (Guo et al., 2015)]. 
 Crystal 1 Crystal 2  
Beamline I04-1 (DLS) I04-1 (DLS) 
Wavelength (Å) 0.9173 0.9173 
Space group C2 C2221 
Unit-cell parameters (Å) 
a (Å) 75.5 70.9 
b (Å) 124.8 119.5 
c (Å) 37.9 131.1 
β (°) 95.1 90.0 






Rmerge (%) 7.3 (96.9) 15.6 (78.2) 
Rmeas (%) 10.0 (132.8) 18.2 (91.5) 
CC½ (%) 99.6 (31.3) 99.3 (83.8) 
Completeness (%) 96.0 (70.8) 99.5 (95.2) 
Average I/σ(I) 8.3 (0.8) 8.8 (2.9) 
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Multiplicity 3.3 (2.5) 6.9 (6.9) 
No. of observed reflections 63,269 (2,588) 93,388 (6,614) 
No. of unique reflections 19,145 (1,024) 13,609 (963) 
Wilson plot B-factor (Å2) 42.1 36.6 
Solvent content (%) 44.6 64.6 
Rfactor (%) 19.4 19.3 
Rfree (%) 27.0 26.8 
RMSD bond lengths (Å) 0.013 0.013 
RMSD bond angles (°) 1.704 1.785 
No. of reflections in working set 19,858 13,652 
No. of reflections in test set 985 732 
Mean protein B-factor (Å2) 47.5 42.0 
 
4.4 Results and discussion 
4.4.1 Quality of the model 
These two crystals diffracted to medium and low resolutions and have been well 
refined as indicated by reasonable R-values and RMSD values. Most residues in 
the models fit well in the electron density map contoured at 1.0 RMSD while 
residues 145-155 of chain B in crystal 1, which are in a loop region, are missing 
probably due to the flexibility. The Ramachandran plot showed that the models 
of crystal 1 and 2 have 97.5% and 98.1% of the total residues in the allowed 
region. Similar to the other Kunitz-type protease inhibitor structures (Krauchenco 
et al., 2003; Song and Suh, 1998), all the loop regions including the reactive-site 
loops are relatively more flexible, which is indicated by high B-factors. This 
inherent high flexibility allows the loops to access the active sites of the target 
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proteases more easily. The 40.3 Å mean protein B-factor of crystal model 1 is 
slightly higher than expected for a resolution of 2.1 Å since it has been reported 
that PDI is very stable (Keilova and Tomášek, 1976a). This is presumably due to 
the less-than-ideal crystal quality as shown in Figure 4.2. 
4.4.2 Overall structure 
Each of the two structures analysed in different crystal forms contain two 
molecules in the ASU. The four molecules in both structures are quite similar in 
the core region, which is composed of 12 β-strands. Around 95% of the residues 
have an RMSD value of the Cα atoms of around 0.2 Å in any pair-wise 
superposition. In contrast, the RMSD values of Cα atoms of the loop regions 
between any two molecules are all above 0.8 Å, with the highest value of 1.1 Å 
between chain A of crystal 1 and chain A of crystal 2. In fact, some of the loops, 
such as the one from Arg154-Phe158, adopt different conformations in different 
structures and different chains. 
The overall structure of PDI is shown in Figure 4.3 which shows a typical β-trefoil 
fold common to several other Kunitz-type protease inhibitors such as PSPI and 
STI. The PDI structure consists of 12 antiparallel β-strands that form six pairs of 
double-stranded β-hairpins. Three of these hairpins (β1-β12, β4-β5 and β8-β9) 
form a short antiparallel β-barrel that is closed by a triangular-like “lid” at one side 
consisting of the remaining three hairpins (β2-β3, β6-β7 and β10-β11). The 12 β-
strands are connected by long protruding loops. The β-trefoil is characterised by 
three structural repeats around a pseudo-threefold axis of symmetry which 
coincides with the barrel axis. Each repetition unit is a four-stranded motif that 
contains about 60 amino acid residues. There are three disulphide bridges in PDI 
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structure known as: S1, Cys48-Cys93, S2, Cys142-Cys159 and S3, Cys150-
Cys153. The S1 and S2 disulphide bridges are also found in STI, which lacks S3. 
The S2 and S3 disulphide bridges apparently reduce the flexibility of the large 
loop from Cys142 to Ala160, which is much smaller and has fewer residues in 
other Kunitz-type inhibitors. There is a 310-helix at positions 91 to 96 which has 
also been found in STI (84-86) (Song and Suh, 1998), but not in this region in 
winged bean chymotrypsin inhibitor (WCI) (Ravichandran et al., 2001) and 
Erythrina trypsin inhibitor (ETI, PDB ID: 1TLE) (Onesti et al., 1991). This 310-helix 
protrudes from the centre of PDI and STI and can be cleaved by subtilisin, which 
is a serine protease, through the bond between Met84 and Leu85 in STI 
(Laskowski et al., 1974). It is possible that this region is the reactive-site loop for 
serine proteases like trypsin. One molecule of N-acetylglucosamine (NAG) has 
also been found connecting to residue Asn19 in all chains in the two crystal 
structures except for chain B in crystal 1. One molecule of carbonate was fitted 
in the map between Asp35 and Gln186 in chain A, crystal 1. 
The overall structure of PDI is similar to the Kunitz-type serine protease inhibitors. 
The structure of several of these inhibitors have been reported including PSPI, 
RASI (rice bifunctional alpha-amylase subtilisin inhibitor, PDB ID: 2QN4, 
unpublished work), STI and WCI. PSPI has the highest amino acid sequence 
similarity of 73% to PDI. The other three protease inhibitors have sequence 
similarities of 32%, 26% and 26%, respectively. Figure 4.4 shows the sequence 
alignment of PDI with these protease inhibitors. Their amino acid sequences are 
more similar in the skeleton part, which is composed of the 12 β-strands, 
compared with the loop regions which contribute to the specificity of the inhibitors. 
Structural superposition also shows that the similarity is mostly in the β-strand 
154 
 
scaffold, with the loops being different among each other. There is statistical 
evidence that the formation of the β-trefoil fold is due to a double gene duplication 
which makes it possible for these Kunitz-type protease inhibitors to have a 
common ancestor (Ponting and Russell, 2000). 
 
Figure 4.3 The overall structure of PDI. The cartoon diagram shows the β-trefoil view from 
the bottom side to the lid. The three disulphide bridges are labelled as S1, S2 and S3 and 








Figure 4.4 Sequence alignment and the secondary structure characteristics of PDI with 
several other Kunitz-type serine protease inhibitors. Beta-strands are labelled according to 
the PDI structure and are indicated by black arrows. All the conserved residues are boxed 
and the fully conserved residues are coloured in white with a red background, while the not 
fully conserved residues are coloured in red. The three disulphide bridges are labelled in 
green numbers. Alignment was performed using ESPript 3.0 website (Gouet et al., 2003; 





4.4.3 Identification of reactive-site loops 
4.4.3.1 Reactive-site loops for trypsin 
The putative reactive-site of PDI for trypsin, as described in UniProt (accession 
number P16348), is around residues Arg67 and Phe68 which was predicted by 
sequence alignment with STI. However, inspection of PDI structure indicated that 
these two residues are located in the middle of a β-strand which is not exposed, 
suggesting that other reactive-sites need to be considered. In order to find out 
possible reactive-site loops for trypsin, the PDI structure was superposed with 
several other Kunitz-type serine protease inhibitor-trypsin complexes including 
STI, WCI and API-A (Bao et al., 2009) using PyMOL. 
Two possible loops were identified with the first one being the loop from residues 
Leu71 to Leu80 (Figure 4.5 region 1), which is the most common reactive-site 
loop for Kunitz-type serine protease inhibitors. Arg63 and Ile64 have been 
discovered to be the P1 and P1’ residues in this loop in the structure of STI. 
Similarly, Leu65 and Ser66 are the P1 and P1’ residues in the equivalent loop in 
WCI (PDB ID: 1EYL). By comparison of several Kunitz-type trypsin inhibitors, it 
has been shown that the P1-P1’ residues are often a combination of two residues 
from Lys, Arg, Leu, Ile and Ser in the following pairs: Lys-Ile (API-A), Arg-Ile (STI), 
Leu-Ile (API-A), Leu-Ser (WCI) and Arg-Ser (ETI). Although there is Leu71-Ser72 
in the 71-80 loop of PDI, it is close to the β4-strand, making it less likely to access 
the active site of trypsin. However, the Gly74-Ile75 were identified as the P1 and 
P1’ residues because it has been reported in other Kunitz-type trypsin inhibitors 
that the relatively conserved Arg or Lys were replaced by a Gly or Glu which gave 
a pair of Gly-Ile or Glu-Ile (Srinivasan et al., 2005). These two residues reside in 
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the middle of the loop that adopts the canonical conformation of the Kunitz-type 
serine protease inhibitors. This would facilitate its recognition by a target protease. 
 
Figure 4.5 Structural superposition. Superposition of PDI structure (red) with the structures 
of PSPI (green), WCI (cyan) and API-A (yellow). The three predicted reactive-sites for trypsin 
and/or cathepsin D are labelled as regions 1, 2 and 3. 
A second reactive-site loop for trypsin was identified by structural superposition 
with API-A. Despite the fact that API-A shares a sequence similarity of only 11.8% 
with PDI, their overall structures are very similar including the 310-helix (Figure 
4.5 region 2) and the three disulphide bridges are at equivalent positions including 
the 3rd one which is not common in Kunitz-type serine protease inhibitors. API-A 
is a double-headed serine protease inhibitor which can bind two trypsin molecules 
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at the same time. Superimposing of PDI and API-A revealed the second possible 
reactive-site loop which is from residues Phe85 to Ile98 in PDI. The P1 and P1’ 
residues are Lys91 and Leu92 which have their equivalent residues as Leu87 
and Ile88 in API-A. As described before, Lys is one of the common residues in 
the P1 position while Leu is not common in P1’. However, it is still reasonable to 
have Leu87 in this position because of its similarity to Ile, which is common in P1’ 
position. This loop lacks a typical canonical conformation of Kunitz-type serine 
protease inhibitors, but the large positively charged Lys91 is protruding out into 
the solvent and would fit well in the trypsin active site. 
4.4.3.2 Reactive-site loops for cathepsin D 
Since no structures of aspartic protease inhibitors have been reported, it is 
difficult to directly identify the reactive-site loops for cathepsin D by structural 
superposition. However, by comparison with other Kunitz-type protease inhibitors, 
the loop from Cys142-Ala160 (Figure 4.5 region 3) in PDI is found to be much 
larger than its equivalent parts in other protease inhibitors. This loop is too small 
to be a reactive-site loop in some other protease inhibitors such as WCI and ETI. 
It contains two disulphide bridges in PDI, which are S2 (142-159,) and S3 (150-
153) as shown in Figure 4.3, with S3 not existing in most Kunitz-type protease 
inhibitors. So it is very likely that this loop is the reactive-site loop for cathepsin 
D. Since aspartic proteases tend to cleave the peptide bonds with hydrophobic 
and β-methylene groups, two possible pairs, Phe148-Leu149 and Phe152-
Cys153, are identified as the P1-P1’ residues which are all located in the middle 
of the loop. Actually, Phe152-Cys153 may be a better option because it can be 
recognised and cleaved by aspartic proteases but possibly cannot be released 
by the enzyme since Cys153 forms a disulphide bridge with Cys150. It has also 
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been found by sequence alignment that Phe152-Cys153 are highly conserved in 
all the aspartic protease inhibitors, whilst Phe148-Leu149 are less conserved. 
None of these residues are conserved in serine protease inhibitors. 
A second possible reactive-site loop could also be the one from Phe85 to Ile98 
containing the 310-helix and the Lys91 residue (Figure 4.5 region 2). Li et al. 
(2000b) reported that an aspartic protease was inhibited by a potent small protein 
IA3 in which the Lys18 residue plays an important role in the inhibition mechanism. 
The positively charged -NH3+ group of IA3 is within hydrogen bonding distance of 
the carboxyl oxygen of Asp32 of the aspartic protease and forms interactions with 
it. The inhibitor protein IA3 also forms a near-perfect amphipathic α-helix during 
the inhibitory process (Li et al., 2000a). The precursors of aspartic proteases have 
also been proved to possess a conserved Lys residue which occupies the 
position of the catalytically important water molecule and inhibits their activity by 
interacting with both of the Asp residues (Richter et al., 1999). For cathepsin D 
specifically, inhibition by a Lys residue based on a similar mechanism was also 
found in a catalytically inactive form. The N-terminal part, which contains the Lys8 
residue, is inserted into the active site cleft of cathepsin D at pH 7.5 and the 
enzyme activity is inhibited (Lee et al., 1998). Figure 4.6 shows the docking result 
of PDI with human cathepsin D using the website ClusPro without restraints 
(Comeau et al., 2004a; Comeau et al., 2004b). The highly unconstrained docking 
did give a good result with the loop containing Lys91 going deeply in the active 
site of cathepsin D in one of the top solutions. The –NH+ 3  group of Lys91 is within 
good hydrogen bonding distance with the four oxygen atoms of the two aspartate 
groups (all around 2.6 to 2.8Å). Structural superposition of the complex with 
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human cathepsin D showed that the –NH+ 3  group occupies the position of the 
catalytic water molecule as well. 
 
Figure 4.6 A docked model of PDI with human cathepsin D. PDI and cathepsin D are 
coloured as green and purple, respectively. The Lys91 (cyan) residue at the end of the 310-
helix is sticking out from PDI core and going deeply into the active site of the cathepsin D. 
The –NH+ 3  group (blue) of Lys91 is within hydrogen bonding distance to the four oxygen 
atoms (red) of the two Asp residues (yellow). [Figure originally from (Guo et al., 2015)]. 
4.5 Summary 
A very large proportion of the soluble proteins in plant tubers such as potatoes 
are protease inhibitors. These inhibitors provide a key defence mechanism 
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against pathogens and their expression is increased during wounding or other 
stress. Potato cathepsin D inhibitor belongs to the Kunitz-type protease inhibitor 
family and inhibits proteases in the aspartic- and serine-protease families. There 
are several isoforms of PDI in potato which share amino acid sequence identities 
as high as 90%. 
The crystal structure of PDI shows that it adopts a β-trefoil fold with three 
disulphide bridges formed between cysteines 48-93, 142-159 and 150-153. The 
third one is very unusual for Kunitz family protease inhibitors, which indicates that 
it may be involved in the functioning of this molecule as a dual serine- and 
aspartic-protease inhibitor. Although the structure is mainly composed of β-
strands, there is a short helical region from residues 91 to 96 which is a known 
reactive region in other serine protease inhibitors. PDI contains a likely 
recognition site for trypsin in this region which has been verified structurally in the 
API-A structure. The unique disulphide bridge in the long proline-rich loop 
indicates its possibility to be the reactive-site for cathepsin D, which is confirmed 
by the fact that this is a verified reactive site for a second trypsin molecule in the 
arrowhead inhibitor, the presence of several aromatic residues in this region, 
which is favourable for cathepsin D binding. However, the projecting Lys91 
residue in the loop (residues 91-96) suggests its possibility to be another 
attractive candidate in view of the structurally-verified ability of the aspartic 
protease active site to interact electrostatically with polypeptides containing this 
basic residue. Docking studies demonstrate that this is a plausible model as well. 
The 2.1 Å structural model and reflection file have been deposited in the PDB 







5. Chapter 5 
Structure of the family B DNA polymerase 











This chapter is based on the work published by Guo et al (2017c). 
5.1 Introduction 
5.1.1 Pyrobaculum calidifontis and Archaea 
Archaea are prokaryotes like bacteria, but they also share similarities with 
eukaryotes. Many proteins involved in information storage and processing 
encoded in their genomes are eukaryotic-like, whilst their operational proteins are 
mostly homologous to bacterial proteins (Forterre et al., 2002; Jain et al., 1999; 
Koonin et al., 1997). They are found in a broad range of habitats but some of 
them exist in extremely hot, salty, acidic, alkaline or high pressure environments. 
Pyrobaculum calidifontis is a hyperthermophilic and facultative aerobic archaeon 
that was first isolated from a hot spring in Laguna, the Phillipines (Amo et al., 
2002). The Latin word Pyrobaculum means ‘fire stick’ and calidifontis means ‘hot 
spring’. The P. calidifontis cells are rod-shaped and are usually 1.5 to 10 μm long 
and 0.5 to 1 μm wide (Amo et al., 2002). The organism has an optimal growth 
temperature between 90 C and 95 C, and an optimal pH of around 7 in aerobic 
conditions. 
5.1.2 DNA polymerases and their classification 
DNA polymerases (EC 2.7.7.7) function not only to replicate DNA but also to 
ensure the replication is accurate and correct. Following an annealed primer, 
DNA elongation is undertaken in the 5’ to 3’ direction with the catalysis by DNA 
polymerases. In addition to the polymerase activity, they can have 3’-5’ and/or 5’-




Based on the sequence homology and structures, DNA polymerases are 
classified into seven families including A (e.g. E. coli Pol I), B (e.g. E. coli Pol II), 
C (e.g. E. coli Pol III), D (e.g. Euryarchaeota Pol II), X (e.g. human Pol β), Y (e.g. 
human Pol η) and RT (e.g. reverse transcriptase). The C and D families are 
mainly replicative polymerases while the others are replicative and repair 
polymerases. Family B was given its name because it shares sequence 
homology with E. coli polymerase II which is encoded by the gene polB. Family 
B DNA polymerases are found in bacteria, eukarya, archaea, viruses, plants and 
even in bacteriophages. They are highly accurate and perform 3’-5’ proofreading 
of newly synthesised DNA so that any replication errors are corrected. 
DNA polymerases, especially those from thermophilic organisms, are used 
extensively in biotechnological methods including PCR, gene sequencing, site-
directed mutagenesis, DNA labelling and diagnostic purposes. The well-known 
Taq DNA polymerase (Taq Pol) was the first one to be characterised (Chien et 
al., 1976) and was then applied in biotechnology. The Taq Pol lacks 3’-5’ 
exonuclease activity which makes those with the ability, such as archaeal DNA 
polymerases, more popular of late because of their higher fidelity. The archaeal 
DNA polymerases are considered to represent the replication mechanism in 
higher organisms because they are in the same family as many of eukaryotic 
DNA polymerases. 
5.1.3 The DNA polymerase from P. calidifontis 
The gene encoding the DNA polymerase from P. calidifontis (Pc-polymerase) 
was cloned into a pET-21a plasmid and the protein was expressed and purified, 
as reported previously by Ali et al. (2011). The enzyme has a molecular mass of 
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approximately 90 kDa and is composed of 783 amino acids. It has an optimal 
temperature of 75 C, a half-life of 4.5 hours at 95 C and an optimal pH of 8.5. 
Thus it has greater thermostability compared with the widely-used Taq DNA 
polymerase. In addition, Pc-polymerase requires magnesium ions for activity and 
has been found to be inhibited by potassium and ammonium ions, while the Taq 
enzyme is dependent on monovalent cations. It is able to PCR-amplify larger 
DNA fragments of up to 7.5 kb. Similar to the DNA polymerases from P. furiosus 
(pfu) and T. kodakarensis (KOD1), Pc-polymerase is of high-fidelity, due to its 3’-
5’ exonuclease activity, which may have great commercial applications in future. 
5.1.4 The structure of DNA polymerases 
Many structures are available for DNA polymerases which show high 
conservation between them. The typical five-domain structure can be described 
as a ‘right hand’ with palm, fingers and thumb domains following the N-terminal 
domain which is followed by the 3’-5’ exonuclease domain (Figure 5.1) 
(Brautigam and Steitz, 1998). The exonuclease domain is composed of anti-
parallel β-strands with several catalytic carboxylate groups. The palm domain, 
which has a more conserved structure than the fingers and thumb domains, 
generally consists of 4 to 6 β-strands, two α-helices and three catalytic 
carboxylate residues. The fingers and thumb domains do not share much 
homology among different families. The fingers domain contains several residues 
whose side chains interact with the incoming deoxyribonucleoside triphosphate 
(dNTP). The thumb domain mainly constitutes parallel or anti-parallel α-helices 
and at least one of them makes contacts with the minor groove of the bound 
duplex. The thumb domain also has the capability of binding proteins known as 
processivity factors that encircle duplex DNA and stabilise the complex, thus 
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significantly improving the processivity of DNA polymerases. For example, the 
processivity of phage T7 polymerase is increased by at least 100 times with the 
help of the thioredoxin from the E. coli host cells, which acts as a processivity 
factor and sterically or electrostatically hinders the dissociation of the DNA 
(Brautigam and Steitz, 1998). 
 
Figure 5.1 Crystal structure of the Thermococcus sp. 9 N-7 DNA polymerase (PDB ID: 
1QHT) (Rodriguez et al., 2000). It is composed of five domains known as the N-terminal, 3’-
5’ exonuclease, palm, fingers and thumb domains which are coloured as blue, green, yellow, 
purple and red, respectively. 
5.1.5 DNA polymerases in disease and as drug targets 
Infrequent clonal somatic mutations have been identified in DNA polymerase 
genes in human tumours and some of them are deleterious. Mutations in a gene 
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that codes for DNA polymerase η have been found in patients with xeroderma 
pigmentosum variant (XPV) (Masutani et al., 1999). Mutations of Pol β and γ 
genes were identified in colon adenocarcinoma (Starcevic et al., 2004) and 
progressive external ophthalmoplegia (PEO) (Longley et al., 2006), respectively. 
Although DNA polymerases have a common catalytic mechanism and share 
extensive homology at the active site(s), several of them have been successfully 
targeted as drug targets. Nucleotide analogues, such as pyrimidine, purine and 
cyclic analogues, preferentially inhibit viral DNA polymerases and are used in 
treatment of infections caused by e.g. HIV (Argyris et al., 2006) and 
cytomegalovirus (Cristofoli et al., 2007). One of the important strategies in cancer 
treatment is to inhibit DNA polymerases that are involved in DNA repair to 
increase the efficiency of chemotherapeutic agents which damage DNA. For 
example, DNA synthesis may be effectively inhibited by drugs targeting the 
exonuclease proofreading or template switching involving the exonuclease and 
polymerase active sites. 
5.2 Project aim 
The aim of the project was to determine the crystal structure of Pc-polymerase, 
find out the unique structural features that distinguish it from other polymerases 
and investigate the reasons for its high thermostability. 
5.3 Methods 
5.3.1 Crystallisation 
Expression and purification of the Pc-polymerase was described by Ali et al., 
(2011). Crystal screening was conducted by use of the hanging-drop method with 
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an enzyme concentration of 15 mg/ml in 20 mM Tris buffer pH 8.2. The same 
crystal screening robot and screening kits were used as described in section 2.3.1. 
The plates were stored at both 4 C and 21 C for the crystal growth. After four 
weeks, two crystals (Figure 5.2) were obtained in condition F4 of the Structure 
Screen 1+2 kit (0.2 M potassium thiocyanate, 0.1 M Bis-Tris propane pH 6.5, 20% 
PEG 3,350). However, following attempts for optimisation failed to reproduce any 
crystals at all. So the original two crystals were mounted in loops with 30% 
glycerol as the cryo-protectant and were flash-cooled before data collection. 
 
Figure 5.2 Pc-polymerase crystals. The crystals were obtained in the F4 condition from 
Structure Screen 1+2. They are approximately 200 microns in two dimensions and 50 
microns thick. One small unit on the ruler is 10 microns. 
5.3.2 Data collection and data processing 
X-ray data collection was carried out at station I02, DLS. Data integration using 
the program DIALS (Waterman et al., 2013) revealed that the crystals belonged 
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to the space group P21, which was confirmed by the program Pointless (Evans, 
2006; Evans, 2011). Scaling and data reduction were performed using Aimless 
(Evans and Murshudov, 2013a), which showed that the better crystal diffracted 
to 2.8 Å. No twinning or translational NCS was present, as indicated by the 
program Phenix.xtriage (Zwart et al., 2005). The solvent content was 50.7% with 
2 molecules in the ASU, as estimated by Matthews_coef (Matthews, 1968). 
5.3.3 Structure determination, refinement and further analysis 
The initial raw structure was determined by molecular replacement with the 
BALBES website (Long et al., 2008), which gave a top solution with a Q-factor of 
0.67 and suggested that it was 99% likely to be a correct solution. The 
corresponding Rfactor and Rfree values were 37.6% and 44.1%, respectively. Four 
homologous structures were used as search models in the molecular 
replacement process. They were DNA polymerases from T. gorgonarius (PDB ID: 
2XHB, 35.2% overall sequence identity) (Killelea et al., 2010), P. furiosus (PDB 
ID: 3A2F, 36.0% overall sequence identity, to be published), T. kodakarensis 
(PDB ID: 1WN7, 35.2 overall sequence identity) (Kuroita et al., 2005) and 
Sulfolobus solfataricus (PDB ID: 1S5J, 35.3% overall sequence identity) (Savino 
et al., 2004). Since the raw model at this stage had a lot of residues fitted poorly 
in the electron density, many rounds of manual rebuilding were conducted by use 
of the program Coot (Emsley and Cowtan, 2004). This included the relocation of 
many ‘shifted’ residues that was guided by the electron density for large aromatic 
side chains. The following refinement using Phenix.refine (Afonine et al., 2012) 
brought the Rfree value down to 35.8%, which indicated that the model had been 
improved after the rebuilding. Following this, NCS refinement with torsion-angle 
restraints using Phenix.refine revealed more electron density in the last domain 
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of chain A and gave an Rfree value of 32.7%. Further manual rebuilding, 
refinement and the introduction of metal ions and the 47 water molecules gave 
final Rfactor and Rfree values of 24.5% and 28.8%, respectively. All the statistics for 
data collection, data processing and refinement are shown in table 5.1. The 
VADAR (Willard et al., 2003) and ESBRI (Costantini et al., 2008) online services 
were used to analyse hydrogen bonds and salt-bridges and the sequence 
alignment was prepared with Alscript (Barton, 1993). 
Table 5.1 X-ray statistics for the Pc-polymerase structure. Values in parentheses are for the 
high resolution shell. 
Beamline I02 
Wavelength (Å) 0.9795 
Space group P21 
Unit-cell parameters  
a (Å) 74.2 
b (Å) 100.7 
c (Å) 119.3 
β (°) 94.7 
Resolution (Å) 118.93-2.80 (2.90-2.80) 
Rmerge (%) 10.3 (77.0) 
Rmeas (%) 12.1 (91.2) 
CC½ (%) 99.1 (58.8) 
Completeness (%) 97.5 (96.9) 
Average I/σ(I) 6.8 (1.8) 
Multiplicity 3.6 (3.7) 
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No. of observed reflections 154,369 (16,405) 
No. of unique reflections 42,313 (4,403) 
Wilson plot B-factor (Å2) 66.8 
Solvent content (%) 50.7 
Rfactor (%) 24.5 
Rfree (%) 28.8 
RMSD bond lengths (Å) 0.004 
RMSD bond angles (°) 0.818 
No. of reflections in working set 42,206 (4,123) 
No. of reflections in test set 2,132 (236) 
Mean protein B-factor (Å2) 73.5 
 
5.4 Results and discussion 
Pc-polymerase has several distinct features compared with other known DNA 
polymerase structures. Figure 5.3 illustrates the sequence alignment of Pc-
polymerase with those from T. gorgonarius, T. Kodakarensis and P. furiosus. 
Although the secondary structure is conserved in all of them, Pc-polymerase has 
a relatively low sequence identity of approximately 37% with the other three, 
which have 80% to 90% sequence identity with each other. Indeed P. calidifontis 

















































































































































































































































































































































































































































































































































































5.4.1 Structure of Pc-polymerase 
The N-terminal domain of Pc-polymerase consists approximately of residues 1-
163 and 360-390. It shows a bilobal feature which has an extra β-hairpin 
composed of 28 residues, compared with the T. gorgonarius, pfu and KOD DNA 
polymerases, inserted in the region which connects the exonuclease domain 
(Figure 5.4). A 7-stranded β-barrel is formed by the addition of this β-hairpin. The 
exonuclease domain extends from residues 164 to 360 that form a 7-stranded 
antiparallel β-sheet enclosed by α-helices. It has one fewer β-strand compared 
with the other enzymes, which are formed of 8 strands, due to the deletion of 
approximately 8 residues at the exposed outer edge of the protein. Several loop 
regions in this domain are quite different, with the largest being 6 Å apart from 
each other in superposition. There are four catalytic residues residing in this 
domain, known as Asp169, Glu171, Asp236 and Asp336, which are involved in 
binding two magnesium ions. Asp169 and Glu171 are located in the same β-
strand which are closer to the magnesium ion, while the other two aspartates are 
located in helical segments. 
The exonuclease domain is connected with the palm domain through a linker 
region (residues 391-404, coloured as grey in Figure 5.4) which is on the surface 
of the enzyme. It adopts a different conformation compared with other archaeal 
DNA polymerases which have an α-helix in this region. Structural superposition 
shows that it is approximately 10 Å apart from the equivalent parts in other 
archaeal enzymes. It is likely that this difference is due to the flexibility and 
exposed nature of this region which would form unfavourable contacts with 
symmetry related molecules if the conformation found in the homologous 




Figure 5.4 The overall structure of Pc-polymerase. The N-terminal, exonuclease, palm, 
fingers and thumb domains are coloured in blue, green, yellow, purple and red, respectively. 
The catalytic carboxylate side chains are coloured in orange and are represented as ball-
and-stick with the three bound magnesium ions showing as dark grey balls. The small helix 
which plugs in the gap between the lobes of the N-terminal domain is indicated by a red star 
and the linker region, between the N-terminal domain and the palm domain, is coloured as 
grey. 
The palm domain, which contains the active site for polymerase activity, is 
composed of two parts formed by residues 405 to 465 and residues 525 to 620 
and are separated by the fingers domain. This first part contains a few small 
helical segments and β-strands while the second one consists of two large helices 
and a cup-shaped β-barrel formed by seven strands. The ‘triad’ formed by the 
three aspartates (Asp420, Asp560 and Asp562) was thought to be essential for 
catalysis in homologous structures (Delarue et al., 1990), however, mutagenesis 
showed that the equivalent residue of Asp560 was not required by human Pol α 
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for catalysis (Copeland and Wang, 1993). It has also been proved by Wang et al. 
(1997) that only two of the three aspartates are invariant which correspond to 
Asp420 and Asp562 in Pc-polymerase. Both catalytic aspartates reside in 
adjacent strands at the same side which look like two teeth in the opening mouth 
of the cup. The electron density for the aspartate residues are well defined 
although there is no density for the catalytically essential magnesium ions. 
The fingers domain (residues 466 to 524) is simply a helix-loop-helix structure 
which leans over the active site of the palm domain. The final thumb domain 
contains residues 625 to 766 and is composed by three helical features with 
several loops. 
5.4.2 Comparison with pfu DNA polymerase 
The Pc-polymerase has several significant structural differences compared with 
the pfu DNA polymerase. A structural superposition of both enzymes based on 
their secondary structures is illustrated in Figure 5.5. As mentioned in the 
previous section, there is an insertion of a β-hairpin at the region between the first 
two domains, which is not close to the active site. The largest difference in the 
exonuclease domain is the loop region formed by residues 173 to 186 which 
adopts a different conformation approximately 10 Å apart from that in pfu 
structure. There is short insertion in a β-hairpin formed by residues 244-247 in 
the pfu structure, which points towards the active site and may affect the catalytic 
properties. Also, the loop region from residues 391 to 404 in Pc-polymerase is 
largely different from its equivalent part in pfu, which has a helical segment in that 
region. The loops between residues 440 and 450, 490 and 494 in Pc-polymerase 




Figure 5.5 Secondary structure superposition of Pc-polymerase with the pfu 
enzyme. The Pc-polymerase structure is coloured red while the pfu structure is 
coloured green. The N-terminal, exonuclease, palm, fingers and thumb domains 
are labelled as N, E, P, F and T, respectively. The thumb domain has apparently 
moved a lot in response to DNA binding. 
5.4.3 Modelling the structure with DNA 
The overall shape of DNA polymerases is like a disk with a hole in the centre. 
There are three deep grooves emanating from the hole formed by the five 
domains. One of these deep grooves, known as cleft D, binds duplex DNA while 
another, referred to as cleft T, binds single stranded template DNA. The third cleft 
is the editing channel that leads to the active site of the 3’-5’ exonuclease. When 
there is a mismatched nucleotide, it is directed towards the exonuclease active 
site through this channel. In response to DNA binding, the fingers and the thumb 
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domains tend to move relative to the palm domain which acts as a clamp to hold 
the DNA. 
A protein-DNA complex of Pc-polymerase was constructed by fitting it to the 
DNA-bound structure of pfu polymerase (PDB ID: 4AIL). The DNA-pfu complex 
was obtained by co-crystallisation of its mutant-type protein with a primer-
template duplex of DNA. Since there are domain movements on binding to DNA, 
the structures were first fitted by the N-terminal and the exonuclease domains, 
followed by fitting the other domains separately with their equivalent parts. The 
modelled complex structure is shown in Figure 5.6. The largest domain 
movement affects the thumb domain which, compared with the original model, 
rotates by 7.6 with its centroid moving by 10.0 Å. As a result of this domain 
movement, its helical hairpin region moves away from the DNA whilst the small 
β-sheet region moves closer to it. The palm and the fingers domains rotate by 
15.5 and 14.1 and shift by 4.0 Å and 1.4 Å, respectively. The 3’ end of the primer 
strand is positioned close to the catalytic residues Asp420 and Asp562 in the 
active site. Interestingly, the linker region composed of residues 391-404 seems 
to partially block the active site which suggests that it is likely to adopt a different 




Figure 5.6 A modelled complex of Pc-polymerase with DNA. It was generated by fitting the 
enzyme domains separately with their corresponding parts in the pfu-DNA complex. Again, 
the N-terminal, exonuclease, palm, fingers and thumb domains are labelled as N, E, P, F and 
T, respectively. The primer-template duplex of DNA is coloured in purple. [Figure from (Guo 
et al., 2017c), reproduced with permission of the International Union of Crystallography 
(http://journals.iucr.org)]. 
5.4.4 Electrostatic surface 
The presence of the clefts T and D can be demonstrated by the solvent 
accessible surface of Pc-polymerase, as shown in Figure 5.7. There are many 
acidic groups which dominate the electrostatic surface potential at the active sites 
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of the polymerase and the exonuclease in the centre region. These acidic 
residues tend to bind the catalytically essential magnesium ions. While the outer 
regions are characterised by a more positive potential which is likely to interact 
with the sugar-phosphate backbone of DNA. 
 
Figure 5.7 The solvent accessible surface of Pc-polymerase. The surface is coloured by 
electrostatic potential and the duplex cleft, the template cleft and the editing channel are 
labelled as D, T and E, respectively, with their general directions indicated by the arrows. 
The central hole is considered as the entry channel for incoming dNTPs that are added to 
the template. [Figure from (Guo et al., 2017c), reproduced with permission of the International 
Union of Crystallography (http://journals.iucr.org)]. 
5.4.5 Thermostability 
The great thermostability of thermophilic proteins can be attributed to several 
factors. These proteins tend to have greater hydrophobicity (Haney et al., 1997), 
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more hydrogen bonds (Vogt and Argos, 1997; Vogt et al., 1997) and salt bridges 
(Haney et al., 1997; Kumar et al., 2000b; Yip et al., 1995; Yip et al., 1998), 
increased helical content, low occurrence of thermolabile residues such as Cys 
and Ser (Russell et al., 1997), high occurrence of Arg, Tyr and Pro (Bogin et al., 
1998; Haney et al., 1997; Watanabe et al., 1997), amino acid substitutions within 
and outside the secondary structures (Haney et al., 1997; Russell et al., 1997; 
Zuber, 1988), better packing, smaller and less numerous cavities, deletion or 
shortening of loops (Russell et al., 1997), increased surface area buried upon 
oligomerization (Salminen et al., 1996) and increased polar surface area (Haney 
et al., 1997; Vogt and Argos, 1997; Vogt et al., 1997). However, it should be note 
that no single factor proposed to contribute toward protein thermostability is 100% 
consistent in all the thermophilic proteins. Kumar et al. (2000a) observed that the 
most consistent trend is shown by side chain-side chain hydrogen bonds and salt 
bridges. They may rigidify a thermophilic protein in the room-temperature range 
and the protein may still be flexible enough at high temperature in order to 
function (Jaenicke and Böhm, 1998). 
By comparison of the thermophilic Pc-polymerase with the mesophilic family B 
DNA polymerase II from E. coli (PDB ID: 1Q8I), it was found that no trend could 
be observed for most of these factors, for example, the hydrogen bond content is 
similar in the two enzymes. About 75% of residues in Pc-polymerase form 
hydrogen bonds while this number is 77% for the E. coli enzyme. However, 
analysis showed that there is significant difference in the salt-bridge content. 
Initial analysis using a cut-off distance of 4 Å between donor and acceptor atoms 
revealed 60 ionic side-chain interactions in Pc-polymerase and 40 in the E. coli 
enzyme. These numbers increased to 212 and 124 (a ratio of almost 2:1) when 
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the cut-off distance was set to 6 Å considering that buried electrostatic 
interactions tend to have a longer range than 4 Å because of the lower dielectric 
constant of the protein interior. Further investigation revealed that this finding is 
consistent in pfu, KOD1 and other archaeal DNA polymerases. Thus when the 
conditions for electrostatic interactions are more relaxed, the difference between 
the thermophilic and mesophilic enzymes is more significant, which suggests that 
the extreme thermostability of Pc-polymerase may, at least partially, attribute to 
the longer-range electrostatic effects. 
5.5 Summary 
The family B DNA polymerase from Pyrobaculum calidifontis (Pc-polymerase) is 
magnesium-ion dependent and highly thermostable, which is indicated by an 
optimal temperature of 75 °C and a half-life of 4.5 h at 95 °C. It is of high-fidelity 
due to its error-correcting 3’-5’ exonuclease activity. Unlike other broadly used 
high-fidelity DNA polymerases which have very high sequence identity to each 
other, such as those from Pyrococcus furiosus, Thermococcus kodakarensis and 
Thermococcus gorgonarius, Pc-polymerase has a very low sequence identity of 
approximately 37%. The crystal structure of Pc-polymerase has been determined 
at 2.8 Å. The domains are arranged in a circular disc-like shape with a narrow 
central channel, which is similar to other DNA polymerases. There are a few 
connected crevices in one face of the ‘disc’ which are involved in binding of 
single-strand and duplex DNA. The central channel is thought to allow incoming 
nucleoside triphosphates to access the active site. Pc-polymerase has several 
unique structural features that distinguish it from other archaeal DNA 
polymerases. The complex of the enzyme with the primer-template duplex of 
DNA was modelled which suggests a large movement of the thumb domain upon 
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DNA binding. The surface potential of the central region of the molecule, where 
catalytic magnesium ions bind, is dominated by acidic groups. Although there are 
many factors which may contribute to the great thermostability of thermophilic 
proteins, the high thermal stability of PC-polymerase may be mainly attributed to 
the large number of salt bridges. 








6. Chapter 6 
Structure and function of the type III pullulan 











6.1.1 Pullulan and starch 
Pullulan, also known as α-1,4- or α-1,6-glucan, is a polysaccharide synthesised 
by the fungus Aureobasidium pullulans from starch (Kim et al., 1990), and is 
composed of repeating units of maltotriose linked by α-1,6-glycosidic bonds or 
repeating units of isopanose joined by α-1,4-glycosidic bonds (Leathers, 2003). 
The ratio of α-1,4- to α-1,6-glycosidic bonds in pullulan is 2:1. It is mainly used by 
the cells to resist predation and desiccation and is involved in diffusion of 
molecules both into and out of cells. Pullulan has been used as a model substrate 
for studying starch-debranching enzymes (Plant et al., 1986) as well as in the 
food and pharmaceutical industries (Shingel, 2004; Singh et al., 2008). 
Starch is one of the most abundant polysaccharides and acts as a storage form 
of energy produced by green plants. Unlike pullulan which is soluble in water, 
starch is insoluble in water. Starches from different origins, plant organs and 
growth conditions have significantly different physical properties while most of 
them are a mixture of two high molecular weight polymers known as amylose and 
amylopectin (Swinkels, 1985). Amylose is a linear molecule formed by 100-
10,000 D-glucose units connected by α-1,4-linkages while amylopectin, which 
constitutes approximately 73-80% of starch, consists of 24-30 α-1,4-linked D-
glucose units joined by α-1,6-bonds, resulting in molecules with 9,600-15,900 
glucose units (Takeda et al., 2003). Amylose and amylopectin possess a latent 
aldehyde group at the end of the polymeric chain that is known as the reducing 
end. Depending on their origin, starches have various industrial applications such 
as manufacture of glucose, maltose syrups and production of other 
oligosaccharides (Rendleman, 1997; Van der Maarel et al., 2002). 
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6.1.2 Enzymes involved in starch catabolism 
Due to the complexity of its structure, depolymerisation of starch into 
oligosaccharides and smaller sugars requires a range of enzymes including 
endoamylases, such as α-amylases (EC 3.2.1.1) which cleave the chain 
internally, and exoamylases, such as glucoamylases (EC 3.2.1.3) which remove 
the terminal monosaccharides sequentially (Hii et al., 2012). Transferases 
hydrolyse α-1,4-glycosidic bonds and transfer part of the donor to form a new α-
1,4- [e.g. amylomaltase (EC 2.4.1.25)] or α-1,6- [e.g. branching enzyme (EC 
2.4.1.18)] glycosidic bond with the acceptor. While the converse reaction, namely 
the hydrolysis of α-1,6-glycosidic bonds, is catalysed by debranching enzymes 
that are classified into the indirect and direct groups (Fogarty and Kelly, 1990). 
The indirect enzyme, amylo-1,6-glucosidase, requires the prior modification of 
the substrate by a transferase to leave a single α-1,6-linked glucose moiety at the 
branch point. The direct enzymes, known as isoamylases and pullulanases, can 
hydrolyse α-1,6-glycosidic bonds directly from unmodified substrate (Hii et al., 
2012). Hydrolysis of starch by amylase enzymes produces low molecular weight 
dextrins and greatly reduces glucose yield, which can be improved by the addition 
of pullulanases. In addition, by using pullulanase together with β-amylase in the 
starch saccharification process, maltose yield could be increased by about 20-
25% (Poliakoff and Licence, 2007). 
Pullulanases, or more precisely pullulan-hydrolysing enzymes, are grouped into 
the glycosyl hydrolase family 13 (GH13), 49 (GH49) or 57 (GH57) (Janeček et al., 
2014; MacGregor et al., 2001) and, based on their substrate specificities and 
reaction products, are classified into five groups: pullulanase I and II, pullulan 
hydrolase I, II and III (Hii et al., 2012). Pullulanase I (EC 3.2.1.41), which was 
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previously called R-enzyme, hydrolyses α-1,6-glycosidic bonds in starch, pullulan, 
glycogen and limit dextrins but does not degrade α-1,4-glycosidic bonds. 
Pullulanase II or amylopullulanase (EC 3.2.1.1/41) acts on both α-1,4- and α-1,6-
linkages in polysaccharides such as starch and limit dextrins, while it generally 
hydrolyses at α-1,6-glycosidic bonds in pullulan, producing maltotriose (Nisha 
and Satyanarayana, 2013). Type I pullulan hydrolase (neopullulanases, EC 
3.2.1.135) hydrolyses α-1,4-bonds of pullulan to generate panose and also 
hydrolyses both linkages of starch and related polysaccharides with a low 
efficiency (Kuriki et al., 1988). Pullulan hydrolase II (isopullulanase EC 3.2.1.57) 
cleaves α-1,4-linkages of pullulan and panose, however, it does not act on starch 
or dextran (Aoki and Sakano, 1997). Type III pullulan hydrolase cleaves both α-
1,4- and α-1,6-glycosidic bonds of pullulan, resulting in the formation of 
maltotriose, panose, maltose and glucose. Until now, only two enzymes in the 
last class have been reported, those from Thermococcus aggregans (TA-PUL) 
(Niehaus et al., 2000) and Thermococcus kodakarensis (Ahmad et al., 2014). The 









































































































































































































6.1.3 Catalytic mechanism 
The catalytic mechanism of pullulan-hydrolysing enzymes is similar to that of the 
α-amylase family. The mechanism is characterised by α-retaining double 
replacement involving two catalytic residues in the active site: a Glu as the 
catalyst and an Asp as the nucleophile (Figure 6.2). The catalytic process can be 
divided into five steps: 1) Glu534 donates a proton to the glycosidic bond O and 
Asp601 nucleophilically attacks the C1 of glucose G1 (A); 2) an oxocarbonium 
ion-like transition state is formed followed by the formation of a covalent 
intermediate (B); 3) the covalent bond is then attacked by a water or a glucose 
molecule (B) which replaces the protonated glucose G2 ; 4) another transition 
state is formed again; 5) a H is transferred from the water or the glucose to Glu534 
followed by the formation of a hydroxyl group or a new glycosidic bond (C) 
(Koshland, 1953; Van Der Maarel et al., 2002). Asp503 is not directly involved in 
the catalytic process, instead, it binds to two OH groups of the substrate and 
plays an important role in the distortion of the substrate (Uitdehaag et al., 1999). 
 
Figure 6.2 The catalytic mechanism of pullulan-hydrolysing enzymes. The amino acids are 
numbered according to the type III pullulan hydrolase from T. kodakarensis (TK-PUL). [Figure 





6.1.4 Characteristics of the type III pullulan hydrolase from T. kodakarensis 
The type III pullulan hydrolase from T. kodakarensis (TK-PUL) possesses both 
pullulanase and α-amylase activities. The enzyme has a molecular mass of 
84.4 kDa with 748 amino acids. TK-PUL has the highest activity at 95-100 °C and 
the pH optima of 3.5 and 4.2 in acetate and citrate buffers, respectively, although 
it is active in a broad pH range from 3.0 to 8.5. It does not require any metal ions 
for the activity and has shown a broad range of substrate specificity including the 
ability to act on pullulan, β,γ-cyclodextrin, starch, amylose, amylopectin, dextrin 
and glycogen (Ahmad et al., 2014). Interestingly, cyclodextrins are well-known 
competitive inhibitors of pullulanases (Duffner et al., 2000) and none of the other 
enzymes have been reported to hydrolyse pullulan so efficiently. In addition, TK-
PUL has a unique ability to hydrolyse maltotriose into maltose and glucose, which 
has not been reported in other homologous enzymes. 
6.1.5 Applications of pullulan hydrolysing enzymes 
Pullulan hydrolysing enzymes have high market value in starch saccharification 
industries to produce glucose, maltose, maltotriose and maltotetraose syrups. 
They increase the glucose or maltose production by 2% and 20-25%, respectively, 
and reduce the total reaction time and cost (Jensen and Norman, 1984). These 
enzymes are also employed as antistaling agents in the bread industry. Staling 
causes undesirable changes such as loss of bread flavour, decrease in moisture 
content and crispness of the crust during storage. It is due to the retrogradation 
of the amylopectin in starch and can be retarded by shortening the amylopectin 
chain length (Champenois et al., 1999). These enzymes hydrolyse the branched 
maltodextrins produced by α-amylase (Carroll et al., 1987), which is required for 
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making bread, and eliminate the gumminess of the bread. They are also involved 
in the preparation of resistant starch, panose and isopanose containing syrups 
(Machida et al., 1986; Zhang and Jin, 2011). 
6.2 Project aim 
The aim of the project was to determine the crystal structure of TK-PUL, which 
would be the first structure of a type III pullulan hydrolyse, and to identify the 




TK-PUL was expressed and purified by Ahmad et al. (2014). Crystal screening 
was carried out by use of the sitting drop method using the same screening kits 
and robot as described in section 2.3.1. Protein samples at 5 mg/ml, 10 mg/ml 
and 16 mg/ml were screened at 21 °C with and without 1 mM Ca2+, D-glucose, 
maltose, maltotriose, panose, n-dodecyl α-D-maltoside, α-cyclodextrin, β-
cyclodextrin and γ-cyclodextrin (all in 10× molar excess except for Ca2+). Many 
crystal clusters for ligand-free TK-PUL were obtained in the Morpheus conditions 
D1, E1, F1, G1 and H1 and many single crystals for the enzyme with n-dodecyl 
α-D-maltoside were obtained in the Morpheus B9 condition. However, all of them 
were of poor diffraction quality which did not allow structure determination. 
Further optimisation revealed that the best ligand-free crystal (Figure 6.3a, 
obtained at 10 mg/ml in 0.1 M carboxylic acids, 0.1 M buffer system 1 pH 6.2, 21% 
P500MME_P20K) diffracted to 2.8 Å whilst the best crystal with n-dodecyl α-D-
maltoside added (Figure 6.3b, obtained at 12 mg/ml in 0.09 M halogen, 0.1 M 
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buffer system 3 pH 8.5, 40% P500MME_P20K) [For details of the conditions, see 
(Gorrec, 2009)] only diffracted to 4.2 Å, although these crystals looked a lot better. 
Selected crystals were mounted in loops before flash-cooling in liquid nitrogen. 
 
Figure 6.3 Crystals of the ligand-free (a) and ligand-bound (b) TK-PULs. One small unit on 
the ruler is 10 microns. 
6.3.2 Data collection and data processing 
X-ray diffraction data were collected at station I03, DLS and the raw data were 
processed using DIALS (Gildea et al., 2014; Waterman et al., 2013) to separate 
multiple lattices for the ligand-free crystal and to integrate diffraction spots for the 
ligand-free and ligand-bound crystals in the space groups C2 and P3221, 
respectively. Both were later confirmed by Pointless (Evans, 2006; Evans, 2011) 
and molecular replacement. Scaling and data reduction were carried out using 
Aimless (Evans and Murshudov, 2013b) and data quality was checked by 
Phenix.xtriage (Zwart et al., 2005). Matthews_coef (Kantardjieff and Rupp, 2003; 
Matthews, 1968) suggested a solvent content of 53.7% and 71.0% for the ligand-




6.3.3 Structure determination 
A partial structure solution for the ligand-free TK-PUL was identified by molecular 
replacement and refinement using the MrBUMP website (Keegan and Winn, 
2008). The Thermus thermophilus HB8 pullulanase structure (Ttha1563, PDB ID: 
2Z1K, 37% sequence identity with TK-PUL, Niwa et al., to be published) was 
used as the search model and residues from 286 to 764 were modelled into the 
electron density which gave a Phaser log-likelihood gain (LLG) value of 235.0, a 
translation function z-score (TFZ) of 12.7 and an Rfree value of 44.7%. Since there 
was a large positive density at the N-terminal end of the partial structure, 
molecular replacement was repeated by use of Molrep (Vagin and Teplyakov, 
2010) with the option SAPTF + local phased RF + phased TF using the partial 
solution as a fixed model and the residues 103-220 of Staphylothermus marinus 
maltogenic amylase (SMMA, PDB ID: 4AEE) as the search model for the partial 
structure (This was performed with the help from Dr Ronan Keegan, STFC, 
England). This enabled placement of an extra 101 residues (185-285) into the 
electron density which filled up all the map and brought the Rfree value down to 
39.5%. It was not possible to build the first 184 N-terminal residues due to the 
lack of the electron density. SDS-PAGE of the TK-PUL sample showed two 
strong bands of approximately 68 kDa and 15 kDa, which suggested that these 
residues might have been cleaved during sample preparation or storage. It was 
spotted that a lot of residues were shifted forward or backward at this stage, thus 
many rounds of manual rebuilding and correction were carried out including the 
relocation of residues guided by the electron density for the large aromatic side 
chains using Coot (Emsley and Cowtan, 2004; Emsley et al., 2010). This was 
followed by further restrained refinement with Phenix.refine (Adams et al., 2010; 
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Afonine et al., 2012; Echols et al., 2012). The ligand-bound structure was then 
determined by molecular replacement using the ligand-free structure as the 
search model followed by a few rounds of refinement. Manual rebuilding or 
correction was not possible due to the low resolution. All the statistics for data 
collection, data processing, structure determination and refinement of the ligand-
free structure are shown in table 6.1. The VADAR (Willard et al., 2003) and 
ESBRI (Costantini et al., 2008) online services were used to analyse hydrogen 
bonds, salt-bridges and other factors related to thermostability of the enzymes. 
Table 6.1 X-ray statistics for the ligand-free TK-PUL structure. Values in parentheses are for 
the outer resolution shell. 
Beamline I03 (DLS) 
Wavelength (Å) 0.9762 
Space group C2 
Unit-cell parameters 
a (Å) 192.6 
b (Å) 63.9 
c (Å) 56.1 
β (°) 93.8 
Resolution (Å) 96.11-2.80 (2.95-2.80) 
Rmerge (%) 16.7 (90.0) 
Rmeas (%) 20.1 (106.2) 
CC½ (%) 98.5 (53.6) 
Completeness (%) 99.8 (98.9) 
Average I/σ(I) 5.4 (1.2) 
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Multiplicity 3.3 (3.3) 
No. of observed reflections 56,033 (7,968) 
No. of unique reflections 17,039 (2,444) 
Wilson plot B-factor (Å2) 47.8 
Solvent content (%) 52.8 
Rfactor (%) 24.2 
Rfree (%) 27.9 
RMSD bond lengths (Å) 0.004 
RMSD bond angles (°) 0.621 
No. of reflections in working set 16,960 
No. of reflections in test set 909 
Mean protein B-factor (Å2) 47.3 
 
6.4 Results and discussion 
6.4.1 Tertiary structure of TK-PUL 
Figure 6.4 shows the tertiary structure of TK-PUL, which consists of an N-terminal, 
a central catalytic and a C-terminal domain. The N-terminal domain contains 
residues 185-280 forming an anti-parallel β-barrel structure. The central catalytic 
domain shows a TIM-barrel structure which is composed of residues from 281 to 
694. The C-terminal anti-parallel β-barrel domain is formed by residues 694 
onwards. The three domains form a triangle which are spatially close to each 
other. 
Following the first β-strand in the central domain is a region (300-350) inserted in 
the TIM-barrel which contains two α-helices, a β-hairpin and a few loops that are 
involved in binding a calcium ion. The third β-strand is followed by another 
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insertion of 50 residues forming a very compact, kernel-like subdomain consisting 
of helical and strand features. There are a few helical segments following the 5th 
and the 6th strands and the last β-strand (8th) is followed by a flap-like structure 
which partially covers the active site and interacts with the kernel-like subdomain. 
 
Figure 6.4 Crystal structure of TK-PUL. The N-terminal, central and C-terminal domains are 
coloured as cyan, orange and red, respectively. The three residues forming the catalytic triad 
are shown in ball-and-stick and the calcium ion is shown as grey sphere. 
6.4.2 Structural difference with homologues 
The sequence alignment of TK-PUL with several homologous structures is shown 
in figure 6.5. There is a signal peptide containing 17 amino acids before the N-
terminus of TK-PUL which was included in the numbering scheme as previously 
reported by Ahmad et al. (2014), thus it is also included here to make it clear and 
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consistent with the report. TK-PUL has a 65.9% sequence identity with TA-PUL 
over 704 residues, whilst it shares only 27%-37% sequence identity with other 
aligned homologues over approximately 480 residues which cover the central 
and the C-terminal domains of TK-PUL. The N-terminal residues 185-280 of TK-
PUL do not share high sequence similarity with the corresponding residues in 
SMMA, however, their tertiary structures are similar. Structure prediction using 
the HHpred website (Soding et al., 2005) suggested that residues 78-180 are 
folded in a similar way to the corresponding region in the AMP-activated protein 
kinase from Rattus norvegicus (PDB ID: 4YEF) although this region could not be 
modelled due to the lack of electron density. 
Figure 6.6 illustrates the structural superimposition of TK-PUL with the maltogenic 
amylases from Thermus sp. (ThMA, PDB ID: 1SMA) (Kim et al., 1999) and 
Bacillus sp. I-6 (PDB ID: 1EA9) (Lee et al., 2002). The TIM-barrel domain of TK-
PUL shares a high structural similarity with that of the homologous proteins, while 
the N- and C-terminal domains are slightly different. TK-PUL is also homologous 
with the type I pullulan hydrolases from T. thermophilus (PDB ID: 2Z1K) and B. 
stearothermophilus (PDB ID: 1J0H) in both sequence and structure, ignoring that 
the former lacks the N-terminal domain. However, the loop regions at the active 
site end of the catalytic domain are quite different in these structures. For 
examples, the TK-PUL enzyme lacks the large insertion in the α-helical region 
following the 6th strand, which forms a flap over the active site cavity in the T. 
thermophilus structure. The spatially-adjacent loop following the 7th strand is 
substantially larger in the TK-PUL enzyme. The calcium-binding loop following 
the first β-strand of the TIM-barrel is considerably larger in TK-PUL and is 
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oriented toward the active site and is likely to be involved in peripheral 







Figure 6.5 Sequence alignment and the secondary structure characteristics of TK-PUL with 
other homologues. Alpha-helices and β-strands are labelled according to the TK-PUL 
structure except for the N-terminal 184 residues which are missing in the structure. All the 
conserved residues are boxed and the fully conserved residues coloured in white on a red 
background, while the not fully conserved residues are coloured in red. Alignment was 




Figure 6.6 Superimposition of TK-PUL with two other homologues. TK-PUL, Bacillus 
cyclomaltodextrinase (CDase, PDB ID: 1EA9) and ThMA (PDB ID: 1SMA) are coloured in 
green, yellow and pink, respectively. 
6.4.3 Active site 
The catalytic triad composed of residues Asp503, Glu534 and Asp601 is located 
at the base of the cavity that contains many exposed aromatic residues as shown 
in Figure 6.7. The very exposed aromatic side chains of Trp465 and Phe468 
suggest a role of binding the hydrophobic faces of substrates which have also 




Figure 6.7 The active site of TK-PUL. The catalytic triad and other aromatic residues that 
are involved in carbohydrate binding are shown as ball-and-stick. 
TK-PUL was also co-crystallised with n-dodecyl α-D-maltoside and the best 
crystal only diffracted to 4.2 Å, which did not allow for a precisely determined 
structure due to the poor electron density. However, molecular replacement using 
the ligand-free structure as a search model and the following refinement indicated 
a correct solution. Inspection of the active site identified a large positive feature 
of electron density where a maltose molecule could be fitted in (Fig 6.8). 
Superposition of this complex structure with the structure of Bacillus subtilis 
str. 168 type I pullulanase complexed with a maltose (PDB ID: 2E9B) indicated 
that these two sugar molecules superposed quite well. This suggests that it is 
very likely for the TK-PUL to possess a maltose molecule in the active site as a 
hydrolysis product of the substrate n-dodecyl α-D-maltoside, which was cleaved 
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at the glycosidic bond between the alkyl and the maltosidic parts. Despite the fact 
that the precise position of the maltose molecule cannot be located, it is in 
hydrogen-bonding distance of the catalytic residues and forms many hydrophobic 
interactions with the aromatic side chains of the residues around. 
 
Figure 6.8 2Fo-Fc map of maltose in the complex structure. The maltose product is shown 
as ball-and-stick in pink, the catalytic residues and the aromatic residues in the active site 
are shown as ball-and-stick in cyan and yellow, respectively. 
6.4.4 Calcium binding loop and vicinal disulphide 
As mentioned in section 6.4.1, the region formed by residues 300-350 is involved 
in calcium binding by octahedral coordination as shown in Figure 6.8. The calcium 
binding site has been reported in many other homologous proteins such as the 
R-47 α-amylase II from Thermoactinomyces vulgaris (PDB ID: 1WZK, to be 
published) and the neopullulanases from Bacillus stearothermophilus (PDB ID: 
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1J0H) (Hondoh et al., 2003). The residues that participate in calcium binding, 
through their main chain or side chain, include Asn303, Gly305, Asn308, Asp309, 
Gly348 and Asp350. The calcium ion is buried, completely dehydrated and is 
likely to play an important role in the stabilisation of the protein. There is also a 
rare vicinal disulphide bridge in this region which is formed by residues Cys342 
and Cys343. This may have an influence on the substrate specificity of TK-PUL 
in a redox-dependent manner because the covalently linked cysteine side chains 
are oriented towards the active site. 
 
Figure 6.9 The calcium binding site of TK-PUL. Several main chain- and side chain-carbonyl 








As mentioned in section 5.3.4.5, many factors may contribute to the 
thermostability of thermophilic proteins including increased hydrophobicity, more 
hydrogen bonds and salt bridges, increased helical contents, low occurrence of 
thermolabile residues such as Cys and Ser, high occurrence of Arg, Tyr and Pro, 
amino acid substitutions within and outside the secondary structures, better 
packing, smaller and less numerous cavities, deletion or shortening of loops, 
increased surface area buried upon oligomerization and increased polar surface 
area. The comparison of some of these factors for several thermophilic and 
mesophilic pullulan hydrolysing enzymes is shown in table 6.2 and those which 
may contribute to the thermostability are coloured as blue. The thermophilic 
enzymes show higher contents of salt bridges, helical segments, Pro, Arg and 
Tyr than the mesophilic ones, whilst the Ser content is much lower. Hydrogen 
bond content is similar in all the enzymes whist Cys content is slightly higher in 











Table 6.2 Thermostability-related factors for several thermophilic and mesophilic pullulan 
hydrolysing enzymes. 
 Thermophilic Mesophilic 
Enzyme* TK-PUL 1SMA 1J0H 2Z1K 2YOC 2FH6 2WAN 
Salt bridges 
(%) 
25.7 29.9 30.6 30.1 20.4 17.6 16.5 
H-bonds (%) 74 73 76 77 75 76 74 
Helix 
content (%) 
25 23 23 31 22 25 15 
Pro 
content (%) 
6.3 6.0 6.0 8.4 3.9 4.5 4.8 
Arg 
content (%) 
4.8 6.0 5.8 8.4 3.9 4.1 2.1 
Tyr 
content (%) 
4.8 5.1 5.4 9.4 3.6 3.6 4.3 
Cys 
content (%) 
0.8 1.4 1.4 0.4 0.6 0.6 0.1 
Ser 
content (%) 
6.3 2.9 3.6 1.9 9.2 9.3 6.5 
* All the enzymes are represented by their PDB ID (except for TK-PUL) as follow: 1SMA, the 
maltogenic amylases from Thermus sp.; 1J0H, the type I pullulan hydrolases from B. 
stearothermophilus; 2Z1K, the type I pullulan hydrolases from T. thermophilus; 2YOC, the 
pullulanase from Klebsiella oxytoca; 2FH6, the pullulanase from Klebsiella aerogenes; 2WAN, 
the pullulanase from Bacillus acidopullulyticus. 
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Hydrogen bonds and salt bridges may rigidify a thermophilic protein in the room-
temperature range and the protein may still be flexible at high temperature in 
order to function (Jaenicke and Böhm, 1998). Kumar et al. (2000a) suggested 
that the difference in the number of salt bridges between the thermophilic and 
mesophilic homologues appear to correlate with the melting temperature Tm of 
the thermophilic proteins . Alpha-helices enhance the rigidity and stability of 
proteins more than β-strands and loops and thermophilic helices favour Arg and 
avoid His and Cys as compared with mesophilic helices (Kumar et al., 2000a; 
Warren and Petsko, 1995). Pro can only adopt a limited conformation due to the 
rigidity of the pyrrolidine ring. It was identified that thermophilic proteins tend to 
have Pro residues at the second sites of β-turns or the first turns of α-helices 
(Bogin et al., 1998; Watanabe et al., 1997), thus Pro exerts crucial effects on 
protein thermostability by controlling their folding. Arg and Tyr may be useful in 
both short and long range interactions due to their large side chains. In addition, 
the guanidium side chain of Arg can form salt bridges which stabilises proteins. 
In contrast, the short side chains of Cys and Ser mostly only form local 
interactions and they tend to undergo oxidation at high temperatures (Russell et 
al., 1997). 
6.5 Summary 
The crystal structure of a thermoacidophilic type III pullulan hydrolase, TK-PUL, 
has been determined to a resolution of 2.8 Å which would be the first structure of 
a type III pullulan hydrolase. The unique properties of TK-PUL, e.g. great 
thermostability and extraordinary stability over a broad pH range, make it an ideal 
enzyme for the starch industry. The first 184 residues are missing in the structure 
which might have already been cleaved during protein preparation. The structure 
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of the last part of the N-terminal (185-280) and the C-terminal domains are 
different from the homologous structures and the loop regions at the active site 
end of the catalytic domain are quite different. The structure of the first part 
(residues 78-180) of the N-terminal domain is predicted to be similar to the 
corresponding region in the AMP-activated protein kinase from Rattus norvegicus. 
The complex structure suggested that n-dodecyl α-D-maltoside may be a 
substrate for TK-PUL, however, no further information can be obtained due to the 
low resolution. The region formed by residues 300-350 is involved in calcium 
binding, which has been reported in other homologous proteins. There is also a 
rare vicinal disulphide bridge formed by residues Cys342 and Cys343 which may 
have an influence on the substrate specificity. The thermostability of TK-PUL and 
a few homologues may be attribute to several factors including the increased 
content of salt bridges, helical segments, Pro, Arg and Tyr and the decreased 















7. Chapter 7 
Structure and function of the 












L-asparaginase (EC 3.5.1.1) catalyses the hydrolysis of asparagine to aspartic 
acid and ammonia. Plants transport nitrogen, in the form of L-asparagine, from 
their roots to growing tissues thus they have a high demand on this enzyme 
(Atkins et al., 1975; Sieciechowicz et al., 1988). When amino acids become the 
primary carbon source in bacteria in anaerobic conditions, the expression level 
of asparaginase can be increased by 100-fold (Cedar and Schwartz, 1967; Cedar 
and Schwartz, 1968). This is an important up-regulation under anaerobic 
conditions as the metabolites of asparagine (as well as glutamine) can feed into 
the citric acid cycle. In contrast, the preferred carbon source glucose is a 
catabolite repressor of asparaginase expression. Enzymes in this family vary in 
their activity on glutamine to produce glutamic acid. Thus asparaginases and 
glutaminases are necessary for cell growth in ammonia-deficient media and their 
expression is activated by the presence of these amino acids in the medium. 
7.1.1 Applications 
7.1.1.1 L-asparaginase as an anticancer agent 
L-asparaginase has been broadly used as a chemotherapeutic agent for 
treatment of acute lymphoblastic leukaemia (ALL) and other hematopoietic 
malignancies. ALL is the most common childhood acute leukaemia and 
contributes to approximately 80% of childhood leukaemias and 20% of adult 
leukaemias (Fullmer et al., 2010). The history can be traced back to the 1950s, 
when Kidd spotted that the progression of murine lymphoma was limited by 
guinea pig serum (Kidd, 1953). This discovery attracted broad interest and it was 
found that only guinea pig serum had the anti-lymphoma activity compared with 
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other animals such as horse and rabbit, and it was only effective against certain 
cancer types. In the 1960s, Broome identified that it was the L-asparaginase in 
guinea pig serum which contributed mainly to the anti-lymphoma activity (Broome, 
1961; Broome, 1963). Treatment with L-asparaginase has been shown to improve 
event-free survival for ALL from <10% to >80% in the last few years (Möricke et 
al., 2008; Pui et al., 2009; Silverman et al., 2001). 
Cancer cells, such as lymphatic cells, have high demand on asparagine for their 
survival and proliferation (Kiriyama et al., 1989; Stams et al., 2003). However, 
due to the lack of L-asparagine synthetase required for L-asparagine synthesis, 
leukemic lymphoblasts and some other tumour cells can only obtain this amino 
acid from blood serum. L-asparaginase hydrolyses asparagine from blood serum, 
leading tumours to a state of cell death (apoptosis), while healthy cells are not 
affected because they possess enough L-asparagine synthetase. In addition, 
studies have shown that L-asparaginase inhibits the mTOR pathway and induces 
an autophagic process which contributes to its anti-leukaemic activity and greatly 
affects leukaemia cells (Russell et al., 2014; Song et al., 2015). Unlike 
conventional cancer therapy, L-asparaginase treatment is highly discriminatory. 
L-asparaginases have been found in various sources including mammals, birds, 
plants, bacteria, fungi and archaea but only those from E. coli (EcAII) and Erwinia 
chrysanthemi (ErAII) have been approved for the treatment of ALL. The E. coli 
enzyme shows a higher activity whilst the E. chrysanthemi enzyme has been 
used to treat patients that are allergic to the former (Albertsen et al., 2001). In the 
USA, the most commonly used form of L-asparaginase is a covalent conjugation 
with PEG, or PEGylation, which improves the bioavailability, biostability and 
reduces the immunological response. The elimination half-life of PEG-
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asparaginase (e.g. 6 days) is five times longer than the native EcAII preparations 
and nine times longer than the ErAII ones. This is an important improvement 
since the enzyme shows a peak activity in the fifth day after an intramuscular 
injection (Shrivastava et al., 2016). In Europe, it is currently a second-line 
treatment only for patients who are allergic to native asparaginases. Side effects 
of L-asparaginase therapy such as immune responses, allergies and anaphylactic 
shock (Soares et al., 2002) may be attributed to several reasons including its L-
glutaminase activity which reduces the plasma L-glutamine level (Avramis et al., 
2002; Villa et al., 1986). Thus looking for alternative sources of L-asparaginase 
with less or no side effects is of great importance. 
7.1.1.2 Other applications 
L-asparaginase has been used to develop biosensors for the analysis of 
asparagine levels in leukaemia and in the food industry. In the designed 
experiments, hydrolysis of asparagine by this enzyme produces ammonium ions 
which induce a pH change that further changes the colour and absorption (Kumar 
et al., 2013). This is a reliable, cheap and user-friendly approach compared with 
other conventionally used methods. 
The enzyme is also widely applied in the food industry. Acrylamide, also known 
as 2-propenamide, is a colourless and odourless crystalline solid that has potent 
neurotoxicity. It is largely produced from heat-induced reactions, e.g. frying or 
baking starchy foods over 120 °C, and is formed between the α-amino group of 
asparagine and carbonyl group of reducing sugars such as glucose (Friedman, 
2003). Therefore treatment of these foods with L-asparaginase prior to cooking 
significantly reduces acrylamide formation. 
212 
 
In addition, L-asparaginase is also involved in the biosynthesis of amino acids 
such as lysine, methionine and threonine. 
7.1.2 Mechanism of L-asparaginase hydrolysis 
The mechanism of L-asparaginase hydrolysis has not been fully understood. 
However, the process can be divided into two steps through an intermediate 
known as β-acyl-enzyme (Figure 7.1). Firstly, the activated catalytic residue of L-
asparaginase nucleophilically attacks the amide carbon of the substrate L-
asparagine and produces the β-acyl-enzyme intermediate. This is followed by the 
nucleophilic attack of the ester carbon by a water molecule which produces the 
product and frees up the enzyme (Verma et al., 2007). 
 
Figure 7.1 The mechanism of L-asparaginase hydrolysis. Nucleophilic attacks are indicated 
by the arrows. [Figure from (Guo et al., 2017b) originally generated based on Verma et al. 
(2007)]. 
Besides their activity on L-asparagine, these enzymes from different organisms 
showed different activities on L-glutamine and are put into two classes. One class 
has an activity of 2-10% to the L-asparagine hydrolysis activity, while enzymes in 
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the other class have comparable L-asparaginase and L-glutaminase activities 
(Boyd and Phillips, 1971; Chohan and Rashid, 2013; Davidson et al., 1977). 
7.1.3 The L-asparaginase from Thermococcus kodakarensis 
Bacteria produce two forms of L-asparaginases, a cytoplasmic form (type I) and 
a periplasmic form (type II) which is more active and used in chemotherapy. 
Generally, the enzymes form dimers or tetramers (dimers of dimers) with the 
molecular mass of each subunit being around 35 kDa. Type I and type II L-
asparaginases share low amino acid sequence identities e.g. those from E. coli 
have a sequence identity of only 24%. Although the two enzymes catalyse the 
same reaction, type I has a lower affinity for the substrate, for example, the E. 
coli type I L-asparaginase (EcA) has a KM for asparagine of 3.5 mM whilst the 
type II enzyme has that value in the μM range (Schwartz et al., 1966). The two 
isozymes can be distinguished by their sensitivity to thermal activation and by 
their solubility in ammonium sulphate solution (Yao et al., 2005). 
The thermostable L-asparaginase from Thermococcus kodakarensis, TkA, is a 
type I L-asparaginase that is composed of 328 amino acids with a molecular mass 
of 35.5 kDa (Chohan and Rashid, 2013). The enzyme is active as a homodimer 
in solution with the highest activity observed at pH 9.5 and 85 °C. It showed a KM 
value of 5.5 mM against L-asparagine while no glutaminase activity was observed. 






7.2 Project aim 
The aim of the project was to determine the crystal structure of the thermostable 
L-asparaginase, TkA, as well as to identify the differences between it and the 
homologous enzymes from other organisms, which may improve or expand their 
applications. 
7.3 Methods 
7.3.1 Protein preparation and crystallisation 
Recombinant TkA was expressed and purified according to the method described 
by Chohan & Rashid (2013) and the enzyme was stored in 20 mM Tris-HCl pH 
8.0. Screening for crystallisation conditions was conducted by use of the sitting-
drop method with the same Mosquito robot as mentioned in the previous chapters. 
Three different protein concentrations, 5mg/ml, 10 mg/ml and 16 mg/ml were 
applied to the Morpheus screening kit from Molecular Dimensions (Suffolk, UK) 
and the plates were stored at both 21 °C and 4 °C for crystallisation. Crystals 
started to appear in many conditions after 2 days and the best crystals (Figure 
7.2) were obtained at a protein concentration of 10 mg/ml in the optimised C6 
condition [0.09 M NPS, 0.1 M buffer system 2, pH 6.5-7.0, 28.5% (v/v) EDO_P8K] 
[For details of the condition, see (Gorrec, 2009)] at 21 °C. Selected crystals were 
transferred to a 10 μl drop containing 50% of paratone N MD2-08 and 50% of 
paraffin oil to remove the mother liquor surrounding the crystals before flash-




Figure 7.2 TkA crystals. These crystals were pentahedrons composed of two equilateral 
triangular- and three rectangular-faces. Each side of the equilateral triangle is approximately 
250 microns and the width of the rectangle is approximately 60 microns. 
7.3.2 Data collection, data processing and structure determination 
X-ray data collection was carried out remotely at station I03, DLS at 100 K using 
a Pilatus3 6M detector. Automatic data processing using xia2 (Winter, 2010) 
indicated that all the crystals were triclinic and belonged to the space group P1. 
Since this is an uncommon space group, other possibilities were checked by the 
integration of the raw diffraction images with DIALS (Waterman et al., 2013) and 
scaling with Aimless (Evans and Murshudov, 2013b), which suggested that P1 
should be the best option. The best crystal diffracted to 2.2 Å and the data were 
of good quality, as suggested by Phenix.xtriage (Zwart et al., 2005). Analysis 
using Matthews_coef (Kantardjieff and Rupp, 2003; Matthews, 1968) suggested 




The structure was determined by molecular replacement using the program 
Phaser MR (McCoy et al., 2007) with the structure of the type I L-asparaginase 
from Pyrococcus horikoshii (PhA, PDB ID: 1WLS, 59% sequence identity to TkA) 
(Yao et al., 2005) as the search model. Manual rebuilding and correction were 
accomplished using Coot (Emsley et al., 2010) followed by TLS, local NCS and 
restrained refinement by use of Refmac5 (Murshudov et al., 1997; Murshudov et 
al., 2011). Model validation was performed using MolProbity (Chen et al., 2010). 
All the statistics for data collection, data processing, structure determination and 
refinement are shown in table 7.1. The VADAR (Willard et al., 2003) and ESBRI 
(Costantini et al., 2008) online services were used to analyse hydrogen bonds, 
salt-bridges and other factors related to thermostability of the enzymes. 
Table 7.1 X-ray statistics for the TkA structure. Values in parentheses are for the outer 
resolution shell [Table from (Guo et al., 2017b)]. 
Beamline I03 (DLS) 
Wavelength (Å) 0.9763 
Space group P1 
Unit-cell parameters 
a (Å) 70.7 
b (Å) 71.0 
c (Å) 107.7 
α (°) 72.1 
β (°) 76.2 
γ (°) 87.8 
Resolution (Å) 68.65-2.18 (2.26-2.18) 
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Rmerge (%) 6.3 (121.9) 
Rmeas (%) 7.5 (143.4) 
CC½ (%) 99.8 (58.8) 
Completeness (%) 97.4 (97.2) 
Average I/σ(I) 10.1 (1.3) 
Multiplicity 3.5 (3.6) 
No. of observed reflections 342,457 (35,236) 
No. of unique reflections 98,478 (9,841) 
Wilson plot B-factor (Å2) 50.0 
Solvent content (%) 47.3 
Rfactor (%) 19.8 
Rfree (%) 22.6 
RMSD bond lengths (Å) 0.017 
RMSD bond angles (°) 2.010 
No. of reflections in working set 98,475 
No. of reflections in test set 4,894 
Mean protein B-factor (Å2) 47.7 
 
7.4 Results and discussion 
7.4.1 Quality of the model 
The structure of TkA L-asparaginase was determined by molecular replacement 
and was refined to a resolution of 2.2 Å. Data reprocessing with DIALS suggested 
only two possible Bravais lattice types: mI or aP. The mI lattice had an RMSD 
values of 1.44 and an Rmerge value of 70.3% when the data were integrated into 
the corresponding C2 space group. However, the aP lattice had these two values 
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of 0.14 and 6.3%, respectively, when the data were integrated into the P1 space 
group. Thus the crystal belongs to the P1 space group with 6 monomers in the 
ASU, which gives a solvent content of 47.3%. The electron density of the first four 
chains (A, B, C and D) is of good quality whilst that of chain E is relatively poor. 
Many regions in chain F have very poor electron density. Indeed, the first four 
chains are characterised with B-factors of around 43.6 Å2, while chains E and F 
have higher B-factors of 53.3 and 59.3 Å2, respectively. Data analysis suggested 
that the data were of good quality and no anisotropy or translational NCS was 
spotted. Analysis with Find_ncs from the PHENIX suite (Terwilliger, 2013) 
suggested six NCS related chains (Figure 7.3) and deleting of the bad region in 
chain F increased the R-values by approximately 3%. Density-modification did 
not make any improvement. Analysis with MolProbity indicated that 95.5% of the 





Figure 7.3 The six NCS related monomers of TkA in the ASU. Chain idenfiers 
are shown. 
7.4.2 Overall structure 
The six chains in the ASU of TkA share a very similar structure with RMSD values 
ranging from 0.08 to 0.15 Å for Cα atoms. When considering chain A only, the 
RMSD value between TkA and E. coli type I & type II L-asparaginases are 1.11 
Å and 1.67 Å, respectively. Thus TkA has a similar overall fold to that of the type 
I and II L-asparaginases. 
Each subunit of TkA consists of an N-terminal and a C-terminal α/β domain 
connected by a linker loop formed by residues 185-203 (Figure 7.4). The N-
terminal domain contains an 8-stranded mixed β-sheet (β1, β4-8, β11 and β12) 
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flanked by 4 α-helices (α1-4). It has been shown that the β-hairpin composed of 
strands β2 and β3 is highly flexible and is often characterised by poor or no 
electron density. The β-hairpin is involved in substrate binding and catalysis and 
adopts ‘open’ and ‘closed’ conformations (Nguyen et al., 2016). However, this 
area is characterised with good electron density in all the subunits of TkA. Chain 
B and D show a more ‘open’ conformation compared with EcA (PDB ID: 2P2D) 
(Yun et al., 2007) whilst the other chains adopt a more ‘closed’ conformation, 
leaving that of the E. coli enzyme somewhere between them (Figure 7.5). Of 
greater significance than the fact that these subunits adopt either ‘open’ or ‘closed’ 
conformations in TkA is that the α1-helix has moved to a great extent toward the 
active site in all the subunits. The α4-helix has also moved slightly toward the 
active site. Thus it is very likely that these two helical segments also participate 
in substrate recognition in addition to the flexible β-hairpin. Leaving the main 
sheet between the two domains is another β-hairpin formed by β9 and β10, which 
may participate in subunit adhesion. The same as other type I L-asparaginases, 
TkA is active as a homodimer and the active site (indicated by the red star), which 
is located in the pocket around the two catalytically important residues Thr11 and 













































































































































































































































































































































































































































































































































































































The relatively smaller C-terminal domain is formed mainly by a 3-stranded parallel 
β-sheet (β13-15) and 5 α-helices (α5-9). There is also a putative allosteric site 
which is located between the β15-strand and the α8-helix (indicated by the green 
asterisk in Figure 7.4) and is involved in asparagine binding (Yun et al., 2007) 
which activates a cooperative conformational switch from an inactive to an active 
form. 
The sequence alignment of TkA with several homologues is shown in Figure 7.6. 
TkA shares a 58.3% and 60.6% sequence identity over all residues with the 
L-asparaginase from Pyrococcus furiosus (PfA) and the L-asparaginase I 
homologue protein from Pyrococcus horikoshii (PhA), respectively. It only has 
sequence identities below 30% with EcA, EcAII and ErAII. However, there are 
many highly conserved regions in all of these proteins including the active site, 




Figure 7.6 Sequence alignment and the secondary structure characteristics of TkA with other 
homologues. Alpha-helices and β-strands are labelled according to the TkA structure. All the 
conserved residues are boxed and the fully conserved residues coloured as white with a red 
background, while the not fully conserved residues are coloured as red. Alignment was 
performed using ESPript 3.0 website (Gouet et al., 2003; Robert and Gouet, 2014) [Figure 
from (Guo et al., 2017b)]. 
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7.4.3 Active site 
As mentioned before, TkA is active as a homodimer (Figure 7.7a) and many 
residues from two neighbouring subunits are involved in substrate recognition as 
well as catalysis. Structural comparison identified that these residues in TkA 
include Thr11, Tyr21, Ser54, Thr55, Thr85, Asp86 and Lys156 from one subunit 
as well as Tyr233’ and Glu275’ from the neighbouring subunit, most of which are 
conserved in L-asparaginases (Figure 7.7b). One of the two key residues 
participating in catalysis, Thr11, resides in the β-hairpin whose flexibility is 
considered to be deeply involved in the activity of the enzyme. The other key 
residue, Thr85, is located in the loop between the α3-helix and β5-strand and 
mediates sequential ‘ping-pong’ nucleophilic attacks together with Thr11 during 
amidohydrolysis (Harms et al., 1991). Since some unexpected electron density 
was identified in the active site of each monomer, many molecules have been 
fitted in an effort to identify what it is including the substrate asparagine and the 
product aspartic acid. However, this was finally interpreted and successfully 
refined as a phosphate ion which was one of the components in the crystallisation 
buffer and has been reported in other asparaginase structures (Tomar et al., 2014; 
Wehner et al., 1992). The phosphate ion occupies the binding site for the 
substrate and forms many interactions with the side chains of the neighbouring 
residues including Thr11 and Thr85. Tomar et al. also suggested that binding of 
a ligand (asparagine, citrate or phosphate) stabilises the flexible β-hairpin which 
acts as a gatekeeper and prevents further substrate entry. However, in the 
publication reported by Yun et al. (2007), this hairpin is still not visible in the Asp- 
or Asn-bound structures. In addition, the B and D chains in the TkA enzyme adopt 
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a more ‘open’ conformation than that of the ligand-free E. coli type I L-
asparaginase (PDB ID: 2P2D). 
 
Figure 7.7 Dimer assembly and the active site of TkA. a) The dimer assembly formed 
between chain A (yellow) and B (green). b) The active site formed by residues from both 
chain A (yellow) and B (green). The two key threonine residues involved in catalysis are 
coloured as cyan and other residues participate in substrate recognition are coloured as 
orange. A phosphate (purple) ion has been identified to bind tightly in the active site in each 
subunit, with the hydrogen bonds showing in dashed lines [Figure from (Guo et al., 2017b)]. 
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Yun et al. (2007) indicated that L-asparaginases which have high L-glutaminase 
activity possess smaller residues at the equivalent position of residue Gly237’ in 
TkA. They predicted that those having a glycine at this position should have 
substantial glutaminase activity. However, whilst TkA does possess a glycine at 
this position, no glutaminase activity has been observed. 
7.4.4 Thermostability 
As mentioned in section 5.3.4.5, many factors may contribute to the 
thermostability of thermophilic proteins including increased hydrophobicity, more 
hydrogen bonds and salt bridges, increased helical contents, low occurrence of 
thermolabile residues such as Cys and Ser, high occurrence of Arg, Tyr and Pro, 
amino acid substitutions within and outside the secondary structures, better 
packing, smaller and less numerous cavities, deletion or shortening of loops, 
increased surface area buried upon oligomerization and increased polar surface 
area. The comparison of some of these factors for several thermophilic and 
mesophilic L-asparaginases is shown in table 7.2 and those which may contribute 
to the thermostability are coloured as blue. The dimeric structure was used in the 
calculation. The factors that may contribute to the thermostability of the 
investigated thermophilic L-asparaginases include the increased content of salt 
bridges and Arg and the decreased content of Cys and Ser. The salt bridge 
content seems to be the most consistent and significant factor that can be 
attributed to the great thermostability of all the investigated thermophilic enzymes 
in this thesis including the DNA polymerases, the pullulan hydrolysing enzymes 




Table 7.2 Thermostability-related factors for several thermophilic and mesophilic L-
asparaginases [Table from (Guo et al., 2017b)]. 
 
Thermophilic Mesophilic 
Enzyme* TkA 1WLS 4Q0M 2P2D 3NTX 2OCD 
Salt bridges (%) 20.0 17.5 19.0 13.9 9.2 9.9 
H-bonds (%) 73 72 73 71 73 73 
Helix content (%) 29 30 28 29 29 28 
Pro content (%) 5.5 4.0 4.0 6.5 5.3 6.2 
Arg content (%) 7.0 4.6 4.6 4.4 4.1 3.0 
Tyr content (%) 3.0 3.7 3.4 4.1 3.3 3.9 
Cys content (%) 0 0 0.6 0.3 0.3 0.6 
Ser content (%) 4.3 6.7 4.9 4.7 7.4 5.9 
* All the enzymes are represented by their PDB ID (except for TkA) as follow: 1WLS, the 
L-asparaginase I from Pyrococcus horikoshii; 4Q0M, the L-asparaginase I from Pyrococcus 
furiosus; 2P2D, the L-asparaginase I from E. coli; 3NTX, the L-asparaginase from Yersinia 
pestis; 2OCD, the L-asparaginase I from Vibrio cholerae. 
7.5 Summary 
The crystal structure of TkA has been determined at 2.2 Å in the P1 space group 
with 6 monomers in the ASU forming three dimeric pairs. Each subunit of TkA 
consists of an N-terminal and a C-terminal α/β domain connected by a linker loop. 
TkA is active as a homodimer and many residues from the neighbouring 
molecules in a dimer are involved in substrate recognition as well as catalysis. 
The N-terminal domain contains a highly flexible β-hairpin which adopts ‘open’ 
and ‘closed’ conformations. The β-hairpin is observed to adopt different 
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conformations in different subunits of the TkA structure. It was usually only 
observed in L-asparaginase structures that adopt a ‘closed’ conformation whilst it 
is characterised with good electron density in all the subunits in TkA structure. 
One phosphate ion has been built in the active site. The great thermostability of 
TkA may be attributed to the higher Arg content, lower numbers of Cys and Ser, 




















8. Chapter 8 
Expression, purification and crystallisation 
of the juvenile hormone diol kinase from the 











Juvenile hormones (JHs) are a family of insect acyclic sesquiterpenoids which 
have multiple roles in regulation of many aspects of insect physiology including 
metamorphosis, sexual maturation, development and reproduction (Riddiford et 
al., 2003; Wyatt and Davey, 1996). For example, these compounds maintain 
growth of the larva and are also involved in the production of eggs in female 
insects. JHs are produced in the corpora allata, a pair of endocrine glands behind 
the brain, released into the haemolymph and are transported to various tissues. 
JH titres are precisely regulated by biosynthesis and degradation at different 
developmental stages. There are at least three enzymes participating in the JH 
degradation pathways known as JH esterase (JHE) (Hammock and Sparks, 
1977), JH epoxide hydrolase (JHEH) (Share and Roe, 1988) and JH diol kinase 
(JHDK) (Maxwell et al., 2002a). JHE is involved in the first pathway in which the 
methyl ester moiety of JH (Figure 8.1a) is hydrolysed to produce JH acid (JHa, 
Figure 8.1b). JHEH takes part in the second pathway where the epoxide moiety 
of JH is hydrolysed to form JH diol (JHd, Figure 8.1c). JHDK converts JHd to JH 
diol phosphate (JHdp, Figure 8.1d) which is the principal end product of JH 




Figure 8.1 Structure of JHs and JH metabolites. 
To date only three JHDKs have been reported including those from Manduca 
sexta (Manse-JHDK) (Maxwell et al., 2002a; Maxwell et al., 2002b), Bombyx mori 
(Bommo-JHDK) (Li et al., 2005) and Spodoptera litura (SlJHDK) (Zeng et al., 
2015). Bommo-JHDK has a 54% sequence identity with both Manse-JHDK and 
SIJHDK. It is also considered to be homologous to Drosophila melanogaster 
sarcoplasmic calcium-binding protein-2 (dSCP2) and shares a 46.4% sequence 
identity with dSCP2 (Maxwell et al., 2002b). Proteins in this family usually contain 
EF-hands that bind calcium ions (Nakayama and Kretsinger, 1994) and Li et al. 
(2005) suggested that JHDKs belong to a novel class of kinases with high 
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architectural similarity to calcium-binding proteins. Bommo-JHDK shares 36% 
sequence identity with the calexcitin from Doryteuthis pealeii which is a calcium 
binding protein composed of 4 EF-hands (PDB ID: 2CCM). The sequence 
alignment for Bommo-JHDK with several homologous proteins is shown in Figure 
8.2. 
 
Figure 8.2 Sequence alignment and secondary structure characteristics of Bommo-JHDK 
with other homologues. All the conserved residues are boxed and the fully conserved 
residues coloured in white with a red background, while the not fully conserved residues are 
coloured in red. Alignment was performed using ESPript 3.0 website (Gouet et al., 2003; 
Robert and Gouet, 2014). 
JHDKs are active as homodimers with a molecular mass of 20-21 kDa for each 
subunit. They are characterised by pH optima of 8.0-8.5 and an optimal 
temperature of around 22 °C. These enzymes require magnesium ions for 
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catalysis and are very prone to metal poisoning. Calcium ions inhibit JHDK 
activity at micromolar levels. They have a preference for ATP to convert JH to 
JHdp, but can also catalyse the reaction using GTP as the phosphate donor. Due 
to their role in degradation of JH in insects, JHDKs may be a good drug target for 
development of pesticides. 
8.2 Project aim 
The aim of the project was to determine the crystal structure of Bommo-JHDK, 
and to identify the structural characteristics of this ‘novel’ class of kinases. 
8.3 Methods 
8.3.1 Plasmid re-construction 
The Bommo-JHDK gene was a gift from Sheng Li, Chinese Academy of Sciences 
and Weihua Xu, University of Science and Technology of China. The gene was 
previously inserted into a pET-11a plasmid (Novagen, Millipore, Hertfordshire, 
UK) by a former group member, which did not allow a highly purified protein to be 
produced due to the lack of an affinity tag. Attempts to crystallise the crude protein 
failed to produce any crystal. 
The pET-11a plasmid containing the JHDK gene was amplified in DH5α cells 
(Invitrogen, Thermo Fisher Scientific, Dartford, UK), purified by a GeneJET 
Plasmid Miniprep Kit (Thermo Fisher Scientific, Dartford, UK) and concentrated 
to 200 ng/μl followed by a double-digest with BamHI and NdeI restriction enzymes 
at 37 °C for 3 h to extract the Bommo-JHDK gene. The gene was separated from 
the digested and non-digested plasmid by electrophoresis on an agarose gel and 
was then extracted from the gel by electrophoresis again followed by a 
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purification using ethanol precipitation. It was then ligated on a pET-16b plasmid 
(pre-digested by BamHI and NdeI) (Novagen, Darmstadt, Germany), which has 
an N-terminal 10×His-tag, using a T4 DNA ligase following the protocol described 
in the manual (Thermo Fisher Scientific, Dartford, UK). The JHDK-pET-16b 
complex was amplified, purified and the presence of the JHDK gene was 
confirmed by gene sequencing. 
8.3.2 Protein expression and purification 
DNA transformation was undertaken according to Method i of the appendices, 
protein expression was performed following Method ii of the appendices using 
the standard method without heat shock. Protein purification was achieved firstly 
by using a HisTrap HP column (GE Healthcare, Buckinghamshire, UK) (binding 
buffer: 20 mM imidazole, 50 mM NaH2PO4, 300 mM NaCl, pH 8.0, elution buffer: 
500 mM imidazole in binding buffer), followed by a Superdex 75 (GE Healthcare, 
Buckinghamshire, UK) gel-filtration column (buffer: 50 mM Tris, 100 mM NaCl, 
pH 7.5). 
8.3.3 Crystallisation 
Screening for crystallisation conditions was accomplished using the sitting-drop 
method at 21 °C with the same screening kits as mentioned in section 3.2.1. The 
same Mosquito crystal screening robot was used to dispense 400 nl of each 
protein, at 10 mg/ml and 20 mg/ml, plus 400 nl of the corresponding well solution 
into each drop. Only one crystal was obtained in the JCSG-plus H3 condition (0.1 
M Bis-Tris pH 5.5, 25% PEG 3,350) after a few months. Further optimisation 
using 24 well hanging drop plates with 2 μl drop size showed that crystals with 
better diffraction quality (Figure 8.3) could be obtained reproducibly in exactly the 
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same condition, however, it took approximately 5 months for the protein to 
crystallise. Efforts were made in order to identify conditions that require a much 
shorter time for crystallisation, such as different crystallisation temperatures and 
additives as well as methods like proteolysis (Keegan et al., 2014) and lysine 
methylation to reduce surface entropy (Sledz et al., 2010) were tried, but no 
crystal-like object was obtained. 
 
Figure 8.3 A crystal of Bommo-JHDK. One small unit on the ruler is 10 microns. 
8.3.4 Making a heavy metal derivative 
Since attempts to determine the crystal structure by molecular replacement failed 
to give any correct solution, a heavy metal derivative was made by soaking the 
selected crystals overnight in a drop of the corresponding well solution containing 
10 mM Na2PtCl4. These crystals were then transferred into a drop of the well 
solution but no Na2PtCl4 to ‘soak out’ any unbound heavy metal ions. All the 
crystals including the native and the derivative ones were cryo-protected with 




8.3.5 Data collection, data processing and attempts to determine the 
structure 
Data collections for both the native and the derivative crystals were performed at 
station I03, DLS. As guided by a fluorescence scan (Figure 8.4), three MAD 
datasets were collected for each derivative crystal at different wavelengths known 
as the peak (pk), the inflection (if) and the high remote (hrm) points. Automatic 
data processing using xia2 (Winter, 2010) indicated that both crystals were 
monoclinic and belonged to the space group P21, which was confirmed by 
Aimless (Evans and Murshudov, 2013b). The native and the derivative crystals 
diffracted to 2.0 Å and 3.9 Å, respectively. All the statistics for data collection and 
data processing are shown in table 8.1. Analysis using Matthews_coef 
(Kantardjieff and Rupp, 2003) suggested 4, 5 and 6 molecules per ASU with a 
solvent content of 61.4%, 51.8% and 42.1%. 
 
Figure 8.4 Fluorescence spectrum of a JHDK-Pt derivative crystal. 
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Table 8.1 Data collection and data processing statistics for the native and derivative Bommo-
JHDK crystals. Values in parentheses are for the high resolution shell. 
 Native Derivative 
 
 pk if hrm 
Beamline I03 
Wavelength (Å) 0.9763 1.0721 1.0723 1.0633 
Space group P21 
Unit-cell 
parameters 
    
a (Å) 65.6 66.4 66.3 66.4 
b (Å) 79.4 76.8 76.6 76.8 
c (Å) 100.9 105.8 105.5 105.8 
α (°) 90.0 90.0 90.0 90.0 
β (°) 91.6 91.3 91.3 91.3 










Rmerge (%) 10.7 (153.0) 10.6 (50.3) 10.0 (51.5) 9.0 (77.3) 
Rmeas (%) 11.6 (165.4) 12.9 (60.5) 12.2 (63.4) 11.0 (93.2) 
CC½ (%) 99.9 (62.0) 98.4 (70.8) 98.5 (68.4) 98.7 (65.7) 
Completeness (%) 100.0 (100.0) 98.0 (97.4) 98.0 (94.8) 92.0 (16.1) 
Anomalous 
completeness (%) 
 87.1 (4.3) 86.9 (4.2) 81.2 (8.0) 
Average I/σ(I) 10.8 (1.2) 5.7 (2.3) 6.0 (2.0) 6.3 (1.2) 





 1.6 (1.6) 1.6 (1.5) 1.6 (1.7) 
Anomalous 
correlation 




482,495 25,382 28,541 31,210 
No. of 
unique reflections 
71,164 8,478 9,556 10,490 
Wilson plot 
B-factor (Å2) 
32.4 105.0 109.6 106.5 
 
Structure determination using computer programs and online services based on 
molecular replacement did not give any correct solution including the programs 
Phaser MR (McCoy et al., 2007), Molrep (Vagin and Teplyakov, 2010) and the 
online services MrBUMP (Keegan and Winn, 2008) and BALBES (Long et al., 
2008). Attempts on different search models and different parts of the search 
models also failed. Molecular replacement with all the structures in the whole 
PDB database was carried out using the website SIMBAD (Keegan et al., 2016), 
which did not give any correct result, either. Experimental phasing was carried 
out using the SHELX (Sheldrick, 2010) and CRANK2 (Skubák and Pannu, 2013b) 
web services, unfortunately, MAD phasing was not successful which was likely 





8.4 Results and discussion 
8.4.1 Plasmid re-construction, protein expression and purification 
The original Bommo-JHDK gene in a pET-11a plasmid did allow for successful 
protein expression, however, due to the lack of an affinity tag, attempts to purify 
the protein with ammonium sulphate precipitation and ion exchange gave a 
mixture of JHDK with a few contaminants including a nucleic acid. Screening for 
crystallisation conditions with the mixture did not produce any crystals. The 
JHDK-pET-11a construct was amplified and was incubated with BamHI and NdeI 
to extract the JHDK gene. Figure 8.5 shows the result of the double-digest, the 
bands for the insert at the bottom clearly indicate that the extraction was 
successful (pET-11a is 5677 bp and the JHDK gene is 558 bp). Since it was a 
double-digest and the NdeI restriction enzyme was already expired for some time, 
the efficiency of the digest was very low. The insert was then extracted from the 
gel by electrophoresis and purified by ethanol precipitation, which was followed 
by the ligation of the gene into a pET-16b plasmid. The successful ligation was 
confirmed by gene sequencing. 
Bommo-JHDK was expressed in BL21 (DE3) cells and was purified by a Ni-
column followed by a Superdex75 gel-filtration column, as indicated by the bands 
at around 25 kDa in Figure 8.6 which stand for the protein plus a few extra 
residues at the N-terminal including the 10×His-tag. Approximately 10 mg of 




Figure 8.5 Gel electrophoresis result for the JHDK-pET-11a double-digest. 
 
Figure 8.6 SDS-PAGE for Bommo-JHDK expression and purification. M, NI, I, S, P, F and E 
indicate the marker, non-induced, induced, supernatant, pellet, flow-through and eluted 
samples, respectively. 
8.4.2 Crystallisation 
As described in section 8.3.3, Bommo-JHDK crystals can be obtained 
reproducibly in 0.1 M Bis-Tris pH 5.5, 25% (w/v) PEG 3,350, however, it takes 
approximately 5 months to grow these crystals to a suitable size for diffraction. 
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Running an SDS-PAGE with the dissolved crystals showed a band with a 
molecular mass of around 22 kDa which is about 2-3 kDa smaller than the sample 
after purification. Thus the protein might suffer some proteolysis during long time 
crystallisation process in which some of the N-terminal residues were cleaved off 
which was essential for the crystallisation. The same phenomenon was observed 
in a homologous protein, calexicitin, which was expressed with a pET-16b 
plasmid as well (Beaven et al., 2005; Erskine et al., 2015). 
Due to the long time required for crystallisation, many efforts were made in order 
to get crystals in a shorter time. Successful methylation for lysine residues, 
chymotrypsin and trypsin proteolysis are indicated by lanes MT, C and T in Figure 
8.7. For those treated with chymotrypsin and trypsin, different fragments were 
separated by gel-filtration and were subjected to crystal screen separately. 
Different metal ions were also added during crystallisation. However, no crystal 
was obtained. 
 
Figure 8.7 Lysine methylation and proteolysis of Bommo-JHDK by chymotrypsin and trypsin. 
The marker, native, methylated, chymotrypsinolysed and trypsinolysed samples are 
indicated by M, N, MT, C and T, respectively. 
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8.4.3 Attempts to determine the structure 
Molecular replacement did not give any correct solution. Possible reasons could 
be 1) the protein may have a completely different structure from that of the 
‘homologues’ identified by sequence comparison, ignoring that the closest 
structure (calexcitin, PDB ID: 2CCM) has only 36% sequence identity; 2) the 
protein may have many local/domain movements which frustrate the programs. 
The auto-processed anomalous data are of poor quality which is indicated by 
statistics such as the low anomalous completeness and the negative anomalous 
correlation. As shown in Figure 8.8, the anomalous signal for the data collected 
at the ‘if’ and ‘hrm’ points is only significant at resolution lower than 10 Å, whilst 
that of the pk data is not significant at all. The data collected at the ‘pk’ point 
suffered some radiation damage due to a not appropriate data collection strategy 
in which they were collected after those collected at the ‘if’ and ‘hrm’ points, 
perhaps a more gentle strategy needs to be used next time. Data reprocessing 
can improve the anomalous completeness to over 86% for both the inner and 
outer shells at 7 Å. However, the anomalous correlation is still lower than 0.25 for 
the inner shell and negative for the outer shell. MAD phasing and auto building 
using the auto-processed and reprocessed data failed to give a correction 




Figure 8.8 Anomalous signal analysis against resolution. 
8.5 Future work 
1. Better data collection strategies can be carried out in future in order to collect 
as much data as possible with a minimum radiation damage. 
2. It is worth making a selenomethionine derivative protein in which the possible 
heavy atom sites are already known. 
3. With the development of technologies, other phasing methods such as phasing 
with calcium or sulphur atoms become more feasible and may help to determine 
the Bommo-JHDK structure. The recently available long-wavelength MX 
beamline I23 at DLS is designed for solving crystallographic phase problem using 




















X-ray crystallography is one of the dominant methods in studying protein 
structures which are essential in understanding their functions. Seven different 
proteins have been studied by X-ray crystallography combined with other 
methods and the information obtained can be used as guidance for applications 
in many areas such as drug discovery and biological industry. 
The outbreaks of human epidemic nonbacterial gastroenteritis are mainly caused 
by noroviruses. The ligand-free crystal structure of SV3CP has been determined 
to 1.30 Å and a system for growing high-quality crystals has been established. 
The non-covalent compounds that have been identified by the in-crystallo 
screening with SV3CP give useful information for engineering novel compounds 
as therapeutic agents. Screening with covalent fragments is on-going. 
The enzyme PBGD is one of the key enzymes in tetrapyrrole biosynthesis. It 
catalyses the formation of a linear tetrapyrrole from four molecules of the 
substrate PBG. Three mutations have been made affecting Asp82 in BPBGD 
which are D82A, D82E and D82N and their crystal structures have been 
determined at resolutions of 2.7, 1.8 and 1.9 Å, respectively. These structures 
reveal that whilst the D82E mutant possesses the DPM cofactor, in the D82N and 
D82A mutants, the cofactor is likely to be missing or disordered. Comparison of 
the mutant BPBGD structures with that of the WT enzyme shows that there are 
significant domain movements and suggests that the enzyme adopts “open” and 
“closed” conformations, potentially in response to substrate binding. 
PDI is a glycoprotein which inhibits both the aspartic protease cathepsin D and 
the serine protease trypsin. The first crystal structure of PDI has been determined 
to a resolution of 2.1 Å, revealing that PDI adopts a typical β-trefoil fold with a 
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core and several protruding inhibitory loops, which is typical of the Kunitz-family 
protease inhibitors. The NAG moiety was confirmed by clear electron density. 
Possible reactive-site loops for cathepsin D and trypsin have been studied which 
indicate that PDI is an unusual bi-functional inhibitor. 
Investigations of the other three thermostable enzymes gave insight into their 
catalytic mechanism and factors contributing to the high thermostability. Pc-
polymerase is a family B DNA polymerase from Pyrobaculum calidifontis. The 
crystal structure of Pc-polymerase has been refined to a resolution of 2.8 Å and 
several unique features have been identified which may account for its high 
processivity. A complex model with the primer-template duplex of DNA suggests 
the large movement of the thumb domain upon DNA binding. The high 
thermostability may be attributed to the large number of salt bridges. 
TK-PUL is in the class of pullulan-hydrolysing enzymes that have been widely 
used in starch saccharification industries. The crystal structure of TK-PUL, which 
would be the first structure of a type III pullulan hydrolyse, has been determined 
which revealed that the structure of the last part of the N-terminal and the C-
terminal domains are different from the homologous structures and the loop 
regions at the active site end of the catalytic domain are quite different. The 
complex structure suggested that n-Dodecyl α-D-maltoside may be a substrate 
for TK-PUL, however, no further information can be obtained due to the low 
resolution. The calcium binding site and the rare vicinal disulphide bridge have 
also been studied. The thermostability of TK-PUL and a few homologs may be 
attribute to several factors including the increased content of salt bridges, helical 
segments, Pro, Arg and Tyr and the decreased content of Ser. 
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TkA catalyzes the hydrolysis of asparagine to aspartic acid and ammonia. The 
crystal structure of TkA has been determined at 2.2 Å. Many residues from the 
neighboring molecules in a dimer are involved in substrate recognition as well as 
catalysis. The N-terminal domain contains a highly flexible β-hairpin which adopts 
‘open’ and ‘closed’ conformations. The β-hairpin are observed to adopt different 
conformations in different subunits of TkA structure. The β-hairpin was usually 
only observed in L-asparaginase structures that adopt a ‘closed’ conformation 
whilst it is characterised with good electron density in all the subunits in TkA 
structure. One phosphate ion has been built in the active site formed by the 
neighbouring subunits. The great thermostability of TkA may be attributed to the 
higher Arg content, lower numbers of Cys and Ser, but mainly to the increased 
content of salt bridges. 
Juvenile hormone diol kinases (JHDKs) are a class of enzymes which are 
involved in the JH degradation pathway. Proteins in this family usually contain 
GTP-binding motifs and EF-hands that bind calcium ions. The expression, 
purification and crystallisation systems for Bommo-JHDK have been established, 
however, more efforts are required to determine the crystal structure. 
The phasing method molecular replacement was predominantly involved in the 
determination of the structures summarized above. Since the introduction of the 
original concept of molecular replacement in the early 1960s (Huber, 1965; 
Rossmann and Blow, 1962), it has developed impressively, partly due to the 
dramatic evolution of computer hardware and software, which has resulted in a 
faster, more flexible and in many cases fully automated methodology. In addition 
to the relatively fast programs Molrep and Phaser MR, pipelines such as MrBUMP 
and BALBES are available which automate the process of structure solution 
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including model selection, preparation, molecular replacement, refinement, etc. 
Mr_Rosetta (DiMaio et al., 2011) takes advantage of the structure-modelling field 
and combines that with crystallographic molecular replacement, model-building, 
density modification and refinement. ARCIMBOLDO (Rodriguez et al., 2009) and 
AMPLE (Bibby et al., 2012) attempt ab initio modelling by performing molecular 
replacement solution with small fragments and then build up full structures from 
these fragments. SIMBAD carries out sequence independent molecular 
replacement based on the available database and is good to identify contaminant 
proteins or to help find homologous structures in difficult cases. 
The structure determination (or attempts) of the proteins involved in the projects 
were mainly based on molecular replacement but each was slightly different. In 
the most straightforward cases where there was high sequence identity between 
the search model and the target structure (e.g. BPBGD mutants, PDI and TkA), 
the structure was determined by simply running Phaser MR or Molrep. For the 
SV3CP structure, previous attempts (by many) to determine the structure in the 
P61 space group (2.8 Å) by molecular replacement using the 2IPH structure 
(protein-inhibitor complex) as the search model failed to give a correct solution, 
which might be due to a combination of packing conflicts and structural difference 
(e.g. the moved β-hairpin and the loop which adopts different conformations in 
different chains). Truncating the last 8 residues (which are not observed in the 
inhibitor-free structure) did give a correct solution in Phaser MR and clashes 
between these residues from neighbouring molecules were observed in the C2 
and P61 structures by superposing them with the 2IPH structure separately. 
Attempts to determine the structure of Pc-polymerase by Phaser MR and Molrep 
did not give a correct solution due to the large domain movements in the target 
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structure compared with the search model. The problem was solved by using the 
BALBES online service which searched for the domains separately with models 
generated from different DNA polymerases. The structure determination of the 
last 500 or so residues for TK-PUL was performed by using the MrBUMP web 
service. The N-terminal residues 185-280 were identified by a combination of the 
phase information from the partial structure with the use of Molrep (SAPTF + local 
phased RF + phased TF) to position a search model generated from a remote 
homolog identified by HHpred. Attempts to determine the JHDK structure by both 
molecular replacement and MAD have not yet succeeded. In addition to the 
programs and online services such as Phaser MR, MrBUMP and BALBES, 
SIMBAD has been used but this did not give any plausible solutions. Efforts to 
determine the structure by ARCIMBOLDO were hampered due to the lack of a 
grid or supercomputer. While other molecular replacement services, such as 
Mr_Rosetta, AMPLE and experimental phasing methods are worth trying as 
future work. The structure determination and challenges encountered are 
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i DNA transformation 
Plasmid DNA (50 ng) is added to 20-50 μl of competent cells. The cells are then 
stored on ice for 30 min followed by a heat shock at 42 °C for 30 s in a water bath 
before placing back on ice for another 5 min. 200 μl of Luria Broth (LB, Sigma-
Aldrich, Dorset, UK) is then added to each 20 μl cells and the cells are grown at 
37 °C, 300 rpm for 1 h in a ThermoMixer (Eppendorf, Stevenage, UK). The culture 
is then spread on an LB-agar plate containing appropriate antibiotics. The agar 
plate is incubated at 37 °C overnight. 
ii Expression 
Expression is undertaken in 2 L flasks containing 500 ml LB and appropriate 
antibiotics. A 500 μl culture from a 10 ml overnight starter culture is inoculated 
into each flask and grown at 37 °C, 150 rpm to mid-log stage with an OD600 of 0.4 
to 0.6 in an Innova 43 shaking incubator (New Brunswick Scientific, New Jersey, 
US). For a heat shock method, the culture is then grown at 42 °C for 25 min 
followed by cooling for 5 min in ice water. The cells are induced by 0.5 mM or 1 
mM IPTG and the bacterial growth is continued for 40 h at 16 °C, 150 rpm. For a 
standard method, the cells are induced by 0.5 mM or 1 mM IPTG followed by 
shaking at 37 °C, 150 rpm overnight. The culture is centrifuged at 14,000 g, 4 °C 
for 20 min with a Beckman Coulter Avanti J-26 XP ultracentrifuge (Beckman 
Coulter, Buckinghamshire, UK) and the cell-pellet obtained is then re-suspended 
and sonicated in a buffer containing 50 mM Tris, 100 mM NaCl, pH 7.3 using a 
Soniprep 150 sonicator (MSE, London, UK) to lyse the cells. The lysate is then 
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centrifuged at 55,000 g, 4 °C for 40 min and the supernatant is stored on ice 
before purification. The expression is checked by SDS-PAGE using the non-
induced culture as a control. 
iii Nickel affinity chromatography 
Each supernatant solution which has been confirmed to contain the desired 
protein by SDS-PAGE is passed through a 1 ml His-trap FF nickel affinity column 
(GE Healthcare, Buckinghamshire, UK) to purify the His-tagged protein. The 
purification is achieved using the following buffers: 
Binding buffer: 50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 8.0 
Wash buffer: 50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 8.0 
Elution buffer: 50 mM NaH2PO4, 300 mM NaCl, 500 mM imidazole, pH 8.0 
For a manual run, buffers and supernatant are loaded on the column through a 
0.45 μm filter using a 10 ml syringe with a flow rate of approximately 1 ml/min. 
The column is equilibrated with 10 ml of the binding buffer followed by sequential 
introduction of the supernatant and 10 ml of the wash buffer to bind the His-
tagged protein and to remove the non-specifically bound substances. Finally, 5 
ml of the elution buffer is used to elute the desired protein from the column. For 
an automatic run, pre-filtered degassed buffers and supernatant are loaded by 
using an ÄKTA Start FPLC system (GE Healthcare, Buckinghamshire, UK) and 
the process is monitored by UV absorbance at 280 nm. All the flow-throughs are 
collected for SDS-PAGE analysis. The protein concentration in the eluted sample 
is determined using a Nanodrop spectrophotometer (Labtech International Ltd., 
East Sussex, UK) at 280 nm with the calibration of the extinction coefficient. The 
His-tag is removed by the addition of an appropriate protease, e.g. thrombin 
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(Merck, Darmstadt, Germany) followed by overnight dialysis in a GeBaflex-tube 
dialysis kit (Gene Bio-Application Ltd., Slough, UK) in 50 mM Tris, 100 mM NaCl 
pH 7.3 at room temperature/4 °C to remove the cleaved tag and imidazole. 
iv HiTrap Benzamidine affinity chromatography 
Thrombin is removed by passing the protein solution through a 1 ml HiTrap 
Benzamidine FF column (GE Healthcare, Buckinghamshire, UK). The purification 
is carried out using the following buffers: 
Binding buffer: 20 mM Na3PO4, 150 mM NaCl, pH 7.5 
High salt wash buffer: 20 mM Na3PO4, 1.0 M NaCl, pH 7.5 
Benzamidine elution buffer: 20 mM p-aminobenzamidine in binding buffer 
Buffers and the protein sample are loaded on the column through a 0.45 μm filter 
using a 10 ml syringe with a flow rate of approximately 1 ml/min. The column is 
equilibrated with 10 ml of the binding buffer followed by sequential introduction of 
the protein sample and 10 ml of the binding buffer to bind the thrombin and to 
remove the non-specifically bound substances. 5 ml of the high salt wash buffer 
is applied to elute the protein from the column because it forms ionic interaction 
with the column. Finally, 5 ml of the elution buffer is used to elute the thrombin 
from the column. All the flow-throughs are collected for SDS-PAGE analysis. 
v Gel-filtration chromatography 
The eluted sample is concentrated in a 20 ml, Vivaspin centrifugal concentrator 
(GE Healthcare, Buckinghamshire, UK) by use of an Allegra X-12R centrifuge 
(Beckman Coulter, California, USA) at 3250 g and 4 °C. The column (e.g. 
Superdex 75) is equilibrated firstly with 3 bed-volume of degassed appropriate 
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buffer with a flow rate of 1 ml/min. The sample is then loaded onto the column 
followed by running with the same buffer and flow rate. The separation of the 

























Figure B1Comparison of amino acid sequences translated from DNA sequencing result 
between the WT and mutant BPBGDs. The mutated amino acids are indicated by the arrows. 
